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Abstract
In biosystems, chemical and physical fields established by gradients guide cell migra-
tion, which is a fundamental phenomenon underlying physiological and pathophys-
iological processes such as development, morphogenesis, wound healing, and cancer
metastasis. Cells in the supportive tissue of the brain, glia, are electrically stimu-
lated by the local field potentials from neuronal activities. How the electric field may
influence glial cells is yet fully understood. Furthermore, the cancer of glia, glioma,
is not only the most common type of brain cancer, but the high-grade form of it
(glioblastoma) is particularly aggressive with cells migrating into the surrounding tis-
sues (infiltration) and contribute to poor prognosis. In this thesis, I investigate how
electric fields in the microenvironment can affect the migration of glioblastoma cells
using a versatile microsystem I have developed. I employ a hybrid microfluidic design
to combine poly(methylmethacrylate) (PMMA) and poly(dimethylsiloxane) (PDMS),
two of the most common materials for microfluidic fabrication. The advantages of the
two materials can be complemented while disadvantages can be mitigated. The hybrid
microfluidics have advantages such as versatile 3D layouts in PMMA, high dimensional
accuracy in PDMS, and rapid prototype turnaround by facile bonding between PMMA
and PDMS using a dual-energy double sided tape. To accurately analyze label-free cell
migration, a machine learning software, Usiigaci, is developed to automatically seg-
ment, track, and analyze single cell movement and morphological changes under phase
contrast microscopy. The hybrid microfluidic chip is then used to study the migration
of glioblastoma cell models, T98G and U-251MG, in electric field (electrotaxis). The
influence of extracellular matrix and chemical ligands on glioblastoma electrotaxis are
investigated. I further test if voltage-gated calcium channels are involved in glioblas-
toma electrotaxis. The electrotaxes of glioblastoma cells are found to require optimal
laminin extracellular matrices and depend on different types of voltage-gated calcium
channels, voltage-gated potassium channels, and sodium transporters. A reversibly-
sealed hybrid microfluidic chip is developed to study how electric field and laminar
shear can condition confluent endothelial cells and if the biomimetic conditions affect
glioma cell adhesion to them. It is found that glioma/endothelial adhesion is medi-
ated by the Ang1/Tie2 signaling axis and adhesion of glioma is slightly increased to
endothelial cells conditioned with shear flow and moderate electric field. In conclusion,
robust and versatile hybrid microsystems are employed for studying glioma biology with
emphasis on cell migration. The hybrid microfluidic tools can enable us to elucidate
fundamental mechanisms in the field of the tumor biology and regenerative medicine.
v
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Chapter 1
Introduction
In this chapter I will first overview glioma, a brain cancer type arising from supportive
cells in the central nervous system (CNS), and the microenvironment associated with
it. The guidance cues in tissue microenvironment will be further introduced and I will
explain how microsystems can be useful to recapitulate microenvironments.
1.1 Glioma: a tumor of supportive cells in the cen-
tral nervous system
The central nervous system (CNS) consists of the brain and the spinal cord, and it
is the biological electrochemical system that integrates, interprets, and responds to
information of the body and from the external environment. The nervous tissue makes
up the majority of the CNS, with 80% of the tissue volume consisting cells and the rest
are extracellular matrices (ECM). There are two major types of cells in the nervous
tissue, neurons and neuroglia. Neurons are excitable cells for sending and receiving
electrochemical signal. Neuroglia are supportive cells roughly 10 times higher in abun-
dance than neurons and maintain homeostasis in nervous tissue by assisting nutrient
delivery, waste removal, and tissue metabolism.
There are four types of neuroglial cells: astrocytes, oligodendrocytes, microglia, and
ependymal cells (Figure 1.1). Astrocytes are star-shaped cells that anchor blood vessels
and neurons, regulate formation of blood-brain barrier, moderate metabolism in the
microenvironment, and repair damaged tissue. Oligodendrocytes wrap the neuronal
axons and myelinate them to increase transduction speed of neuron transmission. Mi-
croglial cells are immune cells in the CNS. Ependymal cells maintain the cerebrospinal
fluid level in the CNS.
Glioma encompass all tumors that originated from the supportive tissue of the
brain, i.e., any tumor formed by transformed neuroglial cells. The clinical presentation
of glioma patients is often associated with CNS-related symptoms such as headaches,
seizures, memory loss, and changes in behavior.
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Figure 1.1: Neuroglial cells in the CNS1. Reprinted with permission of Pearson
Education, Inc., New York, New York.
1.1.1 Epidemiology, classification, and molecular pathology
Among all intracranial central nervous tumors, gliomas are the most common type,
accounting for 31% of all CNS tumors in the US and 81% of malignant CNS tumors2.
In Japan, analyzed by the brain tumor registry of Japan during the period from 2001
to 2004, glioma accounts for 24.9% of all primary brain tumors3.
In general, glioma can be classified based on their glial cell lineage into astrocytoma,
ependymoma, oligoastrocytoma, oligodendroglioma, optic glioma and gliomatosis cere-
bri. The WHO updated an international classification consensus for CNS tumors in
20164. The classification of CNS tumors now includes conventional clinico-pathological
characteristics as well as molecular information to more precisely classify tumor sub-
types that are conventionally difficult due to intermixing of differentiated cells.
In 2016 WHO classification, diffuse glioma can be classified histologically to astro-
cytoma, oligoastrocytoma, oligodendroglioma, and glioblastoma and further sub-typed
according to genotyping of several commonly-found molecular signature among glioma,
such as isocitrate dehydrogenase (IDH), 1p/19q codeletion, α-thalassemia/mental re-
tardation syndrome X-linked protein (ARTX), and O-6-methylguanine-DNA methyl-
transferase (MGMT) (Figure 1.2).
Almost half of the glioma cases are glioblastoma, the most malignant form associ-
ated with poor prognosis, accounting for 10.8% of all primary brain tumors in Japan.
The primary glioblastoma is the most frequent type with de novo development and
dominates in patients over 55 years of age. The primary glioblastoma is often associ-
ated with wildtype IDH and have short life expectancy. On the other hand, secondary
glioblastoma developed from previous diffuse or anaplastic astrocytoma lesions often
bears mutated copies of IDH and better prognosis (Table 1.1). This shows that glioma
are quite heterogenous, complex, and possibly originate from different progenitor cells.
Physicians and pathologists now routinely perform genotyping of patient’s tumor
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Figure 1.2: Classification algorithm for diffuse glioma based on histological
and genetic features in 2016 WHO guidelines for CNS tumors4. Reprinted
with permission of Springer Nature.
Table 1.1: Key characteristics of IDH-wildtype and IDH-mutant glioblas-
tomas4. Reprinted with permission of Springer Nature.
samples to determine therapeutic strategies and prognosis. The Cancer Genome At-
las (TCGA) database started registering sequenced glioblastoma specimens in 2008
and researchers have examined profiles at genomic, transcriptomic, and epigenomic
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level to conclude molecular markers for glioma subtypes with different clinical out-
comes. Based on transcriptional expression profiles5, the gliomas can be sub-typed
into proneural, neural, classical and mesenchymal glioma and have drastically different
prognoses and life expectancies. In the clinics, several molecular markers can pro-
vide physicians to evaluate prognosis of the glioblastoma, including several proteins
in the receptor tyrosine kinase (RTK) family, such as epidermal growth factor re-
ceptor (EGFR)6,7, platelet-derived growth factor receptor (PDGFR)8,9, and vascular
endothelial growth factor receptor (VEGFR)10,11. The phosphatidylinositol 3-kinase-
Akt-mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway is also
involved in the progress of glioma. The PI3K/AKT/mTOR is a pro-survival signal-
ing cascade that is often activated in cancer cells and it is also the common signal
transduction in gliomas. The intracellular signaling of the aforementioned RTK sig-
naling of often amplified through the PI3K/AKT signaling pathway. In glioma, there
is a high mutation rate of RTK pathways and the PI3K/AKT pathway especially in
primary glioblastoma (88%)12–14. The negative regulators of PI3K/AKT pathway,
phosphatase and tensin homolog (PTEN), is a tumor suppressor that is inactivated in
40 to 50% of glioblastoma patients15. The comprehensive glioma genotyping together
with histopathological phenotyping will help physicians to predict and correlate glioma
genotypes to therapeutic responses and prognosis.
1.1.2 Origin and metastasis of glioma
The origin of glioma carcinogenesis is speculated by glioma stem cells, which are orig-
inated from transformation of neural progenitors within the brain regions that have
active neurogenesis such as the subventricular zone (SVZ) and the dentate gyrus (DG)
(Figure 1.3). While ionization radiation to the head and neck is a known risk factor for
development of brain tumor, people suspect that the radio-frequency electromagnetic
field from mobile phones could be a possible brain tumor risk factor. However, in a
recent large international case-control study called INTERPHONE study, researchers
failed to correlate mobile phone use with glioma prevalence16,17. Some virus species
have also been proposed to contribute to glioma-genesis such as cytomegalovirus18,19
and human simplex herpes virus20. The search for risk factors for glioma is still on-
going through Genome-wide Association Studies (GWAS)5.
The cancer stem cell (CSC) hypothesis describes that solid and liquid tumors are
composed of heterogenic groups of cells in which a small subset of cells can self-renew
and contribute to regrowth and resistance of anti-tumor therapy21. Glioma stem cells
(GSCs) have attracted much attention due to their possible involvement in the high
recurrence and therapeutic resistance after surgical, chemo-, and radioactive therapy.
GSCs have been isolated from clinical samples and have shown self-renewal in culture,
outgrowth of a tumor in orthotropic transplant in vivo, and generation diversified
post-mitotic progeny22–25. A marker for GSCs is the CD133 that is also expressed in
multi-potent cells in other tissues. As little as 100 CD133-positive cells can initiate
tumor formation and they are relatively resistant to radiation26.
Thus investigation of the glioma cells and GSCs in the SVZ and DG microenviron-
ments may help us identify the emergence and maintenance of the GSC phenotype,
which is of great interest for therapeutic development.
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Figure 1.3: Speculative relationship of glioma cell of origin of neural pro-
genitors21. Reprinted with permission of Elsevier.
Metastasis is a complex process of primary tumor cells leaving in situ location
and disseminating to other body locations. Metastasis is the main cause of cancer-
related death27,28. During the dissemination, cancer cells first invade the surrounding
microenvironment as single cells or as a collective group (collective cell migration). Two
modes of single cell migration are used, either elongated (mesenchymal) migration or
rounded (amoeboid) migration. Subsequently, cancer cells enter the circulation by
migration through blood vessel walls through intravasation. After traveling through
the circulatory system, the cancer cells extravasate at distant location and start to
grow as new foci (Figure 1.4)29. However, the metastasis of glioma is unique compared
to that of other cancers.
Figure 1.4: Cancer cell metastatic dissemination29. Reprinted with permission
of Springer Nature.
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In glioma, high recurrence after surgical resection is due to the infiltrative nature
of glioma cells into nearby brain tissue30. Previously, due to limited cases of patients
showing disseminated glioma, the medical community assumed that the metastasis of
glioma to body parts outside the CNS was rare31–33, but more case reports suggest
that extra-neural metastasis is also possible and the previous observation could be
due to the short life expectancy of patients with malignant glioma34,35 and also to
different properties of the ECM properties in the brain microenvironment and glioma36
compared to other tissue microenvironments.
1.1.3 Complex microenvironment of glioma
Glioma cells express proteolytic enzymes, serine cysteine metalloproteinases, and ma-
trix metalloproteinases (MMPs), to aid in their digestion of ECM and crossing of brain
structures37–40. This also leads to local dissolution and destruction of the normal tissue.
The MMPs are expressed by glioma cells and can promote the growth and invasion of
the metastasis of the glioma. In high-grade glioblastoma, the cancer cells also produce
ECM molecules such as glycosaminoglycans, fibronectins, tenascin-C, and vitronectin
to modify the local microenvironment and promote infiltration41.
Figure 1.5: The tumor microenvironment of glioblastoma42. (A) The peri-
vascular niche; (B) The peri-necrotic niche; (C) the invasive niche. Reprinted with
permission of Elsevier.
Tumor cells interact with normal cells and adjacent stroma (connective tissues)
within the microenvironment (tumor niche)43–46. The non-malignant cells within the
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tumor microenvironment often possess dynamic and tumor-promoting functions at all
stages of carcinogenesis such as producing factors that stimulate CSC self-renewal. The
tumor cells also interact with the non-malignant cells such as modulating immune sys-
tem, stimulating stromal cells to secrete additional factors, and inducing angiogenesis
to increase nutrient supply for tumor growth47–50. Glioma cells establish and remodel
the microenvironment through secretion of RNAs and proteins or cross-talking with
stromal cells using extracellular vesicles (exosomes)51–53. The normal cells in the mi-
croenvironment can also secrete proteins during the natural defense process against
the glioma. Thus complex chemical gradients could exist in the microenvironment. If
the stoma and tissue polarity were interrupted during the glioma pathogenesis, voltage
gradients and stiffness gradients could also guide the response of glioma cells.
For example, in the subventricular zone of mice brain, where the neural stem cells
also reside, chemical gradients of CXCL12 coexist with a physiological electrical field
that projects toward the olfactory bulb along the rostral migratory stream (RMS)54
(Figure 1.6). While it has been suspected that the RMS only exists in small mam-
mals such as a mice and a rat, recently the existence of RMS in the fetal as well as
adult human brain have also been suggested55. The complex microenvironment in the
subventricular zone may play a pivotal role in the tumorigenesis of glioma.
To date, three types of tumor microenvironments of glioma have been proposed,
the peri-vascular niche for angiogenesis42,56–60, peri-necrotic niche for survival of cancer
stem cells48,61,62, and invasive niche for immune-privileged sanctuary63–66(Figure 1.5).
In the peri-vascular niche of glioma, glioma stem cells are thought to release high
levels of proangiogenic factors to drive migration and growth of endothelial cells to
the tumor site and provide nutrients, while endothelial cells also provide feedback and
maintain the survival of glioma stem cells (Figure 1.7)62.
In the perinecrotic niche, as the tumor grows in size, the level of nutrients and
oxygen tension changes. A hypoxic and necrotic region in the tumor exists and regulates
the phenotype of the tumor67–70 (Figure 1.8). In 2D microfluidics, manipulation of
oxygen concentration can be used to study effects on single cell behavior in hypoxic
condition while in 3D microfluidics with tumor spheroids, a more biomimetic whole
tissue model can be studied instead71,72.
In the invasive niche, cancer cells survive by avoiding the immune system. Mi-
croglia, a specialized immune macrophage cell type in the brain, is known to interact
with glioma and boost glioma invasion by secreting several chemotactic and chemoki-
netic factors64–66,73,74 (Figure 1.9). In some reports, the term of tumor-associated
macrophage is used42,66.
1.1.4 Glioma therapy
The surgical resection is the standard therapy if the lesion can be feasibly removed.
However, malignant gliomas cannot be completely removed surgically due to their
infiltrative nature and the possible existence of cancer stem cells.
Conventional radiotherapy of 60 Gy of partial field external beam irradiation will
be associated as part of the standard treatment. Despite the conventional effort, re-
currence of malignant glioma after surgical and radiotherapy is common and often
accompanied by increased drug resistance. Boron neutron capture therapy is a new
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Figure 1.6: Measurement of electric potential in mouse brain specifically
along the rostral migratory stream54. An electric field is present between the
subventricular zone and the olfactory bulb. Reprinted with permission of John Wiley
and Sons.
modality of radiotherapy for primary brain tumors as well as head and neck cancer75–77.
Non-radioactive Boron-10 agents are given to the patient and boron will accumulate
in cancer cells. The low energy thermal neutron from a nuclear reactor or a linear
accelerated source impacts the boron and releases alpha particles that will only deliver
cell killing effect around the boron, limiting the off-target killing.
In the mean time, chemotherapy has assumed an increased important role in the
treatment, especially the use of temozolomide (TMZ), an oral alkylating agent with
good blood-brain-barrier penetration. When glioma tissue poses hypermethylation of
aforementioned MGMT promoter, the MGMT is silenced and is associated with better
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Figure 1.7: Interactions between GSC and endothelial cells62. (A) From
endothelial cells to GSC; (B) From GSC to endothelial cells.
Figure 1.8: Oxygen levels regulate the phenotype of glioblastoma cells in
the peri-necrotic niche67.
Figure 1.9: Cross-talk between glioma and tumor associated macrophages
(TAMs) in the invasive niche66. Reprinted with permission of Springer Nature.
response to TMZ treatment. Due to the identification of cellular signaling pathways
in glioma molecular pathology, targeted therapeutic agents against these molecules
have also been used (Figure 1.10), such as EGFR inhibitor, PI3K inhibitors, and anti-
angiogenic agents such as anti-VEGF78.
Recently, a novel therapy using alternative electric field for glioblastoma have
been approved by the Food and Drug Administration in the US offered by Novo-
cure. NovoTTF-100A applies 200 kHz alternating electric field (tumor treating field,
TTF) in two perpendicular directions to the brain using a portable non-invasive device
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Figure 1.10: The scheme of major signaling pathways in glioma and their
targeted therapy. Reproduced with permission from Wen et al.78, Copyright Mas-
sachusetts Medical Society.
(Figure 1.11). The field intensity was more than 0.7V cm−1 in the center of the brain.
The mechanism for this treatment was based on interruption of tumor cell mitosis and
proliferation by the alternative electric field presumably through the action on the mi-
totic spindle80. The treatment has demonstrated improvement of life expectancy and
quality of life to patients with glioblastoma79–82.
Combining targeted therapies to inhibit tumor microenvironment through drugs
and electrical stimulation is a potential treatment approach in the future83. Investi-
gating how cells respond to multiplex gradients is essential to create an effective treat-
ment plan. Thus, developing an in vitro platform for effective evaluation of therapeutic
strategy to target glioma microenvironment is urgently needed.
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Figure 1.11: The NovoTTF-100A non-invasive alternative electric field ap-
plication system79.
1.1.5 What microenvironment governs glioma infiltration?
It has been known that not only the genotypic and phenotypic mutations that cancer
cells adopt are important for the tumorigenesis, the microenvironment remodeling and
contribution also play pivotal roles on settlement and dissemination of cancer84,85. The
subjects and mechanisms involved in the establishment and remodeling of microenvi-
ronment is of increasing interest to researchers as it may present new approaches to
treat cancer.
In glioma, the cancer cells are extremely disseminative into the surrounding tissue.
Even if surgical, radio-, and chemo-therapy were successful to remove the primary tu-
mor, glioma often recurs presumably due to the infiltrated GSCs population in a few
years. The infiltrated glioma cells will rapidly grow, interfere with normal cell popu-
lations in the CNS, and cause neural pathology. It is hoped that if the infiltration of
glioma or abnormal growth of glioma can be controlled, response to standard treat-
ment and quality of life for patients can be significantly improved as shown partly from
several targeted therapy trials and Novocure tumor treating field trials86,87.
In short, the ability of understanding and manipulating cancer microenvironment
could provide promising insight to control and inhibit cancer growth and metastasis.
However, the cancer microenvironment is inherently complex so how to establish an in
vitro experimental platform is essential. A microfluidic chip to create multiplex chemi-
cal, voltage, or stiffness gradients can serve as an in vitro platform to mimic the tumor
microenvironment and study how cells respond when multiple stimulations act on them
simultaneously. Modeling the peri-vascular, peri-necrotic, and invasive niche of glioma
and other cancers on a robust in vitro platform is important to elucidate fundamental
processes in glioma tumor biology, formulate biological significant experimental design,
and draw more clinically translational results.
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1.2 Microfluidics and bioMEMS
Microfluidics refer to controlling and manipulating fluid flows with length scales smaller
than milli-meter. The fundamental works in microflows started early by pioneers in
fluid dynamics such as Poiseuille and Knudsen88, who studied extensively the pressure-
driven flow in small cylindrical tubes. The practical development in microelectrome-
chanical systems (MEMS) jump started by Richard Feynman’s prophetic lecture on
microscale science and engineering in the 1960’s.
The boom of microfluidic applications started with extensive development of high-
performance liquid chromatography and on-chip capillary electrophoresis during the
1990s with rapidly technological leap in microfabrication89,90.
At the reduced dimension (Figure 1.12), microfluidics bring several economical and
analytical advantages over macro systems, including low sample and reagent consump-
tion, laminar flow regime at low Reynolds number, diffusion-dominant transport, in-
creased surface area-to-volume ratio, and portability for system integration89–92. Thus,
microfluidics has offered great potential to shed new insights in biological studies89,93.
Figure 1.12: Length scale comparison between several biological and micro-
fabrication structures90. Reprinted with permission of Springer Nature.
1.3 Gradients in the microenvironment as direc-
tional cues
The nature of the extracellular environment determines the mechanical, topographi-
cal, and chemical gradients surrounding a cell (Figure 1.13)94. In extracellular matrix
(ECM), if fibrous structure exists, the topographical features may guide cells by contact
guidance95,96. Due to the three-dimensional tissue hierarchy, stiffness gradients may
exist in the ECM and can guide cells through mechanobiology signaling. If the cell mi-
gration is guided by the stiffness of ECM, it is termed durotaxis97–99. A surface-bound
chemical gradient can also exist on ECM surface and can guide cell migration in the
process called haptotaxis100–104. A soluble chemical gradient and electric field existing
in the medium can also guide cell migration in chemotaxis105,106 and electrotaxis107–110.
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Figure 1.13: Cells can be guided by physical as well as chemical cues94.
Reprinted with permission of Oxford University Press.
1.3.1 The chemical gradient microenvironment
Chemical gradients in the physiological system
During the early development of a multicellular organism, tissue patterning and for-
mation of polarity are pivotal. Tissue patterns are formed by cells in multicellular
organisms that are potentially independent but function together to form a whole
organism through different rates of cell growth and tissue regeneration111–113. The
observation prompted the early postulations of a formative substance gradients influ-
encing the organism development, proposed by developmental biologists such as T.H.
Morgan and C.M. Child114,115.
Alan Turing proposed that chemical substances affecting the tissue form (namely
morphogens), can self-organize into spatial patterns from homogenous distribution
through reaction-diffusion type models116. The morphogen gradients then provide
the spatial information to guide cell behavior in pattern formation during organism
development (Figure 1.14)111,117. Some examples of morphogens include members of
the hedgehog (Hg) family118–120, Wnt family members121–124, and some members of the
transforming growth factor-β (TGF-β) family125–128.
For example, sonic hedgehog protein (Shh), a vertebrate protein of the hedgehog
family involves in the patterning of neural tube development and limb bud develop-
ment118,129. A disturbed Shh concentration gradient from ectopic transplant results
in malformation of neural tube or duplication of limbs (Figure 1.15)120,129. The Shh
protein also participates in maintenance and survival of adult neural progenitors130.
Although critical issues such as how morphogens are moved through a tissue and
how morphogen gradients are maintained are not entirely clear, it is widely understood
that chemical gradients of different sorts exist in the tissues throughout the lifecycle
of an organism, such gradients participate in all aspects of biological processes such as
regeneration, homeostasis, inflammation, and cancer112,113,131–133.
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Figure 1.14: Mechanisms for generating morphogen gradients117. (Left) A
tissue produces the morphogen at the compartment interface. (Right) A restricted
group of cells release morphogens within a field of responsive cells. Reprinted with
permission of Elsevier.
Figure 1.15: Ectopic production of Shh induced a mirror image of chick
wing bud120. Reprinted with permission of The Company of Biologists Ltd.
Cell responses to chemical gradients
Chemical gradients (chemoattractants) of proteins such as morphogens, growth factors
and small molecules can guide cell migration. Cell migration is a fundamental biological
process that exists in the development of the organism throughout life in physiological
and pathological conditions including wound healing, inflammation, and cancers134.
The directed cell migration towards chemical gradients is called chemotaxis and can
be categorized by how the cells move (Table 1.2)106,135–137.
The first step of chemotaxis is the binding of chemoattractant molecule to specific
receptors such as receptor tyrosine kinases, G protein coupled receptors, etc136,138. The
second step is the development of stable cell polarity by activation of local signaling
pathways and cytoskeleton (Figure 1.16)105,139. The third step involves retraction at
the rear (trailing) edge of the cells leading to cell locomotion.
The signaling pathways involved in chemotaxis are complex and often have cross-
talks. Elucidating the functions of molecular targets in each chemotactic signaling
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Table 1.2: Types of directed cell migration106. Reprinted with permission of
Springer Nature.
Figure 1.16: Cell polarity during chemotaxis of the calcium gradient139.
pathway towards different chemical gradients is important for understanding funda-
mental biology and also for discovery of therapeutics in pathological conditions (Fig-
ure 1.17)106.
Creation of chemical gradients in microfluidics
In microfluidic systems, the Reynolds numbers are low and viscous effect dominates.
Thus, many microfluidic systems are used to manipulate the distribution of chemical
species which is of great interests to analytical chemistry and biology140–142.
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Figure 1.17: Complex signaling pathways in regulation of chemotaxis106.
Reprinted with permission of Springer Nature.
The mass transport can be described by mass balance as shown in Equation 1.1:
∂c
∂t
+∇ · (−D∇c) + u⃗ · ∇c = R, (1.1)
where c is the concentration of the chemical species, D is the diffusivity of the chemical
species in the fluid, u⃗ is the velocity field of the fluid, and R is a reaction rate expression
for the chemical species.
In the case that an electric field exists, polyelectrolytes such as proteins can migrate
in the electric field according to the charge number they carry. The mass transport
considering the convection, diffusion and electrical migration can be described as:
∂c
∂t
+∇ · (−D∇c− zumFc∇V ) + u⃗ · ∇c = R, (1.2)
where c is the concentration of a given chemical species, D is the diffusivity of the
chemical species in the fluid, z is the charge number of the ionic species, um is the ionic
mobility of the ionic species, F is Faraday constant, V is the electric potential, u⃗ is the
velocity field of the fluid, and R is a reaction rate expression for the chemical species.
Several macro migration assays were also developed to study single and collective
cell migration guided by chemical gradients as shown in Figure 1.18143.
Conventional methods for creation of chemical gradients used explants of tissues
that excrete growth factors to place near the target cells and examined if target cells
were attracted or repelled by the transplant. Subsequently micropipette-based and
photomanipulation-based assays were developed for generating localized sources of
guidance cues144 (Figure 1.19).
More recently, microfluidic chips have been developed to create chemical gradients
in a stable and controllable fashion145. The most common design for creating chemical
gradient is the use of serial mixing microfluidic channel known as the Christmas tree
network (Figure 1.20A). The chemical gradient can also be generated by simple diffu-
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Figure 1.18: Commonly used macro migration assays143. Reprinted with per-
mission of Elsevier.
Figure 1.19: Classical methods of generating chemical gradients144.
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sion between two laminar flows (Figure 1.20B). Using diffusion through series of small
microfluidic channels can also establish chemical gradients (Figure 1.20C). Utilizing
hydrogels as the 3D cell model, chemicals can also diffuse through the hydrogel and
establish chemical gradients (Figure 1.20D).
Figure 1.20: Microfluidic-based concentration gradient generator145.
Reprinted with permission of Springer Nature.
1.3.2 The voltage gradient microenvironment
Endogenous voltage gradients creating stable current in physiological sys-
tems
In human bodies, endogenous electric field is generated by either a voltage generator
or a power source. Two main power sources exist in a living system, the epithelium
surrounding the organs and body, and the lipid bilayer of biological membranes.
The resting potential arises from the differential ion transport in living cells (Fig-
ure 1.21). The resting membrane potential can be calculated based on the concentra-
tions of major ion species, which are sodium (Na), potassium (K), and chloride (Cl)
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Figure 1.21: Classification of ion transporters on biological membranes146.
Reprinted with Permission of Springer Nature.
according to the Goldman equation:
∆Ψ =
RT
F
ln PCla
i
Cl + PKa
e
K + PNaa
e
Na
PClaeCl + PKa
i
K + PNaa
i
Na
, (1.3)
R is the ideal gas constant, T is the temperature in Kelvin, F is the Faraday’s constant,
P is the permeability of each ion, and a is the ion activity denoted i or e for intracellular
or extracellular.
In the case of polarized tissue, the voltage differences across polarized membrane,
also known as transepithelial potential (TEP), across the epithelium or biological mem-
branes, originate from differential ion transportation by asymmetrically distributed
transporters or ion channels (Figure 1.22)110,147,148.
The endogenous electric fields play a pivotal role in wound healing149–153, embryo-
genesis154–157, morphogenesis157,158, neurogenesis54,159,160, and regeneration161,162. The
endogenous electric field has also been proposed as a possible contributing factor to
cancer metastasis163–165.
The physiological electric fields established by TEP differences in numerous tissues
have been measured. The physiological TEP difference across a corneal epithelium
is around 25 - 40 mV created by differential expression of ion transporters on apical
and basolateral sides of the tissue148. When a tissue polarity disruption (wound) is
created on corneal epithelium, ionic fluxes of primarily chloride ions flow into the wound
site, establishing an electric field. Similar endogenously generated electric field is also
measured in a skin wound (Figure 1.23)166.
The endogenous EF also has an important role in embryo morphogenesis. Pertur-
bation of membrane potential and therefore the endogenous EF by molecular manipu-
lation of ion channel expression can cause developmental defect and ectopic formation
of organs. For example, manipulation of H+-V-ATPase affects left-right asymmetry
in xenopus, zebrafish, and chick embryo development and causes heterotaxia167 (Fig-
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Figure 1.22: Molecular basis of endogenous electric field148. After establish-
ment of tissue polarity, asymmetrical distribution of ion channels usually can be found
to contribute to biased ionic transport. The biased ionic transport maintains an elec-
tric potential difference across the epithelium (transepithelial potential). In the case
of wound healing, disruption of the epithelium creates a break in the electric circuit
and a net ionic flow contributes to an active endogenous electric field. Reprinted with
permission of Elsevier.
Figure 1.23: A wound on mouse skin and measurement of the wound-
associated electric field166. Reprinted with permission of John Wiley and Sons.
ure 1.24). Local perturbation of membrane potential can also induce ectopic eye for-
mation in Xenopus species168.
In the ductal structures of mammary gland and prostate, TEP differences have also
been measured169,170. In the breast duct, the TEP is +30 mV in the lumen whereas
in the prostate duct the TEP is -10 mV, reflecting the heterogenic nature of TEP in
different tissues (Figure 1.25). Interestingly, it has been found that despite the com-
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Figure 1.24: Heterotaxia in zebrafish when H+-V-ATPase subunits are in-
hibited during early embryogenesis167. Reprinted with permission of the Com-
pany of Biologists Ltd.
pletely different TEP between the two tissues, under in vitro electric field, the tumor
cells for the two tissues both migrate toward lumen direction. This correlation has
been the theoretical basis of endogenous EF’s contribution to cancer metastasis164,171.
Figure 1.25: The polarities of transepithelial potential in mammary and
prostate ducts correlate also with the direction of breast and prostate cancer
cell migration relative to an EF in vitro110. Reprinted with permission of the
Company of Biologists Ltd.
Aside from endogenous electric field generated by passive and primary active ion
transporters to form the resting potential, the cells in the neuromuscular system ex-
press a set of membrane ion channels that can create ion fluxes upon stimulation by
voltage (voltage-gated) or chemical (ligand-gated)172. The membranes of the cells in
neuromuscular system are termed electrically excitable membranes. Upon activation,
ion fluxes of excitable membranes create a rapidly propagated electrical message over
membrane surfaces, called action potential172–175. The action potential is the funda-
mental unit of electrical activities in the neuromuscular system and the firing frequency
and strength of it sum up to the complex electrical patterns in the central nervous sys-
tem and the neuromuscular system (Figure 1.26)173.
The pulsatile firing of action potentials by neurons propagates into tissues. The
amplitude and frequency of local field potentials (LFPs) at any given position in the
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Figure 1.26: The anatomy of an action potential173. Reprinted with permission
of Springer Nature.
tissue depends on the proportional contributions of all the action potentials and tissue
impedance properties (Figure 1.27). The local field potentials in the brain, heart, and
muscles are the electrical activities measured by the electroencephalogram, electrocar-
diogram, and electromyography176–178.
Figure 1.27: Electric field in the nervous system ultrastructure178.
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Therapeutics using an externally applied electric field
Historically, electrical stimulation has been used as therapeutics dated back in Roman
Empire with an electric fish179. While external defibrillator or electroacupuncture may
be more familiar in current medical practice, electrical stimulation as part of thera-
peutic regime has been studied with a long history of contemporary medicine. Geddes
categorized the medical applications of electricity either by static electricity or by a
steady electric current (galvanism)180. The static electricity is generated by placing
patients in between capacitors applied with high voltage difference. Such static elec-
tricity in particular has been found to promote bone growth, by mechanisms similar to
stress-generated potentials (SGP) in the bone179. On the other hand, electric field can
also be artificially applied by steady electric current delivered through direct-contacted
or capacitively-coupled electrodes. The effect of the galvanism has been reported in
researches involving wound healing, limb regeneration, spinal cord regeneration, etc,
with particular focus on the effect of direct current electric field because it is believed
that direct current electric field is the primary if not the only type of electric field in
the physiological systems179.
For the externally applied alternating current electric field (acEF), while a majority
of investigations into biological effects of acEF are initiated due to concerns of radio-
frequency (RF) electromagnetic field (EMF) emitting from cell phone or the extremely
low frequency EMF from electricity grid, there is still yet compelling evidence to solidly
suggest that acEF causes cancers. However, specifically for glioma and some other solid
tumors, alternating current electric field has been shown to inhibit the mitotic spindle
and to stop the proliferation of the cancer cells in the Novocure’s tumor treating field
technology as discussed in Section 1.1.4. The readers are referred to specialized review
texts for more details147,179,181,182.
Cell responses to voltage gradients
Cell response to direct current voltage gradients Under in vitro direct current
electric field (dcEF) stimulation, cells may demonstrate directional migration toward
cathode or anode, called electrotaxis or galvanotaxis183–188.
In neurons under direct current electric field stimulation, the electric field can fur-
ther guide or reorient the outgrowth of neurites, termed galvanotropism107,108,189–192.
This interesting behavior prompted on-going studies of using electric field for nerve
regeneration193–195.
Moreover, in vitro, dcEF stimulated cells often showed perpendicular alignment to
the electric field vector196–202. Although this behavior appeared to be associated with
cytoskeleton and Golgi apparatus, it is less studied. Whether or not electro-alignment
participates in pattern formation in vivo is not yet elucidated.
Pulsed direct current electric stimulation also have effects to promote metabolism.
Note that the amplitude and frequency of the electric field used for cell stimulation
usually are not as high and as strong as ones that used for nucleic acid delivery by
electroporation203.
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Cell responses to alternating current voltage gradients Despite the general
belief that only dcEF exists in the physiological systems, the alternating current electric
field can also further impose modulation and affect the endogenous EF. Under alter-
nating current electric field stimulation, it has been reported to increase metabolism
and production of antibodies in hybridoma cells204.
In addition, alternating current electric field has been shown to align the mitotic
spindle and affects cell division205,206. Palti et al., discovered that an alternating electric
field with intermediate frequency can affect mitotic spindle formation and cause cell
deaths in glioblastoma cells80,206. The discovery initiated the development of tumor-
treating field technology and is now a food and drug administration (FDA)-approved
therapy for recurrent glioblastoma207,208.
Biophysical and biochemical signaling in electrotaxis The mechanisms under-
lying electrotaxis are complex. While many cells show electrotaxis to dcEF and many
cellular signaling pathways have been identified, not all cells share the same signal-
ing pathway under EF stimulation. While the electrotaxis involves biochemical signal
transduction for activation of cell migratory machinery, it is believed to be initiated
by a biophysical mechanism powered by the electric field110.
Biophysical activation of electrotaxis Biophysically, there are several hy-
potheses on initial steps of electrotaxis (Figure 1.28).
Firstly, through bioelectrical activation, membrane potential depolarization by dcEF
could directly activate voltage-gated ion channels or voltage sensitive proteins and also
influence activity of several passive ion channels. Voltage-gated ion channels such as
voltage-gated sodium channels164,171,209–211 and voltage-gated calcium channels212–214
have been shown to be important to the electrotaxis of several breast cancer cell lines,
prostate cancer cell lines, or human keratinocytes. Passive and active transport ion
channels such as Na+/K+ ATPase212, Na+/H+ exchanger215, and H+-V-ATPase167,216
have been found to be associated with the electrotaxis response of a cell. Discovery of
a voltage sensitive protein with PTEN phosphatase activity (Ci-VSP) also suggests it
possibly being an upstream sensor for electrotaxis, but so far there is no direct proof
of its expression in all cells and its implication to electrotaxis217–219.
Secondly, from early membrane protein mobility observations in embryos and cells
under dcEF, researchers found polarized membrane receptors, suggest a possible acti-
vation of the receptors. Several hypotheses based on electrokinetic transport of mem-
brane proteins are proposed so electrokinesis is widely accepted as a fundamental
mechanism for electrotaxis (Figure 1.30). The membrane proteins are driven by in
situ electrophoresis187,220–223, which is the lateral movement of charged proteins on
the membrane driven by dcEF, and electro-osmosis224, in which nano-scopically an
electro-osmotic flow forming at the Debye layer of the cell membrane can sweep the
membrane proteins. As a result, membrane proteins including many major cellular
signaling proteins polarize toward either cathode or anode. Activation of asymmetri-
cally distributed membrane components would lead to biased cellular signaling which
confers the direction cue for migration. The directional migration can happen even
if the ligands in the extracellular medium do not have any concentration gradient.
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Figure 1.28: The mechanisms of cell response to EF are complex110,196.
Although polarization of membrane proteins has been considered as the activation of
electrotaxis, several reports suggest that the polarization of membrane proteins does
not necessarily decide the directionality or activation of the signaling196,225,226.
Moreover, many membrane receptors reside in cholesterol-rich or sphingolipid-rich
microdomains (caveolaes) on the cellular membrane (Figure 1.28). EF-induced co-
alescence of lipid raft or polarization of membrane receptors can lead to non-ligand
mediated autoactivation227.
Thirdly, integrins are proposed to be an electromechanical transducer for the electro-
osmosis flow leading to activation of cell migration228–230. Recombinant expression of
different integrins on Chinese hamster ovary (CHO) cells can mediate the electrotactic
direction of them231. Other cell junction proteins such as E-cadherin have also been
found to be an essential part of electrotaxis232.
Signaling amplification through biochemical pathways in electrotaxis
After cells sense the electric field, it is expected that the signal is amplified through
a biochemical signaling. Receptor tyrosine kinase proteins have been reported to be
activated in cells under dcEF stimulation by in situ electrophoresis, including epider-
mal growth factor receptor (EGFR)233–242, vascular endothelial growth factor receptor
(VEGFR)243–245, fibroblast growth factor receptor (FGFR)185, insulin receptor246, and
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Figure 1.29: The hypothesis of electrokinetic based migration of membrane
proteins as the cause for electrotaxis184,224. (A) In situ electrophoresis of sig-
naling receptors; (B) Electro-osmosis of integrins to contribute to electromechanical
signal transduction. Reprinted with permission of Elsevier.
hepatocyte growth factor receptor (HGFR)247. Ligand-gated ion channels such as
acetylcholine receptors are also reported as key regulators in electrotaxis of muscles
cells223,248–251. Although electrotaxis of Dictyostelium (slime mold) is found to be in-
dependent of Gβ protein, part of G-protein couple receptor (GPCR) signaling252, other
GPCRs such as beta-2-adrenergic receptors are found to be involved in the electrotaxis
of different cell lines253–255 accompanied by complex bimodal responses to different
concentration of GPCR agonists254.
In the intracellular signaling of electrotaxis, PI3K/Akt signaling256,257 is the most
common signaling pathway activated in electrically stimulated cells. Several membrane
or intracellular phosphatases165,256,258 are also found to participate in the regulation of
intracellular signaling of electrotaxis. But calcium signaling, reactive oxygen species,
MAP Kinases, protein kinase C, Rho GTPases, and cyclic AMP signaling are also
present and reported in the electrotaxis of different cell types213,254,259–264.
Summary of current understanding of complex nature of signaling network in EF
stimulated cells is shown in Figure 1.30265.
Creation of voltage gradients in microfluidics
Stable voltage gradients can be easily created within a microfluidic channel. The
electrical resistance R of a microfluidic channel is described by the Ohm’s law as
R = ρl/A where ρ is electrical resistivity of the fluid, l is the length of the channel,
and A is the cross-sectional area. In a microfluidic channel, the cross-sectional area
is extremely small so that a strong electric field can be created by a small electric
current. Conventional apparatus for creation of voltage gradients uses a rectangular
microfluidic chamber flanked by two cover glasses in a petri dish (Figure 1.31)266. The
electrical stimulation is applied through agar bridges connected into the microfluidic
chamber. The agar bridges prevent the cells being contaminated to electrolysis product
by isolating them from the electrodes.
Multiplexing can also be achieved by designing microchannels with different widths198
or connecting networks202 (Figure 1.32). The small configuration of microfluidic chips
makes them suitable for real-time observation of cell migration on a microscope. For ap-
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Figure 1.30: An abstract signaling network in EF stimulated cells265.
Reprinted with permission of Elsevier.
Figure 1.31: The setup of a conventional device to create voltage gradi-
ents266. (A) The setup diagram; (B) The photoimage of the setup. Reprinted with
permission of Springer Nature.
plications that require collection of cellular products after experiment, microfluidic de-
vices with extremely large cell culture area can be specially fabricated196 (Figure 1.33).
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Figure 1.32: The microfluidic approach for creation of multiple voltage
gradients on a single chip. (A) Multiple electric fields using varied widths198;
(B) Multiple electric fields using interconnected channel networks202. Reprinted with
permission of Elsevier and AIP Publishing.
Figure 1.33: A microfluidic device for creating uniform voltage gradient to
a large area of cell culture196. (A) The top view of the large microfluidic device;
(B) The side view of XLEFC showing the flow direction of chloride ions which are
driven by the external dcEF.
1.3.3 Multiplex gradients in 2D microfluidic chip
Cell migration plays a critical role in physiological and pathological conditions. How
cells respond to different gradients simultaneously and the strength of the responses
are important. Recent researches in microfluidics focus on building in vitro systems
to systematically and simultaneously control multiplex directional cues and study the
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cell behavior in complex gradients (Figure 1.34)183.
Figure 1.34: Complex gradients can guide cell migration183. Reprinted with
permission of Oxford University Press.
An intuitive approach is to place two chemical gradients in direct opposite direction,
i.e., in the tug-of-war configuration (Table 1.3). The cell responses under the multiplex
gradients are then studied and will demonstrate effect of preference if the guidance of
one gradient overpowers the other.
However, it is known that the in vivo microenvironment is often established with
multiple gradient cues for pattern formation, which are not necessarily competitive.
Several microfluidic designs specifically are restricted to generating perpendicular gra-
dients to avoid the downfall of studying competitive effects of gradients in the tug-of-
war configuration.
Chang et al. used the gas-permeability property of PDMS to create an oxygen
gradient and a microfluidic mixer to create a chemical gradient276 (Figure 1.35). They
demonstrated that the device can be used to screen for anticancer drug efficacy in
different oxygen concentration and also for cell migration study in both chemical and
oxygen gradients. A549 lung adenocarcinoma cells demonstrated chemotaxis towards
SDF-1α gradient and migration toward hypoxic region independently. When cells are
exposed to both gradients, the effect of oxygen gradient overrides that of the chemical
cue.
Kilinc et al. created a dual gradient generator microfluidic chip to create a panel of
chemical combinations for drug screening and study the chemotaxis of MDA-MB-231
cells in chemical gradient of EGF and its inhibitor (Figure 1.36)280.
Advances in microfluidic technologies offer us the tools to create and manipulate the
gradients in the microenvironment. By designing multiplex microenvironment, we can
investigate how cells respond and make decisions. Elucidating the interaction between
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Figure 1.35: A microfluidic device to create perpendicular oxygen and
chemical gradients276. (A) Device design; (B) The orthogonal gradients of oxy-
gen and antitumor drug concentration gradient; (C) A540 lung adenocarcinoma cell
migration is guided by SDF-1α gradient and oxygen gradient. Reprinted with permis-
sion of Royal Society of Chemistry.
Figure 1.36: MDA-MB-231 cell migration in a combinatorial gradient gen-
erating microfluidic device280. (A) Experimental paradigm with orthogonal EGF
and BIBX gradients; (B) Cell images taken with 5 hr intervals in region B in the chip;
(C) Cell images taken with 5 hr intervals in the region C in the chip; (D) Average
velocity magnitude and cell speed in each quadrant. Reprinted with permission of
Oxford University Press.
the cells and the guidance cues can help us to build more biomimetic tissues or develop
better in vitro models for drug discovery.
1.4 Glioma on a chip
Several microfluidic systems have been developed and used on glioma research focus-
ing on drug screening, analysis of cellular signaling283,284, and migration in chemical,
stiffness, topography, and voltage gradients.
For drug screening, the microfluidic chips were designed with parallel chambers or
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Figure 1.37: Microfluidic models for drug screening in glioma re-
search285–287. (A) Liu et al. used parallel chambers to perform drug screening on
glioblastoma cells. Reprinted with permission of Springer Nature; (B) Fan et al. used a
microfluidic mixers to create different drug concentrations for high throughput testing
of cytotoxic drugs; (C) Bui et al. studied glioblastoma response to anticancer drug in
different physically confined environments.
mixers to create different drug concentrations to screen for cell responses on a single
chip simultaneously285,286. Liu et al., used a multiple chamber microfluidic chip to
study the effect of an anticancer drug, colchicine, of different concentrations on a rat
glioma cells (Figure 1.37A)285. Fan et al. built a christmas tree-like microfluidic
mixers to create different drug concentrations and test the drug induced glioblastoma
cell death on this chip (Figure 1.37B)286. Together with drug screening, Bui et al.
showed that a specific Braf molecular mutation contributed to the increased resistance
to a microtubule stabilizing drug toxol in glioma cells when the cells were placed in
physical confinement enabled by microfluidics (Figure 1.37C)287.
The microfluidic chips were also used to create different gradients to study the mi-
gration of glioma cells. Gallego-Perez et al. used microfabricated topographical cues
to study guided glioma cell migration along the topography (Figure 1.38D)288. Wan
et al. used microfluidic taper channels to create EGF gradients to study the chemo-
taxis of glioblastoma cells (Figure 1.38A)289. Ayuso et al. used a 3D microfluidic
to create chemical gradients of fetal bovine serum around glioma tumor spheroid em-
bedded hydrogel and studied the sprouting of the spheroid (Figure 1.38B)290. Direct
physical property of microenvironment could also guide the migration of glioma cells.
Rape et al. used different stiffnesses of polyacrylamide substrates and varied chan-
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Figure 1.38: Microfluidic models for study glioma cell migration288–291.
(A) Study of chemotactic of glioblastoma cells towards EGF; (B) Study of U87MG
spheroids chemotactic migration towards serum; (C) Study of glioblastoma cell mi-
gration on hydrogel of different stiffnesses; (D) Study of glioma migration on surfaces
with micro-scale topographical features. Reprinted with permission of Royal Society
of Chemistry, Springer Nature, and Elsevier.
nel widths to study the stiffness and confinement regulation of glioma cell migration
(Figure 1.38C)291.
Voltage gradients could also guide the migration of glioma cells. Direct current
electric field stimulated normal astrocytes did not show electrotactic migration but
several glioblastoma cell lines such as U87, C6, U251 showed cathodal migration (Fig-
ure 1.39)292. The migration had been found to involve Akt and ERK signaling pathways
and might be mediated by reactive oxygen species.
Interestingly, another report using brain tumor initiating cells freshly isolated from
patient tumors showed anodal migration both in 2D and 3D biomimetic hydrogels
(Figure 1.40)293. This could be due to the differences of substrate coating and stiffness.
Huang et al. further identified that heparan sulfate on cell membranes can reg-
ulate the electrotaxis of brain cancer initiating cells294. Lyon et al. reported that
glioma spheroidal aggregates also demonstrated electrotaxis and U87MG glioblastoma
electrotaxis involved PI3K/mTOR/AKT signaling295.
Not just glioma cells but the fetal neural progenitors and astrocytes also demon-
strated electrotaxis. Huang et al. reported that human fetal neural progenitor cells
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Figure 1.39: Electrotaxis of glioma cells292.
Figure 1.40: Galvanotaxis of glioblastoma cells of different transcription
profile type and fetal derived neural progenitor cells (fNPC)293.
migrated toward cathode while the differentiated astrocytes from it migrated toward
anode. Yang et al. also reported that astrocytes derived from adult human brain
tissues migrated toward anode296.
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The selected reports regarding the electrotaxis of glioma and glial cells using mi-
crofluidic systems are summarized in Table 1.4.
1.5 Current challenges and opportunities using mi-
crofluidics in cancer biology
Cancer is a complex systemic disease. Cancer cells grow without cell cycle control
with high mutation frequency that contributes to heterogeneity. The cancer cells can
travel to distant tissues through metastasis that leads to eventual systemic organ failure
and eventual patient death301. Contemporary cancer therapy targets cancer cells for
elimination but the approach resulted in severe side effects and inevitable selective
pressure on heterogeneous cancer cell population. Cancer recurrence and emergence of
drug-resistant clone often occur and limit life expectancies of patients302–304.
In recent years, researches into the microenvironment surrounding the tumor re-
vealed that the microenvironment affected the survival of cancer cells and cancer cells
remodeled the surrounding microenvironment for their own gains and caused tumor
progression84,305,306 (Figure 1.41). Understanding how and why microenvironment is
modified by cancer cells and how microenvironment shapes cancer cells may shed light
on new tumor treatment paradigm: stopping metastasis. If tumor cells are restricted to
their in situ tissues, the cancer might be restricted to benign tumors and life expectancy
as well as quality of life of patients could be potentially increased306,307.
However, the cancer microenvironment is complex and composed of chemical and
physical gradients in the ECM as well as intricate cell-cell interactions (Figure 1.41). To
create a robust in vitro model for the tumor microenvironment is an important step to-
ward mechanistic understanding. Some recent researches focused on using microfluidic
technologies for spatiotemporal control of microenvironment to create tissue-on-a-chip
devices for more biomimetic translational studies94,268,308,309. However, to accurately
mimic the in vivo microenvironment to control the cell fate and cell behavior demands
a robust platform encompassing control in both extracellular chemical gradients, stiff-
ness gradient, and voltage gradients. How to design and fabricate such platform is
the first step to probe into the delicate tumor microenvironment and elucidate the
fundamental tumor biology as well as discover new therapeutic targets.
In 2D microfluidic chips, cells are cultured on the substrate and the microenviron-
ment can be manipulated by fluid flow, chemical transport, and electrical stimulation.
The cell responses to gradients in the microenvironment can be easily observed through
microscope at high magnification. In 3D microfluidic chips, hydrogels mimicking the
extracellular matrix are used to embed singularized cells or multicellular spheroids to
recapitulate cell-cell and cell-matrix interactions and realize a more biomimetic model
compared to the 2D counterpart. However, in 3D microfluidic chip, special structural
designs are required to hold the spheroids in place or pattern the hydrogels in the
microfluidic channel with consideration of the material mechanical properties such as
stiffness of the cells and yield stress of the hydrogel. Moreover, multicellular spheroids
or cells in the hydrogel may not be on the sample focal plane so the microscopic observa-
tion is more difficult. A 2D microfluidic design to prove the feasibility of the concept is
usually a good first step and hydrogel based platform can be subsequently incorporated
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Figure 1.41: The tumor microenvironment is complex and composed of
peri-vascular, metastatic (invasive), and peri-necrotic niches50. Reprinted
with permission of Royal Society.
into the design to fabricate a more biomimetic 3D organ-on-a-chip model50.
1.6 Research aims
In this thesis, I aim to investigate the interactions between the cells and the microen-
vironment (niche) in glioma. I hypothesize that the physiological electric field in the
brain might participate in the migration and metastasis of glioma with other coexisting
gradients in the microenvironment, such as chemical ligands. The electrical fields can
also have effects on stromal cells and render them more susceptible to interaction with
glioma cells.
To test these hypotheses:
• First, a robust in vitro experiment platform must be developed. Common mi-
crofluidic prototyping materials are limited by their properties. In Chapter 2, I
describe the key criteria for building 2D microfluidic chips for cell culture and
the development of novel hybrid microfluidic platforms for high throughput ex-
periments to study glioma biology.
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• Secondly, an easy-to-use tool to accurately track cell migration under label-free
phase contrast microscopy is still lacking. To that end, I establish a machine
learning approach for segmenting and tracking of single cells in Chapter 3.
• Thirdly, I discuss the investigation of migration and the underlying mechanisms
of glioma cells under electric fields, specifically involving voltage-gated calcium
channels on a hybrid microfluidic system in Chapter 4.
• Lastly, I investigate the adhesion of glioma to vascular endothelial cells as a part
of the infiltration process in Chapter 5.
Chapter 2
Hybrid microfluidic platforms for
reliable in vitro cell studies
Abstract
Robust and easy-to-use microfluidic chips are vital to reliably culture cells in microenviron-
ments. Although miniaturization offers various advantages of microscale physical phenomena,
the accompanied complex integration hinders versatility and microscale interfacial phenom-
ena become important, which can impact cell viability by microbubbles. Therefore, designing
a functional microfluidic platform with microscale physics and cell viability in mind is a crucial
step before probing the biological process. In this chapter, I introduce briefly the keypoints
for designing and fabricating 2D microfluidic platforms for cell culture. A standard thermo-
plastic chip for cell culture is introduced. Next, a hybrid PMMA/PDMS microsystems is
introduced for studying various topics in glioma cancer biology. A hybrid PMMA/PDMS
chip design for high-throughput glioblastoma electrotaxis study is first described and later
used in the work described in Chapter 4. Subsequently, a reversible hybrid PMMA/PDMS
chip for glioblastoma-vascular adhesion study is introduced in detail for the work in Chap-
ter 5. Hybrid microfluidics approach combines the advantages of thermoplastic microfluidics
and PDMS microfluidics and mitigates some of their respective disadvantages. Versatile
3D microfluidic designs and world-to-chip interfaces can be implemented while maintaining
high spatial dimensional accuracy on vital microfluidic channel dimensions. The hybrid mi-
crofluidic approach is suitable for rapid prototyping of complex designs to answer biomedical
questions in laboratory settings.
2.1 Introduction: development of 2D microfluidic
cell culture platforms
Miniaturization offers advantages such as reduced cost and precise control of microen-
vironment, yet it faces certain challenges. At microscale, the geometries and surface
properties in microfluidic chip as well as the interface to connect reagents in macroscale
to microfluidic chip, also known as “world-to-chip” interface, need to be considered
carefully and tailored to the biomedical questions.
In this chapter, I discuss key aspects of designing a continuous-flow microfluidic
bioMEMS system focused on cell studies. Open-surface microfluidics such as in digital
microfluidics or surface acoustic wave microfluidics, two-phase microfluidics such as in
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droplet microfluidics, and capillarity flow microfluidics such as in paper microfluidics,
are beyond the context of this thesis. Readers are referred to specialized review articles
regarding the physics and the applications in those devices93,310.
2.1.1 Designing microfluidic chips
When designing microfluidic devices, the fluid mechanics and chemical transport in
microsystems must be considered and respected to avoid tedious revision cycles.
Governing equations in microsystems Understanding the fundamental physical
phenomena dominating at the microscale is critical. Based on the fundamental work in
fluid dynamics, it is useful to employ dimensional analysis when considering microfluidic
systems89.
In continuous microfluidic systems, the fluid flow without bubbles at microscale
follows the fundamental conservation laws and the fluids can be considered as incom-
pressible. By mass conservation, the velocity and the density of the fluids are linked
and can be expressed by the continuity equation311:
∂ρ
∂t
+∇ · (ρu) = 0, (2.1)
where the gradient operator in the cartesian coordinate system,∇ = (∂/∂x, ∂/∂y, ∂/∂z).
For the velocity field of incompressible fluids, it satisfies:
∇ · u = 0. (2.2)
To further describe the motion of incompressible Newtonian fluid (assuming the
liquid of consideration is Newtonian), wherein the stress is linearly related to the rate-
of-strain, in microscale, the velocity vector u and pressure p are related by the Navier-
Stokes equation:
ρ
(
∂u
∂t
+ u · ∇u
)
= −∇p+ µ∇2u+ fb, (2.3)
where fb represents body forces (per unit volume) that act on the Newtonian fluid.
The Navier-Stokes equation describes the conservation of momentum. Note in
Equation 2.3, the shear viscosity µ is assumed to be a constant as in Newtonian fluids,
however, real-world fluids may be non-Newtonian and in some microfluidic flows, tem-
perature variations could cause significant variation in µ, where the velocity profiles
can be significantly affected.
The Navier-Stokes equation is difficult to solve analytically because it is a non-
linear differential equation, but in a simple microfluidic geometry with incompressible
fluid away from the inlet and the outlet, if the flow is fully developed, the non-linear
term in Equation 2.3, u · ∇u = 0, can be eliminated311.
Using common microfluidic fabrication methods, we can obtain channels with rect-
angular or nearly rectangular cross-sectional shapes. In the simple microchannel form,
where a channel is much wider in comparison to its height h ≪ w, which is also
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known as a Hele-Shaw flow cell, the velocity profile across the channel is parabolic.
And the relationship between the flow rate and the pressure can be approximated by
Equation 2.4:
Q =
(
1− 6× 2
5
pi5
h
w
)
wh3
12µl
∆p. (2.4)
Analogous modeling of fluidic network and electrical network The two el-
ementary rules of electric circuits are Ohm’s law and Kirchhoff’s law. In Ohm’s law,
the electric resistance R is dependent on the system and the materials with electrical
resistivity of ρ while relating the linear change between the electric potential ∆V and
the current I in the following relationship:
R = ρ
∆V
I
. (2.5)
The Kirchhoff’s law describes the conservation of charge, where in steady states,
for a node of a circuit where N number of currents I meet:
N∑
i=1
Im = 0. (2.6)
The electrical circuits are described with algebratic relations that are also analo-
gous to those of fluids in a channel network as far as continuity equation and single
phase fluid dynamics apply. In microfluidics, the rate of mass of transported fluid,
the force needed to move the fluid, and the viscosity of the fluid are analogous to the
current, electrical voltage difference, and the electrical resistance in an electric circuit
(Table 2.1)311.
For electrical systems, ∆V is the potential difference, I is the electrical current and
R is the electrical resistance. when such analogy is translated into fluid mechanics, with
single-phase laminar flow, ∆p is the pressure difference, Q is the volumetric flow rate,
and RH is the hydrodynamic resistance. The electrical power is used to describe the
energy/time dissipated and equals to I2R and analogous to Q2RH in a fluidic circuit.
The Ohm’s law relates the current density j to the electric field E by conductivity σ
of the material. The corresponding Darcy’s law in flow dynamics relates the average
velocity uavg to the pressure gradient by permeability k and viscosity µ. In a cylindrical
tube of radius a, the electrical resistance R is similar although not analytically identical
to the hydrodynamic resistance RH in fluid mechanics.
The fluidic resistance of a Poiseuille flow in a rectangular microchannel is given
by89:
RH =
12µl
wh3
[
1− h
w
(
192
pi5
∞∑
n=1,3,5
1
n5
tanh(npiw
2h
)
)]−1
, (2.7)
where µ is the fluid viscosity, l is the channel length, w is the channel width, and h is
the channel height. If channel is much wider compared to its height h≪ w, the fluidic
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Table 2.1: The analogous comparison between electrical and fluid mechan-
ical expression of steady state flow in a cylindrical tube311. Reprinted with
permission of Springer Nature.
Electrical relation Fluid mechanical relation
V = IR ∆p = QRH∑N
i=1 Ii = 0
∑N
i=1Qi = 0
Power = I∆V = I2R Power = Q∆p = Q2RH
j = σE (Ohm’s law) uavg = − kµ∇p (Darcy’s law)
R = ρl
pia2
RH =
8µl
pia4
resistance can be reduced to :
RH =
12µl
wh3(1− 0.53 h
w
)
. (2.8)
Consideration of hydraulic resistances of microchannels in the microfluidic circuits
is especially useful and important when designing the microfluidic chip to manipulate
fluid transport in order to design functional devices with relevant biological questions
in mind312–315. Due to the analogous relationship between the electrical expression
and fluid mechanical expression, the techniques used in electrical circuit analysis can
be performed similarly for hydraulic circuits92. We can also adapt the Ohm’s law and
Kirchhoff’s law to calculate and analyze what the flow will behave in a microfluidic
network. The analog electric circuit simulators such as Simulation Program with In-
tegrated Circuit Emphasis (SPICE) that is part of many electronic design automation
(EDA) software can also be adapted for designing microfluidic circuits316.
Dimensionless numbers in microsystems There are several useful dimensionless
numbers to consider when designing microfluidic chips for cell applications.
1. Reynolds number
The Reynolds number, Re, is a dimensionless parameter to determine if the
system is in the laminar or turbulent regime. It is a measure of competition
between the inertia force over the viscous force in the flow. In general, most
microfluidic chips for cell studies involve Reynolds numbers much smaller than 1
and the flows in the lab-on-chip devices are observed to be laminar.
Re =
ρULc
µ
,
=
ρUDh
µ
,
(2.9)
where Lc is a characteristic length scale related to the flow field, U is the char-
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acteristic velocity, ρ is the density, and µ is the dynamic viscosity of the fluid.
In a microfluidic chip with small height, the characteristic length may be the
hydraulic diameter of the channel Dh.
2. Poiseuille number
The Poiseuille number can be used to describe flow resistance in ducts of arbitrary
cross-section and is defined as the product of a frication factor f and the Reynolds
number Re312,317:
Po =
fRe
4
,
= − 1
µ
dp
dx
D2h
2U
,
(2.10)
where µ is the viscosity, dp
dx
is the pressure drop per unit length, U is the velocity
magnitude, and the characteristic length scale Lc used to calculate Re is Dh, the
hydraulic diameter.
The inverse relationship between the friction factor and Reynolds number means
that the pressure drop is linearly proportional to the flow rate312. Many microflu-
idic channels fabricated by micromachining bear a rectangular cross-section, and
the fRe and the Poiseuille number of different geometries have been solved and
reported317. For example, the Poiseuille number of a round capillary has a value
of 16, the Poiseuille number of a microchannel with rectangular cross-section
profile can be calculated by the following equation:
Po(rectangular) = 24(1− 1.3553α + 1.9467α2 − 1.7012α3 + 0.9564α4 − 0.2537α5),
(2.11)
where α is the ratio between height and width (h/w). Using the Poiseuille num-
ber, the relative hydraulic resistance of microchannels with different cross-section
areas can be estimated and compared.
3. Péclet number
Recall the mass balance equation for chemical transport (Equation 1.1), at equi-
librium without reaction, the left hand side describes the passive scalar convection-
diffusion in a uniform fluid:
∂c
∂t
+ u⃗ · ∇c = ∇ · (D∇c) . (2.12)
This equation can be nondimensionalized involving the Péclet number:
∂c∗
∂t∗
+ u⃗∗ · ∇∗c∗ = 1
Pe
∇∗ · (∇∗c∗) . (2.13)
The Péclet number describes the proportional relationship of chemical transport
between convective fluxes and diffusive fluxes. In a system of high Péclet number,
the diffusion is negligible whereas in low Péclet number system, the scalar (i.e.,
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solute concentration) distribution governed by diffusion follows the Fick’s Law92:
Pe =
ULc
D
, (2.14)
where U is the characteristic velocity, Lc is the characteristic length, and D is
the diffusion coefficient of the scalar.
In many microfluidic chips for cell studies, they reside in the limit of low Reynolds
number (laminar) and high Péclet number (minimal diffusion) so as to allow
isolation and patterning of chemical species within the microenvironment.
2.1.2 Rapid prototyping of microfluidic chips
The microfluidics thrive with the advances of the MEMS technologies but is not lim-
ited by the typical silicon materials. Due to the demands on optical transparency
and sterility in many biomedical applications, prototyping microfluidic devices made
significant progress with disposable materials such as thermoplastics, elastomers, and
glasses318,319. To manipulate and control fluids in microscale, tailor-made microfluidic
chips dedicated for specific applications are common, thus microfluidics demands rapid
and simple fabrication processes.
Although the materials of choice are abundant, such as SU8 epoxy320 or perfluo-
ropolymers321,322 for extreme chemical resistance, in this thesis I will focus on the most
common materials. Table 2.2 shows the comparison of pros and cons between different
materials for microfluidic prototyping. In this section, I overview the mainstream tech-
nologies used to fabricate microfluidic chips for cell culture applications focusing on
chip fabrication, world-to-chip interface, and chip assembly (bonding). The keypoints
for successful cell culture on microfluidic chips will also be discussed.
Soft lithography: PDMS microfluidic chips
The standard fabrication method of microfluidic chips takes advantage of the tech-
nologies developed for microelectromechanical systems (MEMS). A specialized tech-
nique adapted from standard MEMS lithography techniques, soft lithography, is widely
adapted for fabrication of poly(dimethylsiloxane) (PDMS) based microdevices323–326.
PDMS is a transparent and biocompatible silicone rubber suitable for fabrication of
microdevices for biomedical applications.
In soft lithography, the desired microfluidic channel patterns are designed and a
photomask is fabricated. A thin layer of photosensitive materials that change property
when exposed to light, also known as photoresists, is coated uniformly on a substrate.
Afterward the pattern is exposed by illumination (usually UV light) through the pho-
tomask or on more advanced systems, the pattern is directly written by laser scanning
or projection through a structured light modulator. The photosensitized pattern is
then developed and obtained as a mold for the microfluidic chip. The mixed uncured
PDMS monomers with cross-linking agents are then poured onto the mold, thermally
cured, and subsequently bonded to a glass or PDMS substrate (Figure 2.1). Through
this process, microstructures in micrometer or nanometer scale can be replicated by
the PDMS326.
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Figure 2.1: Schematic illustration of soft lithography for PDMS fabrica-
tion326. Microstructures fabricated by photolithography as well as nanostructures
fabricated by E-beam lithography can be replicated by PDMS through different pro-
tocols. Reprinted with permission of Springer Nature.
The biocompatibility of PDMS and the soft lithography prototyping for highly ac-
curate microstructures have contributed to the dominant use of the material in today’s
academic as well as industrial communities. Moreover, elastomeric and gas-permeable
properties of PDMS have enabled its use for special lab-on-chip applications such as
actively controlled microvalves327,328 and gaseous gradient microchip329–331 for studies
involving automation and microenvironment manipulation. Furthermore, 3D PDMS
chips can be fabricated by stacking multiple layers of designed structures very similar
to the integration of multi-layer integrated circuits in the MEMS fabrication327,332.
However, the low surface energy of PDMS limited the methods of bonding PDMS
to versatile materials without surface activation. Furthermore, the hydrophobic and
porous properties of PDMS promote adsorption and diffusion of hydrophobic com-
pounds during experiments, making estimation of accurate chemical concentration dif-
ficult. In applications with organic solvent, depending on solubility, often PDMS will
swell and deform. More advanced castable materials such as off-stoichiometry thiol-ene
epoxy (OSTE) with less adsorption of hydrophobic compounds that can replace PDMS
have been developed333.
Thermoplastic microfluidic chip
Adaption of thermoplastics and polystyrene especially for biomedical research became
popular for their biocompatibility and single-use properties. The use of thermoplastics
for microfluidic chip fabrication is also popular for its low cost, potential for mass
production, and biocompatibility.
Thermoplastics microfluidic chip based on poly(Methyl methacrylate) (PMMA),
polycarbonate, and cyclic olefin copolymer (COC) can be fabricated by laser cut-
ting334,338, micromilling335,339, hot-embossing336,340,341 or injection molding337,342,343 (Fig-
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Figure 2.2: Fabrication methodology for thermoplastic microfluidic chips.
(A) Direct-write laser cutting334. Reprinted with permission of Elsevier.; (B) Mi-
cromilling335; (C) Hot embossing336; (D) Injection molding337. Reprinted with permis-
sion of John Wiley and Sons.
ure 2.2). Laser cutting and micromilling is especially well adapted in laboratory settings
while the same design can be fabricated in mass volume using more industrial methods
such as roll-to-roll hot-embossing or injection molding344. PMMA can be easily pro-
cessed using laser cutting or micromilling, but its chemical compatibility and moisture
absorption is not excellent. COC or cyclic olefin polymers (COP) are newly invented
thermoplastics that have better performance in chemical compatibility with high gas
permeability but low moisture permeability (Table 2.3). Therefore, COCs and COPs
have been adapted in biomedical devices and in pharmaceutical packaging.
Although, thermoplastics are favored for microfluidics for its cost-effectiveness and
mass producibility337,346, they have limited chemical compatibility compared to glass
and usually limited spatial resolution (Table 2.2) by prototyping methods in comparison
to PDMS in soft lithography. However, compared to the other two methods, complex
3D microfluidic structures and versatile world-to-chip interface can be realized easily on
thermoplastics through chip stacking and surface treatment. The properties of different
thermoplastics are summarized in Table 2.3345.
Glass microfluidic chips
The main composition of glass is silica, SiO2, but depending on the purity and chem-
ical composition, glass can be categorized as fused silica, borosilicate, and soda lime.
Fused silica is composed of high purity amorphous silica. Borosilica and soda lime
have additives such as boron oxide, sodium oxides, or calcium oxide to lower melting
temperature for manipulability and enhancement for thermal or mechanical properties.
Conventionally, microfluidic structures can be fabricated on glass by using powder
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Table 2.3: Summary of properties for thermoplastics345. Reprinted with per-
mission of AIP Publishing.
sandblasting or ultrasonic milling347 (Table 2.4). Through MEMS fabrication method-
ology such as lithography, dry etching by reactive ion, and wet etching, precise mi-
crostructures in micrometer to nanometers can be fabricated348. In addition, high
power lasers can be used to directly modify glass structures, photopolymerization, and
induce backside wet etching. In the direct modification process, femto-second lasers
can be employed to modify glass, also known as selective laser etching (SLE) (Light-
fab GmbH, Germany)349–351. The portion modified by lasers will have high etching
selectivity compared to pristine counterparts in wet etching agents, e.g., KOH. Pho-
topolymerization of silica-containing agents using ultrafast lasers (Nanoscribe GmbH,
Germany) has been shown to fabricate a full glass microdevice with comparable perfor-
mance of a fused silica device after sintering352,353. In addition, using organic dyes with
high absorbance at diode-pumped solid-state laser wavelength, wet etching within the
microchannels can be achieved through laser-induced backside wet etching (LIBWE)
process354–356.
The advantages for glass microfluidic chips over PDMS and thermoplastics are
optical transparency, dimensional accuracy and stability, and chemical compatibility.
Therefore, use of glass is especially favored in experiments where good surface property
or optical quality are required, such as in electrokinetics, organic extraction, or optical
absorbance in the ultraviolet region357.
Rapid Prototyping using 3D printing
In recent years, 3D printing techniques such as selective laser sintering (SLS), fused
deposition modeling (FDM), inkjet printing, stereolithography, and two-photon poly-
merization or etching have been used to directly fabricate microfluidic chips or fabricate
the mold for the microfluidic chip (Figure 2.3)359–364.
Direct whole chip fabrication with minimum post-processing can save time and ef-
fort during the prototyping phase for microfluidic applications. Most of direct whole
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Table 2.4: The dimension of fabrication in glass microfluidic chips using
various methods351,353,354,358. HF: hydrofluoric acid; RIE: reactive ion etching.
Method Minimum
feature size
Maximum
depth
Aspect
ratio
Design definition
by Mask
Fabricated
structures
Drilling 800 µm >1mm 10 No 2D
Micromilling 500 µm >1mm 10 No 2.5D
Ultrasonic drilling 75 µm >1mm 10 No 2.5D
Electrochemical discharge drilling 50 µm >1mm 15 No 2.5D
Photosensitive glass 50 µm >1mm 20 Yes 2.5D
Powder blasting <50 µm >1mm 2.5 Yes 2.5D
HF etching 1 µm >1mm 1 Yes 2.5D
RIE etching 0.5 µm 10 µm 5 Yes 2.5D
Selective laser-induced etching 10 µm <7mm 700 No 3D
Two-photon photopolymerization 20 µm >1mm 10 No 3D
Laser induced backside wet etching 100 nm <1µm 10 No 2.5D
chip fabrication that is commercially available are based on the FDM method in
poly(Lactic acid)365 or COC (Fluidic Factory, Dolomite®). Industrial-level mass pro-
duction by using 3D printing is possible but is still inferior at current technological
level and cost performance is low when compared to conventional technologies. For
3D printing to replace the mainstream industrial methods such as hot embossing and
injection molding, significant industrial evolutions on both fabrication technologies and
materials need to be realized. For most biomedical applications involving microscopy,
optical transparency is particularly important. Many molds or devices made by 3D
printing do not meet the minimum surface quality standard, hindering the deployment
and application of 3D printing for microfluidics. However, several surface annealing
methods or tailor made materials can realize 3D printed workpieces with higher op-
tical quality366,367. The material biocompatibility and surface quality are key issues
that require revolutionary improvements for 3D-printed microfluidic chips to become
mainstream devices that can be adapted by the biomedical research community.
2.1.3 World-to-chip interface for microfluidic chips
To manipulate the small fluid volume in microfluidic chips, it is necessary to connect the
channels to syringe pumps, pressure source, or electrical connection for fluid actuation.
A robust, versatile, and cost-effective world-to-chip interface is very important for
the success of the microfluidic applications. While many world-to-chip interfaces are
commercially available, it is still common for laboratories to develop custom world-to-
chip interfaces due to individual experimental requirements.
In this section I will briefly discuss the common methods to build world-to-chip
interface especially for microfluidic cell culture. The readers are referred to review
texts for more comprehensive discussion368,369.
1. Direct tubing interfacing
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Figure 2.3: Various 3D printing techniques for rapid prototyping microflu-
idic chips360. Reprinted with permission of John Wiley and Sons.
The most straightforward method to connect tubings is by inserting into the
inlet/outlets in the microfluidic chip.
• Temporary interfacing
For PDMS microfluidic chip, due to the elasticity of the PDMS rubber, a
tubings with outer diameter slightly larger with the inlet/outlet diameter
can securely interface with a PDMS microfluidic chip by directly inserting
the tubes. However, any strains from the tubing on the PDMS may damage
the inlet/outlet interface and cause leakage or introduction of bubbles.
Alternatively, small stainless steel tubes such as those from New England
Small Tubes can serve as an intermediate between PDMS and tubings
with higher stability. The small configuration using small stainless steel
tubes also makes it popular in applications of large scale integration of high
throughput PDMS devices327.
• Permanent bonding
Due to the rigidity in thermoplastics and glass, temporary interfacing of tub-
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ings on them usually are not secure. Alternatively, epoxies or cyanoacrylates
can be used to permanently join the tubings with the inlet/outlet. How-
ever, there is a risk of contamination of the adhesives infiltrating into the
microfluidic chips.
2. Mechanical sealing
Most commercially available world-to-chip interface for microfluidic chips employ
mechanical sealing or have a fluidic interface built or affixed to the microfluidic
chips, such as products from Micronit, S.E.R. Corporation, Microfluidic Chip-
shop, Dasfanh, Dolomite, and Corsolutions.
It is common to employ gaskets (o-rings) to seal the connect ports on the microflu-
idic chips by means of clamping370–372, vacuum suction373, or magnetic sealing374
in single channel format or in multichannel manifold.
Being a reversible sealing method, it is easy to set up experiments using mechan-
ical sealing, however, if the pumping pressure for fluid delivery exceeds the limit
for the interface, leakage may bring problems such as contamination to the cells
culture or microbubbles in microfluidic chips.
3. Special adapters
Special adapters can be affixed on microfluidic chips to connect the chips with
tubings, offering a high pressure withstanding a permanent solution in compari-
son to the mechanical sealing approach. Special adapters with small dead volume,
such as barb, Luer, Mini-Luer or Olive connectors, are invented to easily and se-
curely connect to tubings but usually will require such receiving structures being
fabricated on the microfluidic chips. Some other examples are D-sub-like connec-
tors375 or adapters of special shapes that are fabricated by 3D printing376–378.
4. HPLC fitting
Although specially designed adapters can be used to connect to chips, many
microfluidic research groups choose to use fittings meant for high performance
liquid chromatography (HPLC), such as provided by IDEX Corporation, Waters,
or Cole-Parmer. These commercially available fittings have precise pore sizes to
interface with tubings that will withstand high pumping pressure. For extremely
low dead volume applications, adhesive-fixed Nanoport connectors are also used
such as in on-chip electrophoresis experiments or nanofluidics.
The HPLC fittings are reusable, autoclavable, and chemically stable, making
them extremely suitable for cell applications. Usually the threads of these HPLC
fittings are standard such as M6 or 1/4–20. To interface with HPLC fitting to
microfluidic chip, either threads must be tapped on the microfluidic chip or an
adapter with threads must be affixed to the microfluidic chip (Figure 2.4)196,202,379.
These adapters are commercially available at a reasonable price between USD$0.1
to 0.5 per piece.
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Figure 2.4: Disposable adapters for HPLC fittings379. (Left) A PMMA adapter
with 1/4–20 thread; (Right) A polycarbonate adapter with M6 thread.
Table 2.5: Bonding methods established in Micro/Bio/Nanofluidics Unit at
OIST.
2.1.4 Bonding strategies for microfluidic chips
By the majority of the fabrication methods listed in Section 2.1.2, the microstructures
are fabricated either by an addition or a subtraction approach. Although embedded
3D structures can be made through 3D printing or by non-linear optics as in Lightfab
glass fabrication, the microfabrication technologies stemming from MEMS industry
usually create microstructures affixed to one side of the substrate that require another
substrate to be bonded to form a complete device.
It is also common that the microfluidic chip design is fabricated on a relative cheap
and disposable device with less ideal surface properties but can bond to a more stable or
less processable substrates where reaction happens such as those in PDMS microfluidic
chips bonding to a piece of glass substrate.
Several bonding protocols are validated to support fabrication of microfluidic chips
of different materials in our group (Table 2.5).
Bonding strategies for PDMS based microdevices
PDMS is among the most popular material to prototype microfluidic devices in both
laboratory and industrial settings. However, cured PDMS has a low surface energy,
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limiting its flexibility. Here I overview the most common bonding methods of PDMS
to glass, PDMS, and thermoplastics.
1. PDMS-Glass bonding
The standard method to bond a PDMS to a glass substrate utilizes silanol-silanol
bonds. Due to the low surface energy of PDMS, its surface has to be activated
by collision of high energy gas particles typically generated through vacuum gas
plasma380, vacuum ultraviolet (VUV) irradiation381,382, or corona discharge383.
In some reports, PDMS-glass microfluidics chips are joined reversibly using me-
chanical compression384,385 or vacuum sealing386–389. However, these reversible
sealing approaches require utmost cleanliness and flatness of the microfluidic de-
vice to avoid deformation of the microstructures that will cause failure of the
sealing.
2. PDMS-PDMS bonding
Bonding of PDMS to itself or anything other than glass is not as straightforward.
For PDMS-PDMS bonding, we can use oxygen plasma, corona discharge, PDMS
adhesive390, partial curing, and off-stoichiometry curing391.
Typically, PDMS-PDMS direct bonding using O2 plasma or corona discharge do
not achieve high bond strength and may subject to local defects due to non-
uniform surface properties of the cured PDMS. Moreover, the activated surface
will bond immediately after contact, making alignment between PDMS compo-
nents difficult. Alternatively, PDMS adhesives can be used to join two pieces of
PDMS, however, obstruction of microstructures by the adhesives is possible.
By using partial curing392,393 or off-stoichiometry curing332, very high bond strength
of PDMS can be achieved. In partial curing, the PDMS will cure on the mold
as in soft lithography but peel off before the PDMS is fully cured. The partially
cured pieces are aligned and baked further to be completely cured. The working
time window is of essence in partial curing method. In off-stoichiometry curing,
the monomer-to-curing agent ratio is deliberately off-balanced for each pieces.
One PDMS piece typically bears a 7.5:1 ratio while the other bears 15:1. The
former will cure rapidly and still have excessive curing agent within the cured
piece while the latter will be partially cured with high monomer left in the piece.
After alignment and contacting both pieces, during the incubation, the excessive
curing agent in the former piece will diffuse through the interface to the other
and additional cross-linking creates a very strong bonding.
3. PDMS-plastic bonding
Heterogenous bonding between PDMS and thermoplastics is particularly difficult.
However, with specific surface functionalization, PDMS and plastics can be joined
covalently or reversibly.
• Double-sided tape
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Polymeric doubled sided types could be used to join PDMS and thermo-
plastics by curing a thin layer of PDMS with the double-sided tape adhe-
sive394–396. However, the adhesive strength is not high and may subject to
delamination by shear force.
Alternatively, a special dual energy sided tape composed of a layer of silicone
type adhesive and a layer of acrylic type adhesive, can be used to join the
PDMS with thermoplastics or other surface397,398. Using double-sided tapes
is an easy approach to assemble complex hybrid microdevices.
• Adhesives and silane-assisted functionalization
Commercial adhesive with a priming step to activate the surface can be
used to join PDMS and alternative material399. Similar surface function-
alization can be used to covalently bond PDMS and alternative materials
other than glass, typically by silanes such as (3-aminopropyl)triethoxysilane
(APTES)400–408.
Figure 2.5: Diagram of silane assisted bonding409. Heterogenous substrates
are treated with plasma and incubated with either APTES or GPTES. Afterward, the
surfaces of two substrates can be bonded after contact to form stable amino-epoxy
bond.
Strong and reliable chemical bonding using amino-epoxy bonds has been
reported in room temperature (Figure 2.5)409. The bond strength can with-
stand stronger solvent such as 99.5% ethanol.
Bonding strategies in thermoplastic chips
The surface energy for thermoplastic is usually high and easy to modify further for
bonding. Several bonding strategies such as thermal annealing, surface activation
bonding, solvent-assisted bonding, or adhesive bonding can be used410.
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1. Thermal annealing
For thermoplastic substrates fabricated with microstructures through laser cut-
ting or micro-milling, the microfluidic chips can be easily completed by assem-
bling, compressing, and heating the assembly above glass transition temperature
(Tg)202,334,411.
Other energy directed methods that generate focused heating can also thermally
anneal thermoplastics chips, such as ultrasound bonding412 or laser welding413.
However, special design or equipment for energy localization are typically re-
quired.
2. Surface activation bonding
The surfaces of thermoplastics are usually hydrophilic and can be easily func-
tionalized. However, while the standard O2 plasma can further render the sur-
face hydrophilic, the thermoplastics such as PMMA or COC cannot be bonded
simply by plasma treatment. Using higher energetic methods such as vacuum
ultraviolet irradiation (VUV) at 172 nm (Ushio, Japan)414,415 or UV/Ozone416,
the thermoplastics substrates such as PMMA or COC, can be joined with their
counterparts of the same material after slight compression and heating below the
glass transition temperature.
3. Solvent-assisted bonding
By using organic solvent to partially melt the surface layers of thermoplastics,
pieces of thermoplastics can be joined after drying of the solvent417–419. However,
using this method will leave residues of solvent as well as monomers that can be
toxic to cells.
4. Adhesive bonding
Using adhesive to bridge between respective plastic materials such as cyanoacry-
late or UV-curable adhesives can yield very high bond strength420. However,
if the channel dimension is very small, the adhesive can infiltrate into the mi-
crochannels and cause blockage. The adhesive can also have cytotoxic effect if in
direct contact, thus this approach should be avoided for cell culture applications.
Bonding strategies in glass chips
1. Thermal bonding
Similar to thermoplastic chips, by heating glass chips above glass transition tem-
perature, the glass microfluidic chips can be bonded to another glass piece421,422.
However, as the material is brittle, careful annealing process is needed to avoid
cracking of the bonded chip.
2. Surface activation bonding
It has been reported by using gas plasma to activate the glass surface, the glass
devices bearing nanofluidic channels can be bonded and withstand pressure of
500 kPa423–425.
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By using potassium hydroxide426,427 or sulfuric acid428,429 to activate the surface,
glass components withstanding extreme vacuum such as space applications can
be bonded.
3. Anodic fusion bonding
For glass-silicon microfluidic chips, the anodic fusion bonding employed in the
MEMS industry is commonly applied430–432. Anodic fusion bonding433,434 allows
glass to join with a metal or a silicon wafer below the glass transition temperature
by using an electric potential to deplete the sodium cation at the bond interface
and allow the drift of singlet oxygen ion into the depletion zone. Formation of
siloxane bonds ensures the irreversible connection between the two pieces.
4. Adhesive bonding
Adhesives, such as UV-curable adhesive, epoxy, SU-8, or PDMS, can also be used
to join glass microfluidic chips435. However, if the channel dimension is very
small, the adhesive can infiltrate into the microchannels and cause blockage436.
2.1.5 Culturing cells on microfluidic chips
Miniaturization of microfluidics provides many advantages compared to conventional
cell culture, such as sterility, low shear stress, low reagent & cell consumption, and pre-
cise microenvironmental control. However, to support good cell growth on microfluidic
chips is not a simple task.
In conventional cell culture, the key parameters are sterility, pH, nutrient, and
temperature. Typical cell culture media are formulated with iso-osmotic medium with
carbohydrate, lipid, and proteins. To ensure acidity remaining in physiological range,
one or multiple pH buffering systems are chosen. Often the CO2/NaHCO3 system is
adapted. The modern cell culture incubators are designed with water jacket heating,
CO2 mass flow control, and high-efficiency particulate air (HEPA) filter, to provide
stable temperature, gas, humidity, and sterile environment. However, when considering
the cell microenvironment on microfluidic chips at low Reynolds number, the chemical
transport and heat transfer processes must be taken into consideration.
To design a good microfluidic chip for cell studies is an integrative problem437. Here,
I give a short discussion on the key issues when developing a cell culture microfluidic
chip.
1. Biocompatibility of substrate and chip material
First of all, the biocompatibility and experimental compatibility of the substrate
and chip materials are very important. For commonly used microfluidic materials
such as PMMA and PDMS, they have good biocompatibility and usually no
particular attention is needed when culturing normal cells. However, for culturing
sensitive cells, such as stem cells and primary neurons, the impurity and low gas
permeability in PMMA or the platinum-based curing catalyst in PDMS may have
impact on cell survival on microfluidic chips.
Also, if the experiments involving strong solvents in later experiment stages,
such as extraction or cell staining, the compatibility of chip materials must be
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considered to avoid dissolution or swelling. Furthermore, if high resolution cell
imaging is required, use of high-precision glass coverslip as the substrate will be
necessary. The bonding between microfluidic chip and the substrate will need
to be optimized to avoid leakage of cell culture system which compromises the
microflow and the sterility.
2. Sterilization
In thermoplastic microfluidic systems, often it is difficult to sterilize the entire
microfluidic chip by steam sterilization due to significant deformation or melting
of the thermoplastics at 121 ◦C under 1–1.2MPa. However, in many cases, simple
UV disinfection of chip surface is enough for sterile cell culture.
The PDMS and glass microfluidic chips can be easily sterilized by steam steril-
ization. However, the fabrication process in the clean room usually ensures good
degree of sterility. In general, with use of sterilized microfluidic chips and steril-
ized accessories such as tubings, no antibiotic supplement in the culture medium
is required.
3. Microbubbles
In microfluidic system, the surface tension effect become significant so microbub-
bles become difficult to eliminate and their presence will significantly impact the
microflow, causing obstructed chemical transport. Furthermore, the air/liquid
interfacial tension at the bubble interface can cause cell death.
Due to the dissolved CO2 gas in the cell culture medium necessary for balancing of
pH, gas bubbles over time will grow bigger (precipitation) and may be displaced
by the media perfusion. The cells along the path of the displaced microbubble
can easily be sheared off. To resolve the problem, several priming methods to
eliminate bubbles in the system or create bubble traps to avoid transport of
bubbles from the world-to-chip interface can be employed202,438,439 (Figure 2.6).
Bubble-free environment is essential to ensure microsystems working as designed
and successful long-term cell culture in them.
Figure 2.6: Priming method to remove bubbles in PDMS devices439.
Reprinted with permission of Springer Nature.
4. Microflows at cell seeding
The volume in microfluidics usually range between nano-liters to tens of micro-
liters. If the microfluidic cell study requires high cell density in the viewfield
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under the microscope, the seeding cell density must be increased to over 1× 106
cells mL−1. In addition, the dead volume in world-to-chip interface must be
considered so sufficient amount of cells can reach the microfluidic channels.
For adherent cells, after cell seeding, an adhesion period must be given to allow
cells to adhere to the substrate. During this period, if there are microflows,
even with velocity of just a few µm s−1 potentially caused by minute pressure
difference, the distribution of cells may be easily affected and may impact cell
adherence, cell health, and differentiation440. Therefore, how cells are being
loaded into microfluidic systems must be handled carefully.
5. Environmental control
The most important thing to consider for long-term cell culture on microfluidic
chips is the environmental control. The gas, nutrient, and heat must be provided
to the cells for cell survival. It is especially appropriate to couple microfluidics
with live cell imaging, however, environmental control for microfluidics chip on
microscopes is also non-trivial. Several companies manufacture on-stage incuba-
tors for live cell imaging, such as Tokai Hit, Okolab, Pecon, Linkam Scientific,
Cherry Biotech, Bioptechs, BLAST Inc, Live cell Instruments, In Vivo Scientific,
and BioSpherix.
An on-stage microscope incubator typically consists of a heating stage, a top
plate with transparent heater, a humidifier, and gas mixer for appropriate gas
concentration. In some cases, a bottom heater composed of a transparent heating
glass can be used as a rudimentary heater to keep cells alive. Integrated solu-
tions may have an environmental chamber surrounding the entire microscope but
requires a long equilibrium time due to the large volume.
I discuss the key points in environmental control for successful cell culture in
microfluidic systems:
(a) Gas permeability of chip materials
First of all, in cell culture systems, the CO2/NaHCO3 buffering is usually
used. To maintain pH stability, the CO2 level needs to equilibrate with the
cell culture medium. For cell respiration, O2 must be accessible to cells.
In PMMA microfluidic chips, usually gas permeability is low which prevents
both gas equilibration as well as gas dissemination, but the CO2/NaHCO3
buffering can be ensured by using pre-equilibrated medium in the CO2 incu-
bator. In PDMS microfluidic chips, the gas permeability is high, thus CO2
and O2 can easily diffuse through the PDMS matrix if the atmosphere is
provided appropriately.
(b) Nutrient and waste perfusion
Due to the low volume in microfluidic systems, the mass transport of nu-
trient are diffusion-dominant in low Reynolds number environment. The
overall mass that cells can access is much less compared to conventional cell
culture systems such as those in petri dishes.
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Therefore, appropriate transport of new nutrient is necessary by perfusing
the microfluidic system. Typical perfusion methods include gravity driven
flow, air pressure driven pumping, peristaltic pumping, syringe pumping,
and electroosmotic pumping (Table 2.6)441,442. In particular, syringe pumps
and air pressure driven pumps are used commonly by researchers in the mi-
crofluidics community. Syringe pumps from Cetoni GmbH, Chemyx, New
Era Pumps, LabSmith, and Havard Apparatus are particularly favored by
many researchers. Fluigent, Elveflow, Corsolutions, and Dolomite also pro-
vide several variants of air pressure-driven pumps for driving microfluidic
flows.
Not only the perfusion but the waste removal is also important to avoid the
toxicity. Moreover, if the waste volume builds up, the hydrostatic pressure
acting on the cells may be large and cause cell death.
Table 2.6: Pumping methods for cell culturing on chips441.
Pumping method Advantages Disadvantages
Gravity-driven flow
1. Simple
2. Inexpensive
3. Power-free
4. Prevents microbubbles
5. No pulsatile flow
1. No direct control
2. Flow velocity changes by time
3. Hydrostatic pressure
Air-pressure driven flow
1. High stability and pulseless flow
2. Possibility to handle fluids in liters
3. Fast response time
4. Control fluids in dead-end channels
1. Require precise pressure supply and control
2. Precise flow rate control requires flow sensor
3. Potential loss of gas equilibrium
4. Works in open system
Peristaltic pump 1. Works in open or close systems2. Produces versatile push or withdraw flow
1. Pulsatile flow
2. Power requirement
3. Large footprints from mechanical parts
4. No pressure measurement
5. No direct flow rate measurement
Syringe pump
1. Closed system ensures sterility
2. Fast setup and easy flow rate control
3. Produces versatile push or withdraw flow
1. Power requirement
2. Long response time
3. Limited volume
4. Minute pulsatile flow
5. No pressure measurement
6. Large footprints from mechanical parts
Electro-osmotic pump
1. No mechanical parts
2. Reversible flow
3. Miniaturization integration possible
1. Power requirement
2. Electrolysis of media and cells possible
3. Difficult to ensure sterility
4. Surface properties are limited
(c) Shear flow in cell experiments
In the body, advection for nutrient and oxygen delivery through the ma-
jor vessels of the circulatory system is necessary while the tissue perfusion
becomes more diffusion limited. In hemodynamic flows, the Poiseuille flow
exerts shear stress to the blood vessel wall lined with endothelial cells. The
shear stress is part of the endothelial homeostasis443–445. It is known that
60 Hybrid microfluidic platforms for reliable in vitro cell studies
confluent endothelial cell layers will respond to shear stress above 1Pa and
align in parallel to the flow vector443,446,447. However, other cell types espe-
cially cells originated from the CNS, often do not like to be stimulated by
shear as it can lead to cell death.
Due to small channel cross-section in microfluidics, it is very easy to create
cell culture platforms with varied shear stress. A stable cell culture platform
with shear stress less than 0.01Pa for cells sensitive to shear can be easily
realized by lowering the flow rate.
In a microfluidic channel, the fluidic resistance of a simple Hele-Shaw flow
cell can be calculated as in Equation 2.8. The shear stress at the channel
wall estimated using the parallel-plate model is:
τw =
6µQ
wh2
, (2.15)
where Q is the volumetric flow rate, µ is the dynamic viscosity of fluids, w
is the width of the microchannel, and h is the height of the microchannel.
However, when considering the shear stress acting on a cell at the bottom
of the microfluidic channel, the geometry of the cell must be considered.
Gaver III et al., have proposed algebraic expression for the shear stress on a
cell which can be considered as a semicircular bulge on a microchannel wall
based on the lubrication theory448. For a cell with radius R in a microfluidic
channel with height of h, dependent on various cell size-to-channel height
aspect ratio, γ = R
h
, the maximum shear stress τ ∗s can be estimated:
(τ ∗s )max =
6µQ∗2−D
h2
{
2.95 γ < 0.25
1.158 + (1− γ)−2 0.25 ≤ γ ≤ 0.85
}
, (2.16)
where µ is the fluid viscosity, Q∗2−D is the flow rate per unit width, h is the
channel height, respectively.
(d) Temperature
To maintain cell survival, appropriate temperature must be supplied. Typ-
ically in cell culture microfluidic systems, 37 ◦C temperature is maintained
by on-stage incubators through passive heating of chips by holders and top
transparent heating lid or through close contact of the bottom of microflu-
idic chip to a transparent heater202.
In many cases, the accuracy of the heater for microfluidic cell culture is
demanding. In microfluidics, the high surface-to-volume ratio is associated
with high heat exchange coefficient and low thermal inertia so very little
power is consumed to keep microsystems stable at bioactive temperature.
However, if the temperature is not optimal in a microfluidic system, the cell
behavior will be significantly impacted.
(e) Relative humidity
Some microfluidic systems employ closed systems to ensure sterility, but
closed systems require accurate balancing of inflow and outflow to avoid
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hydrostatic pressure buildup that can cause cell death. Many microfluidic
systems employ partially closed systems with either inlet or outlet being
exposed to the ambient environment.
In microfluidic chips employing partially closed or opened systems, the ad-
verse effect of relative humidity (RH) is often overlooked. The volume in the
microfluidic system is very low in comparison to any openings on microflu-
idic chips for world-to-chip interface. It is practically difficult to maintain
a 100% relative humid ambient environment, so the water in culture media
tends to evaporate and cause significant osmotic stress to the cells.
The effect of relative humidity on media evaporation can be considered by
vapor pressure using Adren Buck Equation449:
Ps(T ) = 0.61121 exp((18.678− T
234.5
)(
T
257.14 + T
)), (2.17)
where Ps(T ) is the saturation vapor pressure in kPa, T is the air temperature
in degree of celsius. At 37 ◦C the saturated vapor pressure for water is
6279.88Pa with humidity ratio calculated as 0.0411 kg kg−1.
As relative humidity is defined as the ratio of partial water vapor pressure
over equilibrium vapor pressure, the partial vapor pressure at different rela-
tive humidities can be calculated. At a relative humidity of 95%, the partial
vapor pressure is 5965.9Pa with humidity ratio of 0.0389 kg kg−1. At a rela-
tive humidity of 90%, the partial vapor pressure is 5651.89Pa with humidity
ratio of 0.036 98 kg kg−1. At a relative humidity of 75%, the partial vapor
pressure is 4709.9Pa with humidity ratio of 0.0303 kg kg−1.
The evaporation rate can be further calculated using the humidity ratio:
ghr = ΘA(xs − x), (2.18)
where ghr is the amount of evaporated water per hour (kg h−1), Θ is the
evaporation coefficient in (kgm−1 h2) calculated as 25+19v, v is the velocity
of air above the water surface (m s−1), A is the water surface area (m2), xs
is the maximum humidity ratio of saturated air at the same temperature, x
is the humidity ratio air (kg kg−1).
Assuming in a microfluidic chip with an inlet and outlet of 2mm in length
and height of 5 mm, and a straight channel of 8.8 mm× 1 mm × 0.1 mm.
Assuming there is no draft, the total volume of the media is 126.5 µL ≈
126.5mg.
gs(95% RH) = 2.035 mg hr−1, (2.19a)
gs(90% RH) = 3.811 mg hr−1, (2.19b)
gs(70% RH) = 9.99 mg hr−1. (2.19c)
The volume change of water in the microfluidic chip in different relative
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humidities over 8 hours can be calculated by:
∆V = (126.5− (gs × 8))/126.5× 100%. (2.20)
Figure 2.7: Effects of relative humidity on cell culture medium evaporation
in the incubator.
Figure 2.7 shows how the evaporation rate and medium volume change de-
pend on the relative humidity in the incubator. Because the volume in
a microfluidic chip is much smaller than that in a petri dish, evaporation
can cause significant volume change that affects osmolarity. Also, in con-
ventional cell culture, petri dishes or flasks are often covered by a lid or a
cap to avoid contamination or evaporation, which is difficult to implement
in microfluidic chips. If the water evaporates significantly, the osmolarity
stress on cells in microfluidics will be significant and hinders long-term cell
culture.
To resolve this issue, typical microfluidic cell culture system employ partially
or totally closed system or use of anti-evaporative oil. In combination, an
enforced humidifier for on-stage incubators can be built to increase the
relative humidity to the microfluidic chips (Figure 2.8).
In short, to successfully culture cell on chips for biomedical applications, the design
and fabrication of the microfluidics and environmental factors must all be considered
carefully. Ensuring a stable microfluidic cell culture platform is the first step before
the platform can be used for any biomedical applications.
Next, I will introduce the three stable platforms I have developed for microfluidic
cell culture and experiments, including a thermoplastic microfluidic chip, a small hy-
brid PMMA/PDMS microfluidic chip, and a reversibly-sealed hybrid PMMA/PDMS
microfluidic chip.
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Figure 2.8: An enforced humidifier for Tokai Hit on-stage incubator.
2.2 PMMA thermoplastic microfluidic chip for cell
culture
Amicrofluidic electrotaxis chip containing two microchannels with l×w×h of 30×3×0.07mm
was composed of a top poly(methyl methacrylate) (PMMA) chip, a piece of double-
sided tape (PET8018PT, 3M, USA) cut with the microfluidic channels pattern, and
a coverglass substrate (0107242, No. 1.5 high precision, Paul Marienfeld GmbH, Ger-
many) (Figure 2.9A). The PMMA microfluidic chip was fabricated by patterning inlets,
outlets, and fluidic connections on PMMA sheets (0.5mm, CM205x, Chimei Corp, Tai-
wan) using a CO2 laser scriber and bonded thermally (109.5 ◦C, 810N, 30 minutes) as
described previously379. Adapters with M6 threads (SPC-M6-C, Nabeya, Japan) were
glued onto the PMMA microfluidic chip using a UV adhesive (3301, Loctite, USA).
The coverglass substrate was joined with the PMMA microfluidic chip using the cut
double-sided tape after UV disinfection of all surfaces.
The advantages for PMMA thermoplastic microfluidic chip include convenient cre-
ation of complex 3D structures, air-impermeant cell culture environment, and rigid
microfluidic structures. A microfluidic channel can be easily created by laser cutting
channel patterns on a piece of double-sided tape that is also used for joining thermo-
plastic chips to substrates.
By using thermoplastic microfluidic chip with CO2-equilibrated media perfusion and
a simple heater, cells could be cultured for weeks or months on chip202 (Figure 2.10).
The photoimage of the setup can be seen in Figure 2.11, where two thermoplastic chips
are installed on a transparent heater. The cell culture temperature is regulated by an
industrial proportional-integral-derivative (PID) controller and the nutrient is supplied
by syringe pumps.
However, to ensure a bubble-free microenvironment in thermoplastic microfluidic
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Figure 2.9: Schematics of a PMMA microfluidic chip containing two sim-
ple rectangular channels. (A) Three-layer patterned PMMA pieces are thermally
bonded. The PMMA piece affixes to the dish by a double-sided tape. Adapters for
inlets, outlets, and salt bridges (SB) are glued on; (B) A photoimage of the final as-
sembled device.
chip, the fluidic fittings and tubings must be installed before seeding the cells, increasing
the difficulty to adapt by non-specialists. Furthermore the dead volume in the tubings
increases the amount of cells required, increasing the difficulty of using scarce and
precious cells such as primary cells or stem cells.
Figure 2.10: The setup diagram of an electrotaxis experiment using a mi-
crofluidic chip. SB: salt bridges; SMU: source meter unit.
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Figure 2.11: The photoimage of electrotaxis setup using thermoplastic
chips.
2.3 A hybrid PMMA/PDMS microfluidic chip for
electrotaxis study in an on-stage incubator
In biomedical microdevices (BMMDs), biochemical and biophysical microenvironments
can be manipulated by combining device design and operation conditions to probe bio-
chemical and biophysical properties or to investigate biological phenomena. Practical
BMMD designs must consider system integration and fabrication process to reduce the
production volume and cost, ensure the sterilization and user-friendly operation450.
Transparent rigid thermoplastics, such as poly(methyl methacrylate) (PMMA) and
cyclic olefin copolymers (COC), and transparent elastomeric silicone rubber poly(dimethyl
siloxane) (PDMS) are particularly favored in BMMD production in laboratory set-
tings334,451,452.
However, each material has its distinct advantages and disadvantages (see summary
in Table 2.2). By using thermoplastics, fabrication cost is low while bonding strategies
and interconnect choices are more readily available for constructing the world-to-chip
interface. Fabrication of complex three dimensional (3D) internal structures is also
possible in thermoplastics chips, but the spatial resolution of direct-writing methods is
inferior in comparison to lithographic methods334. Alternatively, micrometer-precision
microstructures in PDMS substrates is possible through the soft lithography process, al-
though the process is usually limited to quasi-planar (2.5D) microstructures323. PDMS
is also flexible and highly gas permeable, making it suitable to fabricate BMMDs with
active components such as microvalves, and to create gas concentration gradients for
automated lab-on-chip applications. Although fabrication of complex 3D microstruc-
tures in PDMS BMMDs is possible, it requires complicated multi-step fabrication,
alignment, and off-stoichiometry bonding327. Moreover, PDMS has very low surface
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energy, which limits its bonding and world-to-chip interconnect choices.
The disadvantages of each material are not only restricted to fabrication, but also on
applications. For successful and reliable cell culture in BMMDs, it is essential to ensure
sterility, controlled microenvironment, and guided reagent delivery with bubble-free
conditions437. Bubble prevention is crucial because microbubbles can impose strong
interfacial tensions that shear adherent cells or cause cell damage in the microchannel.
In thermoplastic BMMDs, to minimize air bubbles, the device is often pre-assembled
with reagent delivery components and a world-to-chip interface prior to seeding cells
into the device. As a result, the dead volume tends to be large in pre-assembled
thermoplastic BMMDs, which leads to longer reagent delivery time to cells202. In
PDMS BMMDs, although a delicate buffer exchange procedure can be adapted to
prevent air bubbles in microchannels439, the hydrophobic nature of PDMS often causes
air bubble accumulation at world-to-chip interconnects, which can easily propagate
into microchannels. Moreover, the elastic nature of PDMS is prone to leakage at
interconnects453.
I present an approach to integrate PMMA and PDMS into a hybrid microfluidic
chip to combine the advantages of the two microfluidic engineering while mitigating
some of the disadvantages. High dimensional accuracy can be easily obtained in PDMS
microfluidics so the main microfluidic networks where the manipulation of microenvi-
ronments and cell culture take place is in the PDMS microfluidics. Complex 3D rigid
structures and versatile world-to-chip interfaces can be rapidly fabricated using PMMA
microfluidics. Furthermore, double-sided adhesive tapes have been a primary method
to bond heterogenous substrates in PMMA microfluidics334,454. An dual energy double-
sided tape that is composed of a silicone-type adhesive and an acrylic-type adhesive
can easily bond between PDMS and thermoplastics397,398, further increases the easiness
to rapidly prototype hybrid PMMA/PDMS microfluidic chip.
In this section, I introduce the first design of the hybrid PMMA/PDMS microfluidic
chip that has a small configuration which is suitable to study cell migration in on-stage
CO2 incubators. Highly accurate microfluidic channels can be designed and fabricated
in the PDMS microfluidic chip. Also, bubble-free and gas-permeant microenvironments
can also be easily established in PDMS microfluidics. Versatile and complex 3D world-
to-chip interface such as media reservoir, electrical stimulation, and waste withdrawal
outlets can be easily made in PMMA designs.
2.3.1 Microfluidic chip design: single-layer and double-layer
design
The goal of this work was to design a microsystem to study cell migration under elec-
trical stimulation (electrotaxis) in high throughput manner. Therefore, multiplexing
multiple electric field strengths and suppressing unwanted chemical transport were im-
portant features in the microfluidic design. While single-layer PDMS microfluidics,
i.e., single-height microchannels, was the norm, multilayer PDMS microfluidics offered
more delicate control of the microenvironments.
In this section, I introduce the microfluidic channel design of both single-layer and
double-layer to multiplex electric field strengths and manipulate the fluid flow and
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Figure 2.12: The concept of a small configuration hybrid PMMA/PDMS
microfluidic chip. (A) The 3D rendered model of the final PMMA/PDMS chip.
Double-layer microchannel design in the PDMS is shown; (B) The schematic diagram
of using the PMMA/PDMS chip for electrotaxis experiments. Complex 3D microfluidic
structures and world-to-chip interface are established in PMMA components A & B;
(C) The channel design. The 10 µm-high first layer structures are shown in cyan.
chemical transport. Two 2mm-wide main channels were designed to support study
of two conditions within a single chip (Figure 2.13). Although multiplex electric field
strengths could be created by changing the cross-sectional area of the microchannels,
the hydraulic resistances and shear rate were modified as well198. To avoid so, a R-2R
resistor ladder in electric circuit design was adapted202 so that interconnecting channels
connect the two main channels to create parallel circuits that the electric current was
split in each segment (I : VIII) in the network.
The electric field was applied from the outlets to avoid paracrine signaling from
electrically stimulated cells to control cells residing in section IV and VIII. The spa-
tial dimensions and physical properties of the main channel and the interconnecting
channels in the single-layer and the double-layer design is shown in Table 2.7.
Figure 2.13: The designs of single-layer and double-layer PMMA/PDMS
chips. (A) Single-layer PMMA/PDMS chip; (B) Double-layer PMMA/PDMS chip.
The first layer structures are shown in cyan.
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Table 2.7: Physical characteristics comparison between single-layer and
double-layer PMMA/PDMS chip.
Single-layer Double-layer
Channel type Interconnection Main Interconnection Main
Channel dimension (l×w×h) (mm3) 1.5×0.083×0.1 9×2×0.1 1.5×0.838×0.01 8.95×2×0.1
Hydraulic diameter ( 2wh
w+h
) (mm) 0.0907 0.1905 0.01976 0.1905
Relative RΩ (mm−1) 180.72 45.18 178.99 44.75
RH (Pa sm−3) (×109) 600 55.5 21616.4 55.2
Relative RH 10.82 1 391.88 1
fRe 56.92 89.94 94.47 89.94
Poiseuille number (Po) 14.23 22.49 23.62 22.49
Flow velocity simulated by PSPICE at 20 µLmin−1 (m s−1) 1.44E-19 1.75E-3 2.02E-21 1.75E-3
Reynolds number (Re) 1.30E-17 0.333 4.01E-20 0.333
Péclet number (Pe) 2.91E-13 7460 8.97E-16 7460
Electric circuit modeling The single-layer and double-layer PMMA/PDMS mi-
crofluidic chip were constructed to create multiple electric fields in a R-2R resistor
ladder configuration202,455. The electrical equivalent circuit of the two PMMA/PDMS
microfluidic chips was the same and shown in Figure 2.14. Each segment of the mi-
crofluidic channel network was regarded as an electrical resistor in which relative elec-
trical resistances were calculated and modeled by Ohm’s law and Kirchhoff’s circuit
laws. In the equivalent circuit, the endpoint of R4 and R11, the adjacent segments from
both inlets, were open in the electric circuit. No electric current was flowing through
them so cell migration in these sections could be used to collect control cell data.
According to Ohm’s law, the electrical resistance of a resistor, R, was proportional
to the length and inversely proportional to the cross-sectional area:
R = ρ
l
A
=
ρl
w × h, (2.21)
where ρ, l, A, w, and h were the electrical resistivity of the medium, the length,
the cross-sectional area, the width, and the height of the microchannel, respectively.
Assuming the electrical resistance of R1 being r, the relative electrical resistances of
other segments (R2 : R11) could be calculated accordingly.
The electric current flowing through each resistor was calculated by Kirchhoff’s
circuit law and simulated using PSPICE in the electronic design automation software
(OrCAD Lite, Cadence Design Systems, USA) by:
10r × i2 − 4r × i1 − 4r × i3 = 0, (2.22a)
10r × i3 − 4r × i2 = 0. (2.22b)
By solving the system of equations in Equation 2.22, the ratio of electric currents
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between each segment, hence the ratio of electric field strengths, was derived in Equa-
tion 2.23:
i1 : i2 : i3 = EI : EII : EIII : EIV (2.23a)
= EV : EVI : EVII : EVIII (2.23b)
= 5.25 : 2.5 : 1 : 0 (2.23c)
Figure 2.14: The electrical equivalent circuit model of the PMMA/PDMS
chip.
Hydraulic resistance modeling The hydraulic resistance of a microfluidic channel
network of PMMA/PDMS chips could be modeled and treated like its electric equiv-
alent. Although the single-layer and double-layer PMMA/PDMS chips were designed
to have the same electric equivalent circuit, due to the difference in the hydraulic
diameter, the hydraulic resistances in the two chips were different. The equivalent
hydraulic circuits of single-layer and double-layer PMMA/PDMS chips were shown in
Figure 2.15. The hydraulic resistances of the interconnecting channels (R5 : R7) in the
double-layer design were ≈ 36 times higher than those in the single-layer design due
to the much smaller hydraulic diameter (Table 2.7).
The hydraulic equivalent circuits of the two designs were modeled and the flow ve-
locity were simulated using PSPICE in the electronic design automation software (Or-
CAD Lite, Cadence Design Systems, USA) as shown in Table 2.7. The higher Poiseuille
number and lower Péclet number in the interconnecting channels in double-layer de-
sign compared to those in single-layer suggested that it was more diffusion-dominant in
the double-layer interconnecting channels and the high hydraulic resistances prevented
advection-driven cross-contamination between the two main channels.
Numerical simulation and experimental validation of fluid flow, chemical
transport, and electric field The 3D design models of the single-layer and double-
layer chip were exported from AutoCAD and imported into COMSOL Multiphysics 5.3
(COMSOL Inc, USA). Steady-state coupled simulations using three modules, creeping
flow, chemical transport of diluted species, and electric currents, were performed.
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Figure 2.15: The hydraulic equivalent circuit model of single-layer (A) and
double-layer (B) PMMA/PDMS chips.
To correctly simulate the system, measured material properties of the MEMα sup-
plemented with 10% FBS medium was input (Appendix A). The materials in the
3D model was set as water with density of 1002.9 kgm−3, electrical conductivity of
1.536 Sm−1, dynamic viscosity of 0.000 946Pa s, and relative permittivity of 80.
The boundary conditions were input accordingly for creeping flow, electric current,
and chemical transport of diluted species as shown in Figure 2.13. For creeping flow,
20 µL/min flow rate was used. For chemical transport, 100molmm−3 of 40 kDa dextran
was used as a baseline with diffusion coefficient of 44.7 µm2 s−1 456. For establishment
of 300Vm−1 electric field, 485.5 µAm−2 was set at the anode and electric potential of
0V was set at the cathode.
Stable creeping flow in PMMA/PDMS microfluidic chip Due to the cross-
sectional area differences between the main channels and the interconnecting channels,
the majority of the fluid will flow through the main channels (Figure 2.16).
Figure 2.16: Stable flow field in hybrid PMMA/PDMS chips. Top: single-
layer design; Bottom: double-layer design.
Multiplex electric fields for high throughput electrotaxis studies Multi-
plex electric fields were established by the R-2R resistor ladder design. By theoretical
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modelling, the electric field strength (EFS) ratio between sections EI : EII : EIII : EIV
was 5.25:2.5:1:0. The simulated EFS ratio between the sections agreed with the theo-
retical modelling as shown in Equation 2.24.
EI : EII : EIII : EIV = EV : EVI : EVII : EVIII (2.24a)
= 4.99 : 2.45 : 1 : 0. (2.24b)
The numerical simulation results of the electric field are shown in Figure 2.17.
Figure 2.17: 4.99:2.45:1:0 ratio stepwise electric field established in the hy-
brid PMMA/PDMS chips. Top: single-layer design; Bottom: double-layer design.
The triangular markers represent the limits of stable regions in each segment used in
data analysis and in experiments.
Diffusion-dominant chemical transport in a double-layer PMMA/PDMS
microfluidic chip The chemical transports in single-layer and double-layer PM-
MA/PDMS microfluidic chips were simulated and shown in Figure 2.18. The simula-
tion showed the ideal condition where diffusion was dominant in the interconnecting
channels.
By adjusting the scale of the colormap, the “cross-contamination” events where
chemical leaches from one main channel to another through the interconnecting chan-
nels could be seen more clearly (Figure 2.19). In the double-layer design, it was more
diffusion-dominant in comparison to the single-layer design.
Experimental validation of stable chemical transport in hybrid PM-
MA/PDMS chip Single-layer or double-layer PMMA/PDMS chips were fabricated
and perfused as the same state as in simulation. The chemical transport in the chip
was visualized using fluorescein-conjugated dextran (40 kDa, FD40, Sigma-Aldrich,
USA) or tetramethylrhodamine-conjugated dextran (40 kDa, D1842, Thermo Fisher
Scientific, USA) in Fluorobrite DMEM (Gibco, USA). The dyed media were loaded
separately in two 2.5mL syringes (Terumo, Japan) and the channels was primed at
20 µLmin−1 for 10 minutes before reducing to 20 µL h−1 (cell culture experiment flow
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Figure 2.18: Chemical transport simulated in hybrid PMMA/PDMS chips.
Top: single-layer design. Bottom: double-layer design.
rate), followed by capturing microscopy images with 10min time lapse epifluorescence
microscopy (Ti-E, Nikon, Japan).
In the single-layer channel design, the interconnecting channels had relatively low
hydraulic resistances compared to those in the double-layer design. As a result, any
slight disturbance in the pressure affecting microfluidic flow such as slight hydrostatic
pressure difference between two media reservoirs or slight withdrawing speed differ-
ence in syringe pumps could result in advection of chemicals from one microchannel to
another (Figure 2.20), causing “cross-contamination” events and limiting the experi-
mental throughput of the PMMA/PDMS chip.
In double-layer channel design, the hydraulic resistances of the interconnecting
channels were higher while the electrical equivalent circuit was the same. The laminar
flows through the interconnecting channels were slower and thus limiting the chemical
advection. As a result, the chemical distribution between the two main channels can
be maintained stably for more than 10 hours (Figure 2.21) with only diffusion-driven
contamination limited at the proximity of the interconnecting channels.
Moreover, when cells were injected in the top channel of the double-layer microflu-
idic chip, the cells were not able to pass through 10 µm-height interconnecting channels
and were restricted to its main channel (Figure 2.21). When different cell types were
seeded in separate channels, the double-layer microchannel design could further in-
crease the experimental throughput.
2.3.2 Microfluidic chip fabrication
The fabrication of hybrid PMMA/PDMS chip can be separated into three parts: PDMS
microfluidic chip, PMMA microfluidic chip, and hybrid assembly.
Fabrication of PDMS chip: soft lithography
Single-layer microfluidic chip The single-layer microfluidic chip was designed
in AutoCAD software (Autodesk Inc, USA) and exported as a dxf file. The dxf file was
converted to a GDS2 file using KLayout. The GDS2 files were split into microscopic
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Figure 2.21: Stable chemical transport in double-layer PMMA/PDMS chip
before and after 10 hours. Fluorescein-dextran was perfused in the top channel
(Green) and tetramethylrhodamine-dextran was perfused in the bottom channel (Red).
viewfield-based mask images and exposure recipes were created using the accessory soft-
ware provided along with a maskless lithographic writer (DL-1000, Nano Systems So-
lutions, Japan). The mask was written on a piece of 5-inch and 540 nm-thick AZP1350
photoresist-precoated chrome mask blank (CBL5006Du-AZPFS, Clean Surface Tech-
nology, Japan) by a digital micromirror device (DMD) with 405 nm light source through
a 20X objective at exposure energy of 100mJ cm−2. The exposed chrome mask was
developed in 2.38% tetramethylammonium hydroxide (2.38% TMAH, NMD-3, Tokyo
Ohka Kogyo, Japan) and etched with chromium etchant (651826, Sigma-Aldrich, USA).
Negative photoresist (SU-8 3050, MicroChem Corp, USA) of 100 µm-thick was
spinned on a piece of silicon wafer (100mm, p-type, E&M Inc, Japan) using a spin
coater (MS-A100, Mikasa Inc, Japan). After soft baking according to manufacturer’s
protocol, the photoresist-coated silicon wafer was exposed with the aforementioned
chrome mask using a mask aligner (MA/BA6, SUSS MicroTec, Germany) with i-line
UV. The pattern was developed in propylene glycol methyl ether acetate (PGMEA,
Sigma-Aldrich, USA) followed by washing with isopropanol, ultrapure water, and dried
by nitrogen gas. The structure height, i.e., the channel height in final PDMS device,
was confirmed by stylus profilometry (DektakXT, Bruker, USA). The silicon wafer with
microfluidic structures was passivated with 1H, 1H, 2H, 2H-perfluorooctyltriethoxysilane
(FOTS, 667420, Sigma-Aldrich, USA) inside a desiccator under vacuum for 2 hours,
completing the master mold.
To fabricate the PDMS devices, PDMS was mixed and degassed at 10:1 monomer
to curing agent ratio with an orbital mixer (ARE-310, Thinky corp, Japan). PDMS
casting blocks made of PMMA or polytetrafluoroethylene (PTFE) were fabricated
in-house by micromilling with a flat endmill (RSE230-6-50, NS Tools, Japan) on a
computer numerical controlled (CNC) micromill (SLS Micro Mill/4, Minitech, USA)
(Appendix D.2). The silicon wafer was placed in the casting block and mixed PDMS
was poured on the wafer and degassed. After degassing, the PDMS in the casting
block was flanked with a piece of 15mm-thick PMMA block to ensure parallelism of
the top surface. The PDMS was cured under 60 ◦C for at least 2 hours. The depth of
the casting block ensured the exact height of the PDMS chip (4mm).
After curing, the PDMS substrate with the negative impression of the microstruc-
tures on master mold was delaminated and cut into single devices appropriately. In-
let/outlet ports were punched with a 1mm-diameter biopsy punch (BPP-10F, KAI
group, Japan) or by a punch station (18G, Accu-punch MP, Syneo corp, USA). The
port size around 1mm was appropriate for biologist-friendly fluid manipulation using
a 200 µL pipet tip.
Each PDMS device was bonded to a piece of coverglass to complete the PDMS chip.
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To ensure surface quality and optical performance, high-precision borosilicate cover-
glass was chosen (24×60 mm, 170 ± 5 µm thickness, No. 1.5H, Marienfeld-Superior,
Germany). The cover glasses were cleaned by ultrasonification in a washing solu-
tion (1% TFD4, Franklab, France) on a home-made washing stand (Appendix D.3)
fabricated with 3D printing (Form2, Formlabs, USA). The coverslips were washed
thoroughly in ultrapure water, dried, and disinfected with ultraviolet irradiation. The
PDMS devices were bonded to washed coverglasses using an O2 plasma instrument
(AP-300, Nordson MARCH, USA) at 35W for 30 s under O2 mass flow rate of 245
sccm. The bonded devices were placed briefly on 90 ◦C hot plates to strengthen bond-
ing, completing the PDMS chip fabrication.
Double-layer microfluidic chips The PDMS microfluidic chip composed of
double-layer structures followed the similar processes as the single-layer microfluidic
chip except on the master mold fabrication.
In double-layer chip design, the first layer was 10 µm-high and the second layer
was 100 µm. The design was designed in AutoCAD and exported to KLayout. Several
cross-shaped alignment markers were included in the design to assist alignment in the
mold of double-layer microfluidic chip.
A 10 µm-thick layer of photoresist (DWL-5, Micro Resist Technology, Germany)
was spin-coated on a 100mm silicon wafer and soft baked. The first design layer
was directly written by the maskless lithographic writer (80mJ cm−2, DL-1000, Nano
Systems Solutions, Japan) and subsequently hard-baked. Next, without development, a
layer of 100 µm-thick photoresist (SU-8 3050, MicroChem Corp, USA) was spin-coated
on the wafer and soft baked. A chrome mask for the second layer was fabricated using
the same process as explained in the previous paragraph. Using the alignment markers,
the silicon wafer with the first-layer structures was aligned to the second layer structures
on the chrome mask on the mask aligner (MA/BA6, SUSS MicroTec, Germany) and
subsequently exposed (45 s of i-line UV irradiation). The unexposed photoresist was
dissolved away in PGMEA and the wafer was washed thoroughly with isopropanol,
water, and dried with nitrogen gas. After the double-layer master mold was made, the
chip fabrication process followed the same steps as those in single-layer microfluidic
chips. Briefly, the surface was passivated by FOTS and PDMS microdevices were
fabricated through the standard soft lithography process in the casting block to ensure
flat surfaces of the fabricated devices.
Fabrication of PMMA components 3D microfluidic components could be eas-
ily and rapidly fabricated using PMMA. In the PMMA/PDMS microfluidic chip, 4
PMMA components were used including the medium inlet reservoir (component A,
Figure 2.12B), outlet/electrical stimulation interface (component B, Figure 2.12B),
top reservoir, and salt bridge connector. The medium inlet reservoir, outlet/electri-
cal stimulation interface, and top reservoir components are composed of four layers of
2mm PMMA substrates.
The designs were created in AutoCAD software and the patterns were cut on a
piece of 2mm casted PMMA substrate (casted acrylic sheet K, Kanase, Japan) with
a CO2 laser cutter (VLS3.50, Universal Laser Systems, USA). For mass fabrication,
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patterns for multiple devices were arranged together and bonded. Individual pieces
were snapped off by hand after bonding (Figure 2.22).
Figure 2.22: Mass fabrication of PMMA components by CO2 laser cutting.
(A) 4 layers to build the component B (outlet/electrical stimulation interface); (B) 4
layers to build the component A (medium inlet reservoir); (C) 3 layers to build the
connecting salt bridges; (D) 4 layers to build the top reservoir.
3D microfluidic components can be easily fabricated by stacking the laser-cut
PMMA pieces and bonding them under high temperature and pressure. The layers
were aligned by hand and flanked between two pieces of 2mm-thick, 100mm Tempax
float glass wafers (Schott AG, Germany) on a force-controlled programmable hot press
(G-12RS2000, Orihara Industrial co., ltd, Japan). The PMMA pieces were heated
above its glass transition temperature with pressure to form leakage-free 3D microflu-
idic components (118 ◦C, 500N, 30 min).
Device assembly: facile reversible bonding between PDMS and PMMA
using a dual energy double-sided tape A dual energy double-sided tape (85 µm,
No. 5302A, Nitto, Japan) was patterned using the CO2 laser scriber. On No.5302A
double-sided tapes, a silicone-type adhesive and an acrylic-type adhesive were overlaid
on the two sides of a poly(Ethylene terephthalate) (PET) substrate. The silicone-type
pressure sensitive adhesive adhered to silicone rubber, while the acrylic-type adhesive
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affixed to plastic, glass, and metal surfaces. The first report of using such dual energy
double-sided tape was for bonding PMMA and PDMS with sensing applications using
optical waveguides397. I found that there was no cytotoxicity with the tape and it
could be used for cell applications398. The double-sided tape provided an easy and
facile way to bond between PDMS and PMMA, an interface typically hard to join.
Thus, double-sided tape allows us to take advantage of high spatial precision of PDMS
microfluidics and rapid 3D prototyping of PMMA microfluidics.
First a 2mm-thick copper holder made of wire electrical discharge machining (wire-
EDM) and backed with 0.5mm PDMS sheet was attached reversibly to the coverglass of
the PDMS microfluidic chip. The holder served as a rigid weight to hold the microfluidic
chip and to prevent flexing of the thin 0.17mm coverglass (Appendix D.4).
Second, the bonded PMMA component A and B were aligned and affixed to the
PDMS microfluidic chip through two pieces of patterned dual energy double-sided tape.
Third, to balance the hydrostatic pressure between the inlet and outlet to prevent
Poiseuille flow due to hydrostatic pressure, a fluid reservoir was placed to connect
component A and component B. The fluid reservoir was first affixed with 2mm-thick
of PDMS padding using the dual energy double-sided tape. Openings were cut by a
utility knife. Afterward the PDMS part of the top reservoir was affixed to the top of
the component A and B using patterned double-sided tapes, completing the assembly
of the device. The zoomed-in view of the components in PMMA/PDMS microfluidic
chip and the 3D render of the assembled device are shown in Figure 2.23.
Figure 2.23: The assembled PMMA/PDMS chip. (A) The exploded view of
the components for PMMA/PDMS chip; (B) The 3D rendered model of the assembled
device; (C) The photoimage of the assembled device for experiment.
After cell seeding and adhesion, the top reservoir was removed and a piece of 4mm-
thick PDMS slab punched with two outlet holes (21G, Accu-punch MP, Syneo Corp,
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USA) was affixed to the top of component B through the first piece of patterned double-
sided tape (Figure 2.23A), creating an air-tight seal. The device was now completed
and ready for media perfusion and electric field stimulation (Figure 2.12).
2.4 A reversibly-sealed PMMA/PDMSmicrofluidic
chip for concurrent shear and electric field stim-
ulation
The hybrid PMMA/PDMS microfluidic approach has shown promises in the previous
section for constructing a microfluidic chip. The rigidity of PMMA offers versatil-
ity in engineering world-to-chip interface. In this section, I introduce a hybrid PM-
MA/PDMS chip that is composed of a top PMMA interface chip and a PMMA/PDMS
cell culture chip (Figure 2.24). Complex fluidics routing can be designed in the top
PMMA interface chip and it can reversibly seal with the PMMA/PDMS microchannel
device to realize high throughput experiments. The proof-of-concept PMMA/PDMS
device (shear flow and electric field co-stimulation microfluidic chip, SFEFC) will be
validated with high shear rate conditioning of endothelial cells and used for study of
glioblastoma-endothelium adhesion process.
Figure 2.24: The shear flow and electric field co-stimulation microfluidic
chip, SFEFC. SFEFC is composed of a top PMMA interface with fluidics and elec-
trical stimulation interface and a bottom PMMA/PDMS microchannel chip where cells
reside in.
Quick-fit reversible sealing design The shear flow and electric field co-stimulation
microfluidic chip, SFEFC, was designed to maximize experimental throughput and
facileness for experimentalists (Figure 2.25). On the PMMA/PDMS microchannel,
PMMA component can hold certain amount of cell culture media, avoiding trapping
of bubbles at the inlets/outlets in PDMS (Figure 2.25A). Common micropipette tips
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familiar to biologists can be used to manipulate fluids. When starting experiments,
the top PMMA interface chip with fluidic connections can be reversibly sealed to the
PMMA/PDMS microchannel chip through compressive sealing by screws. After each
experiment, the PMMA/PDMS microchannel chip and the cells in it could be easily
recovered by removing the screws. A new PMMA/PDMS microchannel chip can be
interfaced with the top interface chip and start the experiment again.
The key advantages of quick-fit SFEFC include: operator-friendly workflow, low
dead volume, low reagent usage, air bubble-free operation, air-tight sealing to sustain
high flow rates, and reusable top PMMA interface chip that can be assembled with
different PMMA/PDMS microchannel chips.
Figure 2.25: Liquid manipulation on the SFEFC. (A) Operator-friendly under-
water fluid manipulation at early stage of chip preparation using the PMMA/PDMS
microchannel chip. Cells are cultured in the microchannels in the PMMA/PDMS
chip; (B) The complete chip can be assembled just prior to on-chip experiments. The
PMMA top interface chip is shown in red dashed box. PDMS slabs on the PMMA top
interface chip compress and seal the interface to the PMMA/PDMS microchannel chip
(inside the black dashed box). After each experiment, the cells in the PMMA/PDMS
microchannel chip can be easily recovered after disassembly.
2.4.1 SFEFC microfluidic chip design: concurrent shear flow
and electric field conditioning
The microchannel design in the SFEFC was constructed to create multiple electric
fields in an R-2R resistor ladder configuration202,455 similar to the single-layer channel
design in Section 2.3. Two 2mm-wide main microchannels with interconnected 100 µm
by 1.5mm (length × width) channels at a spatial interval of 7.5mm in SFEFC created
10 channel segments with various electric field strengths (EFSs) (Figure 2.26). The
segments on the top side of SFEFC had electric current vector flowing against the
shear flow direction, while the segments on the bottom side of SFEFC had electric
current vector flowing along the shear flow direction. This multiplex configuration
provided a platform for high-throughput screening of cellular responses to coexisting
shear flow and electric field. Cells were observed only in the 4.5mm-long observation
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area, in the middle of each segment, 1.5mm from the interconnection channels (where
the electric fields were stable).
Figure 2.26: Channel design in the PMMA/PDMS microchannel chip in
SFEFC.
Electric circuit modeling The electrical equivalent circuit of SFEFC is shown in
Figure 2.27. Each segment of the microfluidic channel network was regarded as an
electrical resistor in which relative electrical resistances were calculated and modeled
by Ohm’s law and Kirchhoff’s circuit laws. In the equivalent circuit, the endpoint of
R5 and R14, the adjacent segments from both inlets, were open in the electric circuit.
No electric current was flowing through them. Cells in the two segments were only
subjected to shear flow.
According to Ohm’s law, the electrical resistance of a resistor, R, was proportional
to the length and inversely proportional to the cross-sectional area:
R = ρ
l
A
=
ρl
w × h, (2.25)
where ρ, l, A, w, and h were the electrical resistivity of the medium, the length,
the cross-sectional area, the width, and the height of the microchannel, respectively.
Assuming the electrical resistance of R1 being r, the relative electrical resistances of
other segments (R2 : R14) could be calculated accordingly.
Figure 2.27: The electric equivalent circuit of SFEFC.
The electric current flowing through each resistor was calculated by Kirchhoff’s
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circuit law and simulated in the electronic design automation software (OrCAD Lite,
Cadence Design Systems, USA) by:
10r × i2 − 4r × i1 − 4r × i3 = 0, (2.26a)
10r × i3 − 4r × i2 − 4r × i4 = 0, (2.26b)
10r × i4 − 4r × i3 = 0. (2.26c)
By solving the system of equations in Equation 2.26, the ratio of electric currents
between each segment, hence the ratio of electric field strengths, was derived in Equa-
tion 2.27:
i1 : i2 : i3 : i4 = EI : EII : EIII : EIV : EV (2.27a)
= EVI : EVII : EVIII : EIX : EX (2.27b)
= 10.5 : 5.2 : 2.5 : 1 : 0. (2.27c)
Numerical simulation of electric field in SFEFC The 3D design model of
the aforementioned microfluidic chip was exported from AutoCAD and imported into
COMSOL Multiphysics 5.3 (COMSOL Inc, USA). Steady-state coupled simulation
of creeping flow and direct current electric field were performed in three dimension
by solving Navier-Stokes equations and Maxwell’s equations. An aqueous medium
with dynamic viscosity of 0.75mPa s, electrical conductivity of 1.44 Sm−1, density of
1001.7 kgm−3, and a relative permittivity of 80 were used to model endothelial cell
growth medium used for the study (Appendix A)398.
In the SFEFC, 10 segments with combinations of shear flow (fixed shear stress
of 1 Pa) and varying electric field strengths provided possibilities for high-throughput
experiments (Figure 2.28).
The simulated EFS ratio, when an electric current of 86.4 µA was carried from one
outlet of the SFEFC to the other outlet, is shown in Equation 2.28:
EI : EII : EIII : EIV : EV = EVI : EVII : EVIII : EIX : EX (2.28a)
= 9.72 : 4.97 : 2.44 : 1 : 0. (2.28b)
2.4.2 Microfluidic chip fabrication
Fabrication of PMMA chips The PMMA interface chip (Figure 2.25) was fab-
ricated by patterning fluidic connections, inlets/outlets, salt bridge (SB) connections,
and M4 screw clamp slots on three 0.5mm-thick PMMA sheets (CM-205x, Chi-Mei
Corp, Taiwan), by using a CO2 laser scriber (VLS3.50, Universal Laser Systems, USA).
The PMMA sheets were joined by thermal bonding, as described in Section 2.3.2.
Adapters with M6 threads (SPC-M6-C, Nabeya, Japan) were glued onto the PMMA
chip using a UV adhesive (3301, Loctite, USA). 2mm-thick PDMS slabs punched with
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Figure 2.28: Numerical results of electric field strength in the shear flow
and electric field co-stimulation microfluidic chip (SFEFC). SFEFC features
10 segments with coexistent electric field and shear flow. I denotes electric current.
From sections I to IV, the shear flow flows against the electric current direction, while
in sections VI to IX, the shear flow flows along the electric current vector.
inlet and outlet holes (1mm) were affixed to the interface chip using a dual-energy
silicone/acrylic double-sided tape (85 µm thick, No. 5302A, Nitto Denko, Japan).
Similar to the interface chip, the PMMA component of the PMMA/PDMS mi-
crochannel chip was fabricated by patterning liquid reservoirs, inlets, outlets, and screw
clamp slots on two 2 mm-thick PMMA sheets. The PMMA pieces were again thermally
bonded.
Fabrication of PDMS chip The PDMS channel chip was fabricated by the soft
lithography method as described in Section 2.3.2323. The single-layer master mold
(100 µm-thick SU-8 3025) was fabricated following steps as described in previous sec-
tions. After the master mold was treated with perfluorosilane, PDMS devices were
fabricated by casting against the master mold.
The PMMA/PDMS chip was assembled by joining the bonded PMMA component
and the PDMS microchannel component with the silicone/acrylic double-sided tape
(No. 5302A, Nitto, Japan). The PMMA/PDMS microchannel chip was completed by
bonding the joined PMMA/PDMS piece to a coverglass (60×24 mm, No. 1.5H, Paul
Marienfeld GmbH, Germany) after O2 plasma treatment (AP-300, Nordson MARCH,
USA). The coverglass was washed thoroughly in an industrial cleaning solution (1%
TFD4, Franklab, France), ultrapure water, and dried under nitrogen gas prior to bond-
ing.
2.5 Summary and prospects
I have developed versatile hybrid PMMA/PDMS microsystems, which offers tremen-
dous potential for manipulation of microenvironment, reagent conservation, and live
cell imaging. However, the high degree of miniaturization demands that microsystems
be tailor made for specific biological applications. Establishment of robust platform is
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the first step toward studying biology in quantitative terms. Specifically, I have cre-
ated three different microsystems suitable for cell culture and stimulating them with
different physical and chemical stimulations in thermoplastics or hybrid thermoplas-
tics/elastomer devices. The hybrid composition approach combines the advantages of
different materials and offers versatility for designing complex 3D design to manipulate
microenvironment while mitigating some of the disadvantages of each material. Despite
of seemingly complicated composition, the hybrid devices can be rapidly prototyped
and fabricated, thus they are suitable for rapid research development in laboratory
settings.
Chapter 3
Usiigaci: Single cell segmentation
and tracking in label-free phase
contrast microscopy enabled by
machine learning
Abstract
Label-free single-cell segmentation and tracking is tantamount to the holy grail of microscopic
cell migration analysis. Contrast-enhanced brightfield microscopy techniques including the
phase contrast microscopy (PCM) can provide vivid stain-free cell visualization. However,
these brightfield images with cells at high density are notoriously difficult to segment accu-
rately; thus, manual segmentation remains the de facto standard practice. In this work, I
develop Usiigaci, an all-in-one, semi-automated pipeline to segment, track, and visualize cell
movement and morphological changes in PCM. Cell-labeling-free, instance-aware segmenta-
tion is accomplished using a mask regional convolutional neural network (Mask R-CNN).
A TrackPy-based cell tracker with a graphical user interface is developed for cell tracking
and data verification. The performance of Usiigaci is validated with electrotaxis of NIH/3T3
fibroblasts and outperforms several open-source software dedicated for PCM cell analysis.
Usiigaci provides highly accurate cell movement and morphological information for quanti-
tative cell migration analysis457.
3.1 Introduction
Cell migration is a fundamental cell behavior that underlies fundamental physiological
processes, including development, tissue maintenance, immunity, and tissue regenera-
tion, as well as pathological processes such as cancer metastasis. Many in vitro as well
as in vivo platforms have been developed to investigate molecular mechanisms under-
lying cell migration in different microenvironments with the aid of microscopy. Using
microfluidic platforms, high throughput cell migration experiments can be performed
to obtain hundreds and thousands of cell microscopy images at short time intervals in
a single experiment.
The movement and morphology changes of single- as well as collective-cell migra-
tion are the core characteristics of cell response to gradients in the microenvironment,
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such as shear stress, surface topology, chemical gradient, and electric field379,458–460.
The holy grail of cell migration analysis is tantamount to quantitative analysis of de-
tailed single-cell level behavior by segmentation and tracking of each individual cells.
However, the data analysis of cell microscopy images associated with high throughput
experiments remains a challenging task to both biomedical engineers and biologists due
to imperfect cell segmentation and tracking461, thus limiting the overall experimental
throughput.
Among bright-field microscopy techniques, Zernike’s phase contrast microscopy
(PCM) is favored by biologists for its ability to translate phase differences from cel-
lular components into amplitude differences, so as to make the cell membrane, the
nucleus, and vacuoles more visible462. However, PCM images are notoriously difficult
to segment correctly using conventional computer vision methods, due to the low con-
trast between cells and their background463. Although advances in quantitative phase
imaging (QPI) by holography, ptychography, or interferometry can provide quantita-
tive phase information of cells instead of amplitude difference as in PCM and make
segmentation easier, the QPI techniques are not widely adopted by biologist as they re-
quire delicate optical setup and alignment464,465. For these reasons, many cell migration
experiments still rely on fluorescent labeling of cells or manual tracking. Fluorescent
labeling of cells requires transgenic expression of fluorescent proteins or cells tagged
with fluorescent compounds, both of which can be toxic to cells and which require
extensive validation of phenotypic changes. Although thresholding fluorescent images
is relatively straightforward, cells that are in close proximity are often indistinguish-
able in thresholded results. On the other hand, manual tracking of cell migration is
labor-intensive and prone to operator error466.
To complement high throughput microscopy experiments, the data analysis must
be automated. Moreover, although many software packages have been developed for
cell tracking, the majority of them handle only fluorescent images and require good
thresholding results467. While some software packages tackle stain-free cell tracking,
outlining each individual cell accurately to the cell boundary remains difficult and often
yields suboptimal results. Without single-cell level segmentation, accurate single-cell
tracking is not possible. Therefore, these packages are limited to positional tracking and
cannot resolve adjacent or touching cells467–471. Moreover, migrating cells in ameboid
or mesenchymal mode often have thin protruding cellular structures for locomotion,
such as blebs or lamellipodia472. These structures exhibit very low contrast even in
PCM, which prevents reliable segmentation, even though they are essential for cell
migration. For detailed discussion of computational methods for microscopy image
analysis, the reader is referred to review texts466,473,474.
In recent years, accurate segmentation and classification of cells or tissue under
microscopy using machine learning methods such as convolutional neural networks
(CNNs) and generative adversarial networks (GANs) have been demonstrated475–480.
Ronneberger et al., first demonstrated that using supervised training of a fully-convolutional
CNN, U-net, cell outlines in PCM can be segmented accurately475. Further, Van Valen
et al., proposed the Deepcell CNN architecture to classify background, cell membrane,
and cytoplasm in pixel-wise manner. Cells can be segmented accurately from the
pixel classification even when cells are in high density and in close proximity to each
other476. However, in Deepcell, fluorescent staining of cell nuclei is still needed for
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optimal segmentation of PCM images. The fact that the high accuracy and flexibil-
ity of the machine learning could even surpass that of specialists has stimulated the
biomedical community to adapt machine learning techniques for automated medical
image analysis481–483.
Figure 3.1: Workflow of Usiigaci. PCM images are processed in a Mask R-CNN
segmentation module into instance-segmented masks. Objects in the masks are linked
and tracked in a Trackpy-based tracking module. Cell migration parameters and plots
are generated automatically in the data processing module.
To address the above challenges, I introduce Usiigaci, an all-in-one, semi-automated
pipeline to segment, track, and visualize cell movement and morphological changes in
stain-free PCM images. Usiigaci, pronounced as /ushi:gachi/ by Hepburn romaniza-
tion, is a Ryukyuan word, ウシーガチ, that refers to tracing the outlines of objects (透
き写し in Japanese), which is an appropriate description of the function of our soft-
ware. Stain-free segmentation is appealing to biologists because cells are free of labeling
damage and their analyses do not suffer from false readings. Usiigaci is composed of
three independent modules: a segmentation module, a tracking module, and a data
processing module (Figure 3.1). Instance-aware segmentation is first performed using a
mask regional convolutional neural network (Mask R-CNN). The segmented masks are
then tracked using a Trackpy-based cell tracker with a graphical user interface (GUI).
Single cell migration variables and visualizations are generated automatically in the
data processing module afterward. The work presented in this chapter is published in
SoftwareX 457.
I first describe the architecture and segmentation performance of Usiigaci bench-
marked with existing software packages such as PHANTAST470, Fogbank471, and Deep-
cell476. Next, the multiple object tracking (MOT) performance of Usiigaci tracking
module is evaluated using MOT metrics484,485. Finally, the usability of Usiigaci for
analysis of cell migration is evaluated by single cell migration variables in biological
context with a dataset of NIH/3T3 fibroblasts electrotaxis.
3.1.1 Computational cell migration analysis
Cell migration is a dynamic process involving complex cellular signaling and can be
categorize as single cell or collective cell migration. In single cell migration, cells mi-
grate individually by interacting with the extracellular matrix (ECM) such as immune
cells migrating in tissues and neural stem cells migrating between cortical layers. Cells
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can also establish cell-cell contact and move as multicellular units in collective cell
migration486,487, such as the epithelial sheet migration in wound healing488.
Contemporary, in vitro 2D and 3D cell migration platforms are preferred over in
vivo platforms for lower cost, easier experimental workflow, and lower biological varia-
tion. Single cell migration on in vitro platforms can be analyzed under high-resolution
microscopes466,489. Using molecular biology tools and optical techniques, cellular be-
havior and subcellular components can be identified for cellular phenotype, lineage,
and molecular mechanisms474,490,491.
Under time-lapse microscopy, cell images can be sampled and the features of the
cells can be extracted reliably if the Nyquist sampling theorem is satisfied for the
tracking492. Guided by directional cues in the microenvironment, cell displaces and
changes morphology to respond to the cue (Figure 3.2). Given the trajectory, the
step-centric variables and cell-centric variables can be derived (Table 3.1). The step-
centric variables are computed for a single cell migration between each consecutive time
frames. The cell-centric variables describe a cell track by summing the step-centric
data across all time frames. By analysis and categorization of cell migration patterns,
phenotypes of cell migration can be identified using principle component analysis or
cluster analysis474,491,493.
Figure 3.2: The single-cell migration parameters extracted from the elec-
trotaxis experiments.
By analysis of microscopy images, several cell tracking data results can be obtained
(Figure 3.3). Valid cell tracks that are tracked correctly are the data that is of users’
interest (Figure 3.3). However, depending on the accuracy performance of the tracker,
interrupted cell tracks or erroneous tracking may happen (Figure 3.3.B.G.H). Also, cells
can undergo mitosis during the experiment and splits into two daughter cells, which the
tracking no longer represents single cell migration (Figure 3.3.C). Moreover, in an actual
microscopy experiment, there will be cells entering the view field, exiting the view field,
or suddenly detaching from the substrate during the experiment (Figure 3.3.D-F).
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Table 3.1: Step-centric and cell-centric variables for describing single-cell
migration.
Step-centric features
Instantaneous displacement di =
√
(xi − xi−1)2 + (yi − yi−1)2
Instantaneous speed si = d(pi−1, pi)/∆t
Turning angle αi = tan−1 (yi−yi−1)(xi−xi−1)
Directional autocorrelation dir − auti = cos (αi − αi−1)
Cell-centric features
Cumulative distance dtotal =
N∑
i=1
d(pi−1, pi)
Net trigonometric distance
(Euclidean distance)
dnet = d(p0, pN) =
√
(xN − x0)2 + (yN − y0)2
Euclidean velocity v¯net = dnettelapsed
End-point directionality ratio ep_dr = dnet
dtot
Orientation Indexorientation =
N∑
i=1
cos 2θi
N
Directedness Indexdirectedness =
N∑
i=1
cosΦi
N
=
N∑
i=1
(xi−x0)
dnet×n =
1
N
N∑
i=1
(xi−x0)√
(xi−x0)2+(yi−y0)2
A good single cell migration tracking software should yield high amount of valid
cell tracks while avoiding erroneous cell tracks that may lead users to derive misleading
interpretation from the data. Since the tracking algorithm may not be perfect, if the
software builds in a validation function for users to check the tracked data, the potential
impact of erroneous tracking can be avoided467,494. How different cell tracks affect the
cell tracking will be discussed in detail in section 3.3.2.
In summary, quantitative cell migration analysis provides high resolution cell in-
formation that can be used to construct in silico cell migration models, drug discovery,
and cell phenotype profiling. Understanding single cell biology demands an analytical
tool that provides high resolution and accurate single cell information.
3.2 Software architecture
I explain Usiigaci’s architecture by its three modules: segmentation, tracking, and data
analysis modules.
3.2.1 Segmentation module
In the segmentation module, PCM images are segmented into instance-aware masks
using a mask regional convolutional neural network (Mask R-CNN) proposed by He et
al.495. The Mask R-CNN model is implemented in TensorFlow and Keras, as originally
open-sourced by Matterport Inc. under the MIT license496–498.
A detailed diagram of Mask R-CNN architecture is shown in Figure 3.4. The Mask
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Figure 3.3: Types of cell tracking results. (A) Valid cell tracks that are identified
consistently and tracked correctly in every frame throughout one time lapse experiment;
(B) Interrupted cell tracks that are tracked correctly (>80% of the time) from start
to end in one time lapse experiment but the data is missing in one or a few frames
within the experiment; (C) Mitosis cell tracks in which cells undergo mitosis and split
into daughter cells. The tracking can no longer represent true single cell migration;
(D) Cell tracks entering the view field in the middle of the time lapse experiment; (E)
Cell tracking fails in the middle of the time lapse experiment; (F) Cell tracks exiting
the view field in the middle of the time lapse experiment; (G) Cell tracks that are
linked incorrectly in tracking; (H) False positive cell tracks identified by tracker due to
primarily segmentation artifacts. Tracking results in (B – F) are considered as invalid
tracks.
R-CNN model is built upon the Faster R-CNN model that has achieved rapid identi-
fication of objects through searching regions of interest (ROIs) on feature maps495,501.
Raw images undergo multiple convolutional operations in a R-CNN backbone, which
is composed of a residual function network (ResNet-101499) and a feature pyramid
network (FPN500), to generate 5 feature maps (C1 to C5). ROIs are searched on fea-
ture maps using region proposal layers. An accurate instance-segmented ROI map is
generated by an ROI align layer to correct for misalignment in the ROIPooling opera-
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Figure 3.4: Detailed architecture of Mask R-CNN module in Usiigaci The
backbone of Mask R-CNN model is a combination of 101-layer deep residual network
(ResNet-101)499 and feature pyramid network (FPN)500. The ResNet-101 is a deep
residual network composed by two types of deep residual functions: (A) identity block
and (B) convolutional block.
tion. After upsampling, entire outlines of individual cells are segmented into polygons
bearing unique identifiers (IDs) in the exported mask. As a result, highly accurate,
instance-aware segmentation of stain-free PCM images is realized.
Training
Training data preparation and annotation Most of publicly accessible dataset
available for benchmarking segmentation or tracking algorithms are based on fluores-
cent images502. A large publicly accessible brightfield microscopy dataset is not avail-
able until recently503. To accurately segment cells in microscopy images, the Mask
R-CNN model must be trained to be specific toward cells. Thus, I prepared training
images using our microscopy setup as the dataset.
Mouse embryonic NIH/3T3 fibroblasts (CRL-1658, American Type Culture Col-
lection, ATCC, USA) and T98G glioblastoma cells (CRL-1690, ATCC, USA) were
cultured and maintained according to guidelines provided by ATCC. NIH/3T3 cells
were cultured in Dulbecco’s modified Eagle’s medium (12800017, DMEM, Gibco, USA)
supplemented with 2.2 g L−1 NaHCO3 and 10% iron-fortified calf serum (CS, Sigma-
Aldrich, USA). T98G cells were cultured in minimum essential medium alpha (12000022,
MEMα, Gibco, USA) supplemented with 2.2 g L−1 NaHCO3 and 10% fetal bovine
serum (FBS, Gibco, USA). Both cell lines were cultured in a humidified 5% CO2 at-
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mosphere (MCO-18AIC, Sanyo, Japan) and subcultured whenever confluency reached
80%. Cells from passages 5 to 15 were used in the migration study. Fluorescently
labeled cells were prepared by incubating 5× 106 cells with 1 µM of CellTracker Green
CMFDA dye (Thermo Fisher Scientific, USA) in 1X Dulbecco’s phosphate buffered
saline (D-PBS, Wako Inc., Japan) for 30 minutes at 37 ◦C according to the protocol
provided by the manufacturer. Cells were washed once in D-PBS and seeded into
microfluidic chips for microscopy.
The two channel PMMA thermoplastic microfluidic chip (Chapter 2.2) was used to
perform electrotaxis assay as the training data data. Briefly, prior to seeding the cells,
the coverglass was coated with 100 µg mL−1 poly-D-lysine (P6407, Sigma-Aldrich,
USA) or Geltrex (A1569601, Gibco, USA) for NIH/3T3 cells and T98G glioma cells
for 2 hours at 37 ◦C. 7.5 × 105 cells mL−1 were seeded into each channel and allowed
to adhere at 37 ◦C. Afterward, the tubing for infusing media and salt bridges were
connected to the microfluidic chip containing adhered cells by fittings (IDEX, USA).
The chips were moved onto a Nikon Ti-E microscope equipped with an in-house trans-
parent heater made of indium-tin-oxide (ITO) glass. Media were steadily infused at
20 µL hr−1 using a two-channel syringe pump (YSP-202, YMC, Japan) and a stable
37±0.1◦C temperature was provided using a heater to culture the cells. A stable elec-
trical current (101.5 µA for 300Vm−1 EF) was applied with a sourcemeter unit (SMU,
2410, Keithley, USA) through salt bridges (1.5% agarose in 1X D-PBS) with a pair
of silver/silver chloride electrodes in 1X D-PBS. Silver/silver chloride electrodes were
fabricated by electroplating a pure silver sheet (0.1 mm-thick, Nilaco, Japan) in 1 N
HCl (Sigma-Aldrich, USA) after being briefly etched in 20% nitric acid (Sigma-Aldrich,
USA)196.
A Nikon Ti-E microscope with Perfect Focus System and motorized XY stage was
used to perform all microscopy experiments. A 10X phase contrast objective and an
intermediate magnification of 1.5X were used for phase contrast and epifluorescence
imaging. Images were captured with a sCMOS camera with 2×2 binning (Orca Flash
4.0, Hamamatsu, Japan) at 20-minute interval in NIS Element software (Nikon, Japan).
The spatial resolution at this setting was 0.87 µm pixel−1. For fluorescence imaging
of CellTracker Green, a FITC-channel filter set was used (FITC-3540C-NTE-ZERO,
Semrock, USA) with an Intensi-light fiber mercury lamp (Nikon, Japan) as the exci-
tation light source. The Perfect Focus System was used for all time-lapse experiments
and all experiments were performed in triplicate.
After each experiment, images were exported from NIS element as tiff files and
automatically organized according to the XY positions using an in-house Python script
included in the Usiigaci’s source code. The tiff files are then ready for segmentation.
Fifty phase contrast microimages of T98G and NIH/3T3 cells were manually seg-
mented in Fiji ImageJ504 with the aid of a drawing tablet (Cintiq pro 16, Wacom,
Japan) (Figure 3.5). Briefly, the boundary of each cell was traced manually with the
freehand tool in ImageJ and saved into the ROI manager. Indexed masks were created
from the manually traced ROIs by using the ROImap function in the ImageJ plugin
LOCI505. A unique index for each ROI, i.e., for each cell, is essential for instance-
aware segmentation and downstream tracking. Phase contrast images were used in tiff
format without modification. A Mask R-CNN model pretrained with the Microsoft
COCO dataset506 was further trained using 50 manually annotated PCM images with
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single cell outlines as a classification class. Among the fifty sets of images, forty-five
sets of them were used as the training dataset and the rest as the validation dataset.
Figure 3.5: An example of the training data for Usiigaci. (A) Phase contrast
image of T98G cells on Geltrex-coated substrate; (B) Cell outlines were manually
segmented and saved into an 8-bit indexed mask. Each color represents a unique set
of cells.
Training setup in Usiigaci and Deepcell The Mask R-CNN model (Figure 3.4)
of Usiigaci was trained using our annotated training dataset on top of a pretrained
Mask R-CNN model with Microsoft COCO dataset from Matterport Inc.506. Addi-
tional training of 100 epochs on the feature pyramid network (FPN) headers and 500
epochs on all ResNet-101 layers were carried out under an Ubuntu 16.04 environment
with Python 3.4, TensorFlow 1.4, Keras 2.1.2, and CUDA 9.1 on an Alienware 15
laptop equipped with a GTX1070 8GB graphics processing unit (GPU) or a NVIDIA
GTX1080Ti 11GB GPU (Manli, Hong Kong) mounted on an Alienware amplifier (Dell,
USA).
In addition, to compare with Deepcell, a state-of-the-art machine learning based
cell segmentation software, a TensorFlow implementation of Deepcell from the origi-
nal authors was modified to use only the phase contrast channel for segmentation476.
The modified Deepcell was trained from scratch using the aforementioned 50 sets of
manually annotated training data. The sample size and training time per epoch were
compared between Usiigaci’s Mask R-CNN module and Deepcell in subsample mode
and fully convolutional mode (Figure 3.6). In the subsample mode of Deepcell, training
data were split into small batches based on the set window size to increase arbitrary
training samples, and the computation time required to complete an epoch increased.
A moderate computational performance improvement was observed when using a GPU
that had more CUDA cores (GTX1080Ti). Usiigaci’s Mask R-CNN model and Deep-
cell in fully convolutional mode used full-size images for training with simple image
augmentation performed at the start of every epoch. Therefore, the time required to
complete an epoch was shorter compared to Deepcell in subsample mode, but more
epochs were needed to increase the accuracy of the results. Training of Mask R-CNN
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Figure 3.6: Comparison of training time and sample number per epoch
using Usiigaci and Deepcell in subsample mode and in fully convolutional
mode.
took only slightly more time than Deepcell despite more layers and trainable parame-
ters in the Mask R-CNN model because the Mask R-CNN had already been trained for
edge detection with the Microsoft COCO dataset (101 layers, 64.7 million parameters
compared to 25 layers and 0.46 million parameters in Deepcell).
When morphologies of the cells or microscopy optical configurations change signifi-
cantly, retraining the neural network may be necessary for optimal results. A training
script was provided as part of the source code to allow users to train new Mask R-CNN
models based on their own data for best performance after proper training data anno-
tation as described previously. The best model was selected by observing accuracy and
loss during the validation step in training. In Usiigaci’s Mask R-CNN segmentation
module, it is essentially a two-class segmentation system, background and whole-cell
outlines. Several hyper-parameters for training can be adjusted by users, such as neural
network backbone configuration, threshold for region proposals network, and number
of anchors for regional proposal networks.
Deployment
Deployment was performed under the same environment as training with GPU acceler-
ation of either a NVIDIA GTX1070 8GB GPU or a NVIDIA GTX1080Ti 11GB GPU.
The inference python script for deployment allowed users to specify a folder path with
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nested folders, and Usiigaci segmented all images in each nested folder and created
8-bit indexed mask images with each cell possessing a unique identifier.
The essential blocks in convolution neural network use probability, so segmenta-
tion errors may exist between the results segmented between different model weight
extracted at the end of different epochs. To obtain an average result, segmentation
with multiple trained model weights and averaging among the results can be specified
in the inference python script in Usiigaci if necessary.
3.2.2 Tracking module
After Mask R-CNN’s instance-aware segmentation, each mask contains segmented cell
outlines that bear unique IDs. The IDs are then used for linking and tracking in the
tracking module built on the Trackpy library507. The features of an ID, such as location,
equivalent diameter, perimeter, eccentricity, orientation, and true solidity, are used as
parameters in Trackpy for tracking. IDs in each consecutive mask in a time-lapse
experiment belonging to the same cell are searched by the Trackpy library using its
default nearest neighbor search option, namely the k-dimension tree algorithm508–510.
Linking and tracking are followed by automatic post-processing, where segmenta-
tion and tracking results are corrected in two steps. In the first step, a cell wrongly
segmented as two IDs is corrected by merging the two IDs. In the second step, IDs
in consecutive frames belong to the same track, but suffering from interrupted events
are re-linked. A GUI based on the PyQt and PyQtGraph library for the tracking
module is developed so that users can verify segmentation and tracking results511,512
(Figure 3.7). Manual verification is important because imperfections in segmentation
can cause errors in tracking.
In addition, cells that undergo mitosis and cells that enter or exit the view field
during the experiment generate tracking results that are not meaningful in single cell
migration studies (Figure 3.3). In the GUI of the tracking module, by imposing a
simple criterion, select complete tracks, the valid tracks containing IDs of ROIs exist
in every frame, can be selected. Thereafter, users can manually verify whether the
tracking is correct by cross-referencing against raw images. The amount of labor in the
proposed workflow is less than that associated with conventional manual tracking379.
Subsequently, centroid and morphology parameters such as angle, perimeter, and area
of each ID in valid tracks can be extracted and produced using the scikit-image li-
brary513. The results are saved into spreadsheets that can be analyzed by users using
the data processing module or other statistical software.
3.2.3 Data processing module
Analysis of single-cell migration data is accomplished in the data processing module
to compute migration parameters for each ID throughout the time-lapse experiment
(Figure 3.2). Several data processing libraries, including the Python data analysis li-
brary (Pandas), NumPy, and SciPy, are used for processing cell migration data514–516.
Step-centric and cell-centric features, such as turning angle, net trigonometric dis-
tance, speed, orientation, and directedness are computed automatically in a Jupyter
Notebook196,517 (Table 3.1). Moreover, automated visualization of cell migration in cell
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Figure 3.7: The GUI of the tracking module in Usiigaci. PCM images of a
time-lapse experiment are shown in the left panel to compare with the Mask R-CNN
segmented masks in the right panel. After tracking, cell tracks are listed on the right
and users can verify data against PCM images and exclude bad cell tracks.
trajectory plots, box plots, and time-series plots is generated with the aid of Matplotlib
and Seaborn plotting libraries (Figure 3.8)518,519.
The data processing module of Usiigaci could import data output by ImageJ, Usi-
igaci tracker, Imaris, or Metamorph. Step-centric and cell-centric variables to quantify
cell migration were computed automatically (Table 3.1). Results were exported into
spreadsheets and could be reanalyzed in other statistical software. Visualizations of
cell migration were also automatically generated by the data processing module (Fig-
ure 3.8). The module was written in Python syntax so that it could be easily reused if
particular functionalities were needed.
Based on the three modules described above, Usiigaci provides an all-in-one, semi-
automated solution for stain-free cell migration analysis in PCM, with a biologist-
friendly workflow.
3.2 Software architecture 97
Figure 3.8: Visualization examples of NIH/3T3 random cell migration gen-
erated automatically by the data analysis module. (A) Cell migration trajectory
plot with each track represented by a color; (B) Cell migration trajectory plot with
cell track segments colored by time; (C) Cell migration trajectory plot with coloring
depending on the displacement of cells in the x direction; (D) 3D representation of cell
migration trajectory; (E) Box plots of cell migration directedness versus time; (F) Cell
migration represented in a scatter plot; (G) Time series plot of directedness in a time
lapse experiment; (H) Frequency histogram plots of cell migration speed, orientation,
turn angle, and change in positions.
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3.3 Performance benchmark for cell segmentation
and tracking
3.3.1 Cell segmentation accuracy evaluation
Phase contrast microscopy images of NIH/3T3 mouse fibroblast electrotaxis under
300Vm−1 direct current electric field (dcEF) for 10 hr in the microfluidic chip were
collected (Figure 2.10). The experiments were performed in triplicates. Segmentation
similarity of Usiigaci was compared with existing state-of-the-art free software for cell
segmentation, including fluorescent thresholding in ImageJ504, PHANTAST470, Fog-
bank471, and Deepcell476. The ImageJ versions of Fogbank and PHANTAST were
used for segmentation similarity evaluation. Segmentation similarity was compared
against human segmentation (manual reference) by segmentation evaluation metrics
(Figure 3.9 & Table 3.2). True positive (TP), true negative (TN), false positive (FP),
and false negative (FN) metrics were extracted by comparing the manual reference and
segmentation results. Jaccard index and F1 scores were calculated for each segmenta-
tion method.
Figure 3.9: Segmentation performance evaluation. MR: Manual reference; Seg.:
Segmentation results; FN: False negative; TP: True positive; FP: False positive; TN:
True negative.
3.3.2 Cell tracking accuracy evaluation
In each experimental dataset, different tracking results could be identified and catego-
rized to describe the performance of a tracker using multiple object tracking metrics
(Figure 3.3 & Table 3.3)484,485. In this dataset, valid single cell migration tracks were
the data of interest. However, due to segmentation errors and tracking errors, the
data also contained several invalid tracking results, such as interrupted tracks, mitosis
tracks, loss of tracking, objects entering or exiting view field, mismatch tracks, and
false positive tracks (Figure 3.3). Interrupted tracks were tracks that were tracked cor-
rectly most of the time (>80% of time) but missing partial information. Mitosis tracks
contained cells that had undergone mitosis, thus could longer represent true single cell
migration. Tracks containing cells that were lost, entering, or exiting view field early
in the experiment could not be analyzed either. Mismatch and false positive cell tracks
must also be excluded.
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Table 3.2: Segmentation evaluation metrics to describe the similarity be-
tween manual reference (MR) and segmentation (Seg.) results.
Segmentation evaluation metrics
True positive TP = MR ∩ Seg.
True negative TN = MR ∪ Seg.
False positive FP = Seg.−MR
False negative FN = MR− Seg.
Jaccard index (IoU) IndexJaccard = TPFN+TP+FP
F1 score F1 = 2TP
2TP+FP+FN
Precision Precision = TP
TP+FP
Recall Recall = TP
TP+FN
Specificity Specificity = TN
TN+FP
Accuracy Accuracy = TP+TN
TP+TN+FP+FN
Using the multiple object tracking metrics in computer vision, I used the multiple
object tracking precision (MOTP) and multiple object tracking accuracy (MOTA) to
benchmark Usiigaci’s tracker performance against manual tracking by a human oper-
ator (thesis author). The multiple object tracking precision (MOTP) described the
total error in estimated positions for matched object-hypothesis pairs over all frames,
averaged by the total number of matches recognized484. MOTP showed the ability of
the tracker to estimate precise object positions. I described the MOTP by means of
average pixel level precision by comparing the polygon shape of each object between
the manual reference and the segmentation result (mean intersection over union). The
multiple object tracking accuracy (MOTA) accounted for all object configuration er-
rors made by the tracker, including missed events, mismatch events, and false positive
events. The detailed definition is shown in Table 3.3.
In addition, I used intuitive tracking quality measures to describe the amount of
valid data based on validity of cell tracks considering the uniqueness of cell migration
data (Table 3.3). The Usiigaci tracker featured a GUI to allow users to manually verify
tracking data. After tracking, valid cell tracks were mixed with invalid tracks, but
valid cell tracks could be selected by a simple criterion, select complete tracks, in which
only cell tracks with objects that were tracked in every frames in the experiment were
selected. The valid cell tracks were then inspected by users through cross-referencing
with raw image sequences to ensure the validity of the tracking result (Figure 3.7).
Furthermore, I benchmarked the overall performance of segmentation and tracking
under the single cell migration analysis context (Figure 3.3 & Table 3.6). Various seg-
mentation and tracking methods including Usiigaci’s segmentation and tracking mod-
ule, Lineage Mapper520, ImarisTrack module of Imaris (v8.4, Bitplane Inc, UK), and
the track object module of Metamorph (Molecular Devices, USA) were benchmarked
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against manual tracking in ImageJ. Segmentation results from Usiigaci, PHANTAST,
Fogbank, and Deepcell as well as phase contrast raw images, or fluorescence images were
input as data into each software package as needed. An ImageJ plugin (BW_Jtrack)
developed by Mr. Emanuele Martini can assist ImageJ tracking and increase manual
tracking speed. Cell-centric parameters of cell migration were used to validate tracking
accuracy compared to manual tracking. All data were represented as the mean ± 95%
confidence interval unless otherwise noted. Statistical comparison of results from dif-
ferent tracking methods was done using one-way analysis of variance (ANOVA) with
Tukey’s post-hoc multiple-comparison test. The significance level to reject a null hy-
pothesis between two datasets was set at 0.05. A p-value (P, the probability for a true
null hypothesis) less than 0.05 represented statistical significance with corresponding
95% confidence level.
3.4 Results and discussion
3.4.1 Mask R-CNN realizes fast and highly accurate whole-
cell segmentation
Stain-free tracking of NIH/3T3 fibroblasts electrotaxis in a 300Vm−1 direct current
electric field (dcEF) for 10 hr under PCM is used to demonstrate unique features of
Usiigaci. Segmentation performance of Usiigaci is benchmarked against state-of-the-art
free software such as PHANTAST470, Fogbank471, Deepcell476 as well as conventional
fluorescent thresholding in ImageJ. Segmentation results of Usiigaci and aforemen-
tioned software are shown in Figure 3.10 and quantitatively analyzed by segmentation
evaluation metrics (Table 3.2). Segmentation similarity can be evaluated using the
mean ratio of intersection over union (mIoU), which is also known as the Jaccard
index (Figure 3.11).
Table 3.4: Segmentation performance averaged among three NIH/3T3 cell
images using various methods. Ch: Channel; PCM: Phase contrast microscopy;
FL: Fluorescence
Ch Jaccard index F1 score Precision Recall Specificity Accuracy
Manual PCM 1 1 1 1 1 1
Automatic threshold FL 0.27±0.03 0.46±0.02 0.97±0.02 0.30±0.01 1±0 0.91±0.01
PHANTAST PCM 0.46±0.02 0.59±0.09 0.70±0.19 0.51±0.02 0.97±0.03 0.91±0.03
Fogbank PCM 0.63±0.02 0.77±0.02 0.65±0.02 0.93±0.02 0.94±0.01 0.94±0.01
Deepcell 3models-avg PCM 0.36±0.04 0.56±0.06 0.39±0.06 0.96±0.01 0.92±0.01 0.92±0.01
Usiigaci 3models-avg PCM 0.72±0.01 0.85±0.01 0.83±0.02 0.87±0.01 0.95±0.04 0.96±0.01
By fluorescence thresholding, thicker cell bodies can be segmented easily, but thin-
ner structures, such as lamellipodia or blebs, often fail to be segmented and contribute
to higher specificity and lower mIoU (Table 3.4 & Figure 3.12). In Fogbank and PHAN-
TAST, images are thresholded by local contrast, thus segmentation is effective only if
single cells are well isolated. The segmentation similarity achieved by Fogbank and
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Figure 3.10: Microscopy of NIH/3T3 cells stained with CellTracker Green
under PCM and fluorescence microscopy, compared with segmentation re-
sults of Usiigaci, Fogbank, PHANTAST, and Deepcell on the PCM image.
Different color represents instances of each region of interest. In Usiigaci, Fogbank, and
Deepcell, each cell is segmented into an instance outline with a unique ID and color.
In segmented masks of fluorescence-thresholded or PHANTAST, cells are segmented
into ROIs using the analyze particle function in ImageJ and filled with pseudocolors
using the ROImap function in the LOCI plug-in. Usiigaci accurately segmented each
individual cell with accuracy superior to that of other software.
PHANTAST is moderately high (mIoU 0.46 and 0.63), but single-cell tracking in im-
ages with high cell density is not effective using these two methods, because individual
cells cannot be distinguished. By classifying cell membranes through machine learning
methods, Deepcell segments high density cells better than conventional methods. How-
ever, due to the pixel-level classification methods in Deepcell, adjacent cells without
clear boundaries are sometimes difficult to segment.
In Usiigaci, entire outlines of cells are segmented correctly in an instance-aware
fashion, even if cells are densely packed. Segmentation results from Usiigaci are highly
accurate. Figure 3.12 shows a segmentation comparison between the manual reference,
fluorescence-thresholded results, Deepcell results, and Usiigaci results. The segmen-
tation similarity of Usiigaci with a single trained model is 2.2 times higher than that
of the fluorescence threshold method. Usiigaci’s segmentation also outperforms other
benchmarked segmentation software (Table 3.4 & Figure 3.11).
In cell migration, cells in mesenchymal migration often have thin protruding cellular
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Figure 3.11: Segmentation similarity averaged among three NIH/3T3 cell
images using various methods. MR: Manual reference; Seg.: Segmented results;
FN: False negative; TP: True positive; FP: False positive; TN: True negative. Seg-
mentation similarity is measured by the mean intersection over union between ground
truth and segmented results (mIoU =
∑
i TPi∑
i(FNi+TPi+FPi)
, as shown in the inset), or also
known as the Jaccard index.
structures powered by the cytoskeleton to effect mechanical displacement, such as blebs
or lamellipodia472. These thin structures have very low contrast even under PCM.
Segmentation results from Usiigaci closely resemble those of manual segmentation,
while both fluorescence-thresholding and Deepcell have weak segmentation on weakly
contrasted cell features such as lamellipodia. Correct segmentation of the entire cell
outline enables researchers to not only track cell movement, but also monitor cell
morphology.
One of the drawbacks of machine learning is the necessity of powerful computing
resources for training as well as deployment of such tools. By taking advantage of
the Mask R-CNN model, segmentation speed is comparable to that of conventional
computer vision methods such as PHANTAST and Fogbank. The segmentation speed
of Usiigaci is three times faster than that of Deepcell. One 1024×1022 image can be
segmented into instance segmented masks in 1.5 seconds on a standard laptop equipped
with a CUDA-compatible GPU (Figure 3.13). Averaging segmentation results from
three different model weights can still be completed in 7 seconds per image. Usiigaci’s
segmentation module based on Mask R-CNN model provides speed improvement of
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Figure 3.12: Segmentation comparison between manual segmentation as a
reference (yellow), fluorescence threshold (red), Deepcell (green) and Usi-
igaci (blue). The magnified region of the PCM image is shown in inset A. Cells in
mesenchymal migration undergo mechanical displacement using lamellipodia472, the
contrast of which under PCM is very low, making it difficult to segment the struc-
ture without labelling cell structures. Outlines of segmentation results from the three
methods are overlaid in inset B. Overall segmentation accuracy on whole-cell outline
by Usiigaci is more superior and resembles more closely to that of the manual segmen-
tation reference.
orders of magnitude over manual outline segmentation. Automating the segmentation
progress significantly alleviates the required workforce for cell migration analysis.
Furthermore, for establishing a useful image analysis pipeline, the software needs
to be reliable even when the imaging settings such as intensity and magnification, or
experimental settings such as different cells and different cell culture substrate. As
shown in Figure 3.14, under low light intensity, both Deepcell and Mask R-CNN in
Usiigaci perform as expected with high accuracy toward whole cell segmentation. How-
ever, as the light intensity increased, the segmentation results generated by Deepcell
are of lower quality compared to Usiigaci. When the substrate is changed from glass
to polystyrene which has increased surface roughness visible under the microscope, the
background interference causes unacceptable cell segmentation in Deepcell but not in
Usiigaci. Also, when the intermediate magnification of the microscope was decreased
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Figure 3.13: The segmentation time of one phase contrast microscopy
(PCM) image acquired by various methods. Data represent the mean ± the
standard error of the mean among three experiments. Note that the time scale to
manually segment cell outlines is different from other methods. Blue bars indicate
data processed using an on-board GPU in the Alienware laptop and orange bars indi-
cate data processed using a desktop GPU.
from 1.5X to 1X, Usiigaci outperforms Deepcell on the segmentation accuracy.
In general, increasing the number of training data will increase the accuracy of
the CNN, but our work demonstrated that a pretrained Mask R-CNN model could be
further transfer trained using a small training dataset to achieve reliable segmentation
with mean intersection over union (mIoU) of 0.72 in an example dataset that the model
was not exposed to during the training (Figure 3.11). The performance of Mask R-CNN
surpassed several segmentation software I benchmarked. The fact that a small transfer
training dataset can fulfill the need for reliable segmentation, this can be appealing
to end users who do not possess extensive computational or experimental resources to
generate large training datasets.
However, the segmentation accuracy may be profoundly impacted if the segmenta-
tion image is significantly different from that in the training dataset (section 3.2.1). A
proper training dataset created by end users with a user-specific experimental config-
uration may be necessary for optimal results.
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Figure 3.14: Higher tolerance to imaging settings during segmentation in Usiigaci. Usiigaci outperforms Deepcell
when images are taken at lower light intensity, higher light intensity, different substrate (polystyrene over glass), and change of
intermediate magnification.
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3.4.2 High performance multiple object tracking using Usi-
igaci tracker
Mask R-CNN segments cells in an instance-aware manner such that each segmented cell
possesses a unique ID (shown with pseudo-color in Figure 3.10). The IDs in consecutive
images are linked and tracked in the tracking module.
The tracking performance of Usiigaci using MOT metrics and tracking quality mea-
sures are measured on a triplicate 10-hr NIH/3T3 electrotaxis dataset. MOT metrics
measure the performance of trackers based on how accurately the objects in every
frame are tracked. Tracking quality can be understood more intuitively by classifying
individual cell tracks in tracking quality measures. The MOT performance of Usiigaci
with or without manual verification is benchmarked against manual tracking as shown
in Table 3.5484,485.
Table 3.5: Summary of multiple object tracking of NIH/3T3 electrotaxis
after 10-hr under 300 V m−1dcEF (31 frames). Metrics are compared among
manual tracking and Usiigaci with and without the select complete tracks criterion
and manual verification. MOTP: Multiple object tracking precision; MOTA: Multiple
object tracking accuracy.
MOT metrics Manual Usiigaci(unverified)
Usiigaci
(select complete track)
Total events 4520a 4470 1736
Miss events 0 145 0
Mismatch events 0 70 0
False positive events 0 165 0
MOTA 1 0.919 ± 0.01 n/a
MOTP (mIoU) 1 0.702 ± 0.012b 0.756 ± 0.009b
Tracking quality measure
Total tracks 155c 291d 61
Valid single tracks 104 56 56
Interrupted single cell tracks 0 21 0
Mitosis cell tracks 5 5 5
Entering view field tracks 19 19 0
Loss of tracking tracks 0 152 0
Exiting view field tracks 27 27 0
Mismatch tracks 0 2 0
False positive tracks 0 9 0
Valid track ratio 0.67e 0.19f 0.92g
a Total objects identified by a human operator.
b Mean intersection over union ratio of all matched-object pairs in mean ± standard error of mean.
c Total cell tracks identified by a human operator.
d Total cell tracks generated by Usiigaci’s tracker.
e Ratio of valid cell tracks to total cell tracks in the dataset identified by a human operator.
f Ratio of valid cell tracks to total cell tracks generated by Usiigaci’s tracker.
g Ratio of valid cell tracks to total cell tracks after the select all tracks criterion.
In manual tracking, the multiple object tracking precision (MOTP) and multiple
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object tracking accuracy (MOTA) are arbitrarily defined as 1. A total of 4520 events
are identified, summed from all frames. After tracking by the Usiigaci tracker, 4470
events are identified with MOTA of 91.9%. By imposing the select complete track
criterion, events belonging to invalid tracks (Figure 3.3.B – H) are easily removed. The
MOTPs describing the total error in positions of matched object-hypothesis pairs in
Usiigaci before and after manual verification are 70.2% and 75.6%, which are similar
to the Jaccard index in segmentation484. The masks of tracked cells correlate well with
those by manual segmentation at pixel level, which suggests that cell movements and
morphology changes can be tracked and analyzed quantitatively.
Tracking quality using the Usiigaci tracker can be understood more intuitively by
classifying individual cell tracks. By manual tracking, 104 valid tracks are found among
155 total tracks. Using the Usiigaci tracker, 291 tracks are generated and many of which
are erroneous due to different types of cell migration tracks (Figure 3.3). The valid
track ratio in Usiigaci is only 19.5% without manual verification. However, by the
select complete tracks criterion, users can select only the tracks with the same ID in
every frame. Valid cell tracks will be among those selected with the criterion. Users
can also verify whether there are any erroneous tracks and exclude them if necessary.
Five mitosis tracks exist in the remaining results and they are excluded manually. The
valid tracks obtained from Usiigaci after manual verification correspond to 54% of valid
tracks identified by a human operator. However, more viewfields can be analyzed to
increase the number of valid tracks with the labor-saving workflow of Usiigaci.
3.4.3 Automated tracking with manual verification ensures re-
liable cell tracking results
Quantitative cellular dynamics analysis requires both accurate cell segmentation and
cell tracking. The accuracy of cell segmentation and tracking are benchmarked under
the context of single cell migration analysis with the dataset of NIH/3T3 electrotaxis
under 300Vm−1 dcEF in a 10-hour time-lapse experiment.
NIH/3T3 has demonstrated classical cathodal migration and perpendicular align-
ment, which is visible by the increase in directedness and the decrease in orientation
(Figure 3.15). Directedness is a metric to show directional cell migration. Directness
is defined as the average cosine between the net trigonometric distance and electric
current vector (Figure 3.2). A group of cells migrating toward the cathode has a di-
rectedness of 1, and random migrating cells possess a directedness of 0 (Table 3.1). The
directedness of NIH/3T3 cells in dcEF is used to benchmark the accuracy of results
tracked by various tracking methods including manual tracking in ImageJ, the track
object module in Metamorph, Imaris Track, and tracking with Lineage Mapper (Fig-
ure 3.16). PCM images, fluorescence images, or segmented masks from either Usiigaci,
PHANTAST, Fogbank, or Deepcell are used in each tracking software accordingly.
Only valid cell tracks that contains cells being tracked in every frame are analyzed.
Capture rate is defined as the ratio between valid cell tracks by a certain method and
valid cell tracks identified manually. The performance of Usiigaci’s Mask R-CNN seg-
mentation and Trackpy-based tracker benchmarked against manual tracking in ImageJ,
Imaris, Metamorph, Lineage mapper are shown in detail in Table 3.6.
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Figure 3.15: Visualization of valid tracks of NIH/3T3 10-hr electrotaxis in
300 V m−1 dcEF. The cathode is on the right side of the view field. (A) Tracked
results from Usiigaci tracker; (B) Cell migration trajectory plot; (C) Directedness of
cell migration; (D) Orientation of cell migration.
While cell tracking in proprietary software such as Imaris and Metamorph yields
results similar to the manual reference, both software packages only provide positional
information about cells, while morphological information of cells is not available. More-
over, Imaris demands fluorescent labeling of cells to obtain good segmentation results
(Table 3.6).
Even though open-source cell tracking software, such as Lineage Mapper is avail-
able520, segmented data may not be directly compatible with Lineage Mapper if single
cells are not segmented into individual instances correctly in every frame. Because Lin-
eage Mapper is fully automatic, a manual verification process is not available in Lineage
Mapper. Imperfect segmentation results lead to erroneous tracking results and invalid
tracks cannot be excluded by users. Directedness of cells segmented by Fogbank and
tracked by Lineage mapper (P<.01, one-way ANOVA with Tukey’s post-hoc) differs
from the manual reference. Cells segmented by Deepcell are not tracked well with
Lineage Mapper (P<.0001, one-way ANOVA with Tukey’s post-hoc). Therefore, seg-
mented results from PHANTAST and Deepcell on NIH/3T3 electrotaxis cannot yield
good data by tracking with Lineage Mapper. While Usiigaci’s segmented masks can
also be tracked using Lineage Mapper, only 22% of cells are tracked compared to the
manual tracking reference. The results from Lineage Mapper are also significantly
different compared to a manual reference (P<.0001, one-way ANOVA with Tukey’s
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Figure 3.16: Directedness of NIH/3T3 electrotaxis after 10-hr, 300 V
m−1 dcEF stimulation analyzed by different segmentation and tracking
methods. Data and labels are arranged based on the type of images-(segmentation
method_tracking method) (capture rate). LM: Lineage Mapper; FL: Fluorescence;
PCM: Phase contrast microscopy; ** denotes P<.01; **** denotes P<.0001.
post-hoc), presumably due to erroneous tracking that cannot be verified manually.
Misinterpretation may be made due to bad results if users do not fully grasp the inner
workings of the tracking process (Figure 3.16).
In contrast, by segmenting and tracking with Usiigaci, 54% of cells can be au-
tomatically tracked when compared to manual tracking. Moreover, directedness and
migration speed of cells analyzed by Usiigaci are comparable to the manual reference
and Metamorph. Migration speed can be over- or under-estimated in Imaris or Lineage
Mapper. Usiigaci is the only automated cell tracking method that provides both cell
movement and morphology change information among benchmarked software pack-
ages. With high segmentation and tracking accuracy, Usiigaci delivers quantitative
cell migration analysis to biologists as an easy-to-use tool for cell migration phenotype
analysis521.
Usiigaci is the only all-in-one solution for automated cell tracking with manual veri-
fication functionality that provides cell movement and morphology change information.
The labor-saving workflow while preserving the capacity for human intervention is es-
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sential to ensure data validity in single-cell migration analysis522. Quantitative analysis
of cellular dynamics performed using Usiigaci offers unique advantages for quantitative
biology studies.
3.4.4 Limitations of Usiigaci
I have shown that Usiigaci’s instance-level segmentation can provide reliable cell outline
segmentation and tracking with improved speed. However, if the cell morphology differs
significantly than that in the training data, the neural network may not perform as
well as expected.
A microscopy photo of confluent T98G glioma cells and its corresponding Usiigaci
segmentation are shown in Figure 3.17. The cell boundaries of confluent cell layer
may be obscured and become less sharp in comparison to those seen in single cell
microscopy images. Lack of clear cell boundaries makes it difficult to be recognized
by the neural network. Therefore, the Mask R-CNN neural network is limited by the
training data. Preparation of proper training data may be necessary for end users
to obtain optimal results if cell morphology and microscopy optical configuration are
significantly different than our current setup.
Figure 3.17: Segmentation results of confluent T98G glioma cells. (A) PCM
image of confluent T98G glioma cells; (B) The corresponding segmentation result.
3.5 Summary and prospects
Usiigaci offers a reliable quantitative solution for segmentation, tracking, and analysis
of cell migration in two-dimensional PCM. No label or special treatment of cells is
required, so that cells can be analyzed under more natural conditions. Entire outlines
of cells are automatically segmented and tracked in Usiigaci, which enables biologists
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to analyze both movement and morphological changes in cellular dynamics in a quan-
titative manner that existing software cannot provide. The labor-saving workflow also
alleviates the workload in comparison to the manual cell tracking method that is con-
ventionally adopted. Further, the manual verification function enables users to verify
the tracking data and ensure data validity. The trainable nature of the Mask R-CNN
model allows Usiigaci to analyze images acquired in other bright-field microscopic tech-
niques, and potentially for 3D cell tracking in the near future.
To benefit the biomedical research community with this tool for automated cell
segmentation and tracking, Usiigaci is open-sourced in a Github repository of OIST
under the Massachusetts Institute of Technology (MIT) license (link). A tutorial video
of Usiigaci’s usage is also available (video link).
Advances in deep learning methods for biomedical image analysis provide unique
opportunities to advance biomedical discovery. Similar deep learning methods for
biomedical image analysis are used to accomplish in silico labeling of cellular compo-
nents in stain-free images and 3D segmentation of noisy medical images523–526. The
analytical capability of Usiigaci can also contribute to the international effort to stan-
dardize cell migration experiments527. In combination with advances in microsystems,
an automated lab-on-chip system for quantitative biology exploration can be developed
in future.
Further development for Usiigaci is envisioned such that it can be deployed on em-
bedded systems and incorporated with a compact automated microscope which can fit
inside a typical cell culture CO2 incubator. The on-line data acquisition and analysis
capabilities can be offered by future version of Usiigaci to realize the automated artifi-
cial intelligence (AI) cytoscope (Figure 3.18). A biology-centered lab can be equipped
with high resolution automated cell analysis capability with such AI cytoscope.
Specifically, a control unit such as a personal computer (PC) or a smart phone for
the automated microscope can be modified with a processing unit for machine learning
such as a GPU, a field programmable gate array (FPGA), or a tensor processing unit
(TPU). After acquisition of raw images, the images can be processed by different CNNs
trained to yield in silico estimation results such as outlines for cell tracking (Usiigaci in
its current form), nuclei, intracellular organelles, cytoskeleton, cell cycle classification,
or senescence classification. These in silico classification results can be saved with raw
images as multi-dimensional data for users to perform a broad range of cell analysis such
as cell motion, cellular state, lineage, and intracellular analysis throughout a time lapse
experiment. Furthermore, a feedback learning function can empower user’s feedback
to further train the CNNs based on users’ data to yield more accurate estimation in
user’s experimental environment.
The specific developmental aims of Usiigaci to realize this future include:
• Increase more training data for different magnification, cell types, and different
brightfield microscopy techniques to become a universal segmentation tool.
• Multi-class segmentation for Mask R-CNN to recognize different cell types for
cell co-culture identification without staining.
• Include lineage tracking function that is essential in fields such as stem cell biology
and neurosciences528,529.
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• Include cell migration phenotype classification function in the data processing
module for quantitative cell migration phenotype analysis491,493.
Figure 3.18: Automated AI cytoscope. A control unit on an automated micro-
scope can be equipped with machine learning processing unit such as GPU, FPGA, or
TPU. An acquired raw image can be inferred by multiple CNNs trained to recognize
cell outlines, nuclei, organelles, cytoskeleton, cell cycle, or senescence. Both the raw
images and inferred results by CNNs are saved into multidimensional data that can
be analyzed by users after the experiment is completed. A feedback learning function
can be built in to further train the CNNs in situ by users’ data to further improve
the CNNs. PC: personal computer; GPU: graphical processing unit; FPGA: Field
programmable gate arrays; TPU: Tensor processing units.
Chapter 4
Electrotaxis of glioma cells using
hybrid PMMA/PDMS
microfluidics
Abstract
Translational research demands reliable biomedical microdevices (BMMDs) to mimic
physiological conditions and answer biological questions. In this chapter, the developed
hybrid PMMA/PDMS microfluidic chip is used for studying glioma electrotaxis in a high-
throughput manner. Four chemical microenvironments whereas each has four electric fields
further support high-throughput screening of glioblastoma cell electrotactic responses in a
single experiment. Uniform cell seeding by submerged operations enables reliable single cell
spatial resolution. The electrotaxis of glioblastoma cells T98G and U-251MG require optimal
laminin-containing extracellular matrix coating and exhibit completely different directional
and electro-alignment tendencies. Anodal T98G electrotaxis and cathodal U-251MG elec-
trotaxis have different fetal bovine serum (FBS) dependencies but both require the presence
of extracellular calcium cation. Further pharmacological investigation into the voltage-gated
ion channels in T98G and U-251MG electrotaxis reveals that U-251MG electrotaxis is depen-
dent on P/Q-type voltage-gated calcium channels (VGCCs) and T98G maybe dependent on
R-type VGCCs. U-251MG and T98G electrotaxis are also mediated by A-type voltage-gated
potassium channel (VGKCs) and acid-sensing sodium channels. Further elucidation of the
role of voltage-gated ion channels in glioma metastasis may be important for developing new
therapeutic and personalized approaches for aggressive glioma. The hybrid PMMA/PDMS
approach provides a simple and flexible platform to create multiplex microenvironments,
making it possible to investigate complicated biological questions in translational research.
4.1 Introduction
Glioma is the most common type of brain cancer and the aggressive form of it, glioblas-
toma, has poor prognosis, high morbidity, and high probability of recurrence530,531, due
to the infiltration nature of the disease. The high infiltrative ability of the cancer origi-
nates from the invasive/migratory ability in glioma stem cells or brain tumor initiating
cells532,533. However, it is now clear that not only the glioma cells are important, but
also the microenvironment in the brain helps shaping the heterogeneity of the glioma534.
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The glioma cells interact with the extracellular matrix, glial cells, and immune cells in
the brain and mediate the formation of peri-vascular, peri-necrotic, and invasive tumor
microenvironments42,50,535,536. Understanding the molecular mechanisms of the inva-
siveness in glioma cells as well as the tumor microenvironment is vital for developing
new therapeutic options and improving the patient outcome537,538.
In the brain, glial cells are immersed in an electric field created by tissue polarity
as well as the local field potentials summed from the actional potentials fired by the
neurons178. The physiological electric fields in the brain may play an important role in
mediating the glioma tumorigenesis and invasion293,294,398. Under a direct current elec-
tric field, depending on the 2D or 3D microenvironment, glioblastoma cells of different
origins migrate toward different electrodes through electrotaxis293–295. Huang et al.,
identified that heparan sulfate and slit-Robo1 signaling mediates the glioma electro-
taxis. In contrary, an alternating current electric field inhibits the mitotic spindle and
arrests the proliferation of glioma79,208. The electrical cue in tumor microenvironment
in the brain has thus been explored as a therapeutic target.
Cells sense the electric field by bioelectrical activation of voltage sensitive proteins,
mechanosensing due to electrokinetic phenomena, with activated chemical signaling
due to electrokinetically polarized membrane receptors (Figure 4.1). The voltage gra-
dient of the electric field creates a large voltage drop at the membrane which can
directly activate voltage sensitive proteins such as voltage-gated ion channels that
are often expressed on excitable membranes at neuronal synapses and neuromuscular
junctions539. Among the voltage-gated ion channels in the brain, calcium channels are
especially important as calcium influx plays a pivotal role in cellular signaling540,541.
Calcium signaling is also important in glioma cell proliferation, resistance to therapy,
and metastasis542–546. Whether or not the calcium signaling in glioma is mediated by
electric field is still an open question.
To study electric field and cell interaction, a reliable in vitro platform that interfaces
with automated microscopy is a prerequisite. Stable electrical stimulation of cells in a
high-throughput fashion is a necessity for rapid screening targets and identifying molec-
ular mechanisms. To this end, I have developed a hybrid PMMA/PDMS microfluidic
platform to reliably study single glioma cell migration under high-throughput electric
field stimulations that multiple agonists/antagonists can be tested at the same time
(Chapter 2.3). In combination with a machine learning-enabled software for automated
cell migration analysis, the electrotaxis of glioblastoma cell line models are studied in
detail (Chapter 3). The hypotheses that glioblastoma electrotaxis is mediated by ex-
tracellular matrices (ECM), chemical signaling, and voltage-gated calcium channels are
tested as follows (Figure 4.1):
A. What are the appropriate extracellular matrices suitable for glioma electrotaxis?
ECM affects cell adhesion, cell migration machinery, and cell-cell junctions547.
Specific cell types express different surface adhesion molecules and thus have
preference toward appropriate ECMs on in vitro platforms. The first step is to
identify the appropriate ECM coating for establishing a stable electrotaxis model
of glioma (Figure 4.1A).
B. Does chemotactic signaling pathways intersect with electrotaxis of glioma?
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Figure 4.1: The hypothetical mechanisms underlying electrotaxis.
The cellular signaling pathways can be grossly categorized by types of receptor
actions, such as enzyme-linked receptors, G-protein coupled receptors, transmem-
brane non-enzymatic receptors, ligand-gated ion channels, or voltage-gated ion
channels548.
Many receptor tyrosine kinase receptors ligands and cytokines are overexpressed
in glioma patients549. To test if the primary signaling pathways in the chemo-
taxis intersect with those in glioma electrotaxis, I investigate if T98G glioblas-
toma electrotaxis is mediated by chemical ligand stimulation from key chemo-
taxis pathways (Figure 4.1B). Some of the key chemotaxis pathways identified to
participate in electrotaxis include epidermal growth factor (EGFR)233–242, vascu-
lar endothelial growth factor receptor (VEGFR)243–245, fibroblast growth factor
receptor (FGFR)185 in the enzyme-linked receptors category. Furthermore, G-
protein coupled receptors and cytokine receptors also have been reported to be
involved in electrotaxis550,551, therefore the common pathways in these categories
related to glioma malignancy are tested, including the CXCL12-CXCR4 axis and
the tumor necrosis factor α (TNF-α) signaling.
C. Does VGCCs mediate the electrotaxis of glioma cells?
VGCCs are among a major class of membrane ion transporters regulating the
calcium influx. While VGCCs abundantly express on the excitable membranes
such as those on neurons and neuromuscular junctions, VGCCs also play impor-
tant roles on glioma biology such as cell proliferation, apoptosis, sensitization to
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ionizing radiation552,553.
VGCCs can be categorized as high voltage activated (HVA) type or low voltage
activated (LVA) type (Figure 4.2)172,554,555. Among the HVA VGCCs, four sub-
types can be identified from electrophysiological and genetic phylogeny, including
L-type (long-lasting, Cav1.1 − 1.4), P/Q-type (purkinje/unknown, Cav2.1), N-
type (neural, Cav2.2), and R-type (residual, Cav2.3) calcium channels. The LVA
VGCCs is composed of T-type channels (transient, Cav3.1− 3.3).
Under electric field stimulation, the VGCCs can be activated by the imposed
electric field (Figure 4.1C). If and how VGCCs participate in the electrotaxis of
glioblastoma may shed new insights for inhibiting glioblastoma infiltration.
Figure 4.2: Subfamilies of voltage-gated calcium channels554.
4.2 Materials and methods
4.2.1 The hybrid PMMA/PDMS chip for high-throughput
electrotaxis experiment
For electrotaxis study of glioma cells, I used thermoplastic microfluidic chips (Chap-
ter 2.2) and hybrid PMMA/PDMS microfluidic chips (Chapter 2.3) described in detail
previously.
The hybrid PMMA/PDMS chip took advantage of the double-layer microchannel
design and permitted experiments of two different cell types or chemical treatments
with four electric field strengths conditions in a single chip (Figure 4.3). Due to the
increased hydraulic resistances of the interconnecting channels in the double-layer hy-
brid PMMA/PDMS chip (Figure 4.3C), the chemical transport was stable over the
course of 10 hours at cell culture-relevant flow rates. Using this design, robust single
cell migration experiments could be performed in high throughput fashion.
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Figure 4.3: The concept of a small configuration hybrid PMMA/PDMS
microfluidic chip. (A) The 3D rendered model of the final PMMA/PDMS chip.
Double-layer microchannel design in the PDMS is shown; (B) The schematic diagram
of using the PMMA/PDMS chip for electrotaxis experiments. Complex 3D microfluidic
structures and world-to-chip interface are established in PMMA components A & B;
(C) The channel design. The 10 µm-high first layer structures are shown in cyan.
4.2.2 Cell culture and maintenance
Glioblastoma cell lines T98G (CRL-1690, ATCC, USA) and U-251MG (IFO50288,
JCRB, Japan) were obtained from the respective tissue banks and thawed according
to the received instructions. T98G and U-251MG were cultured in minimum essential
media α (MEMα) supplemented with 10% FBS and 2.2 g L−1 under 37 ◦C, 5% CO2
moist atmosphere (MCO-18AIC, Sanyo, Japan). The cells were subcultured every
other day or whenever cells reached 80% confluency. Mycoplasma contamination was
checked every three months using a mycoplasma species-specific PCR kit (e-Myco plus,
iNtRON, Korea) on a thermocycler (C1000, Bio-Rad, USA).
Frozen stocks of the cells were prepared by resuspending 1× 106 log-phase cells in
1mL cell banker solutions (Takara Bio, Japan) and cooled down in a freezing container
(Mr. Frosty, Nunc, USA) in −80 ◦C overnight. The frozen cells were then transferred
into gaseous phase of liquid nitrogen for long term storage (Locator 6 Cryopreservation
tank, Thermo Scientific, USA).
4.2.3 General experimental workflow
The cell experiment workflow included salt bridge preparation, priming of microchan-
nels, coating substrate with extracellular matrix, seeding cells, assembly of world-to-
chip interface, and electrotaxis experiment.
On-chip agarose salt bridge preparation 1% agarose (Seakem LE agarose, Lonza,
USA) was dissolved in 1X D-PBS and autoclaved. The agarose was injected on the
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salt bridge locations of the PMMA component B and allowed to gel. The salt bridge
served as a solid electroconductive separation in electrotaxis experiment between the
cell culture media and D-PBS.
Priming for bubble-free microchannels 50 µL of 99.5% ethanol (Wako, Japan)
loaded in 200 µL tips were used to wet the microchannels by capillary flow and gravity
flow. The low surface tension of ethanol easily wetted the PDMS microchannels and
avoided microbubbles. Next, reagent-grade water was put in the opposite reservoir and
was introduced into the microchannels by withdrawing from the tips that loaded with
ethanol in the previous step. The inlet/outlet ports were submerged under water in all
steps afterward to ensure bubble-free microchannels.
Coating of substrate with extracellular matrix proteins 150 µL of extracellular
matrix proteins coating, such as Geltrex, were loaded into 200 µL tips and allowed to
flow into chip passively by inserting the filled tips into the inlets/outlets on the PDMS
chip. The extracellular matrix was coated for 1 hour at 37 ◦C and washed once with
1X D-PBS.
Facile pressure-balanced underwater operation for high fidelity cell seed-
ing The top reservoir was filled with cell culture media until the inlet and outlet
were under the same liquid level, i.e., balancing the inlet/outlet hydrostatic pressure.
The cells were trypsinized (TrypLE, Thermo Fisher Scientific, USA), counted (Muse,
Millipore, USA), centrifuged at 300×g for 5 min, and resuspended in culture media
at 106 cells mL−1. Appropriate amount of cell suspension was injected into the mi-
crochannels using a P200 micropipette. Due to the small volume of a microchannel,
only a minute amount of cell suspension was needed. The cells were allowed to adhere
in the chip under 37 ◦C, 5% CO2 atmosphere for 3 to 5 hours.
For comparison, different approaches of cell seeding were tried such as:
1. Tip loading method
The cells were loaded in 200 µL tips and cells were infused into microchannels
by gravity flow without removing the tips. The cells may flocculate as it passes
through the small bore of micropipet tips.
2. Tip injection method
The cells were loaded in 200 µL tips and cells were injected into microchannels
by micropipette then tips were removed.
Completion of chip prior to experiment After cells attached to the bottom
of microchannels, the cell culture media in the top reservoir was removed. Through
the reversibility of the dual energy double-sided tape (de-ds tape), the top reservoir
was removed by shearing sequentially from component B and component A. The top
liner of the first ds tape on component B (Figure 2.23A) was removed and a PDMS
slab punched with two holes (21G, Accupunch, Syneo, USA) was affixed to that ds
tape, completing the PMMA/PDMS chip. The PMMA/PDMS chips were affixed
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with double-sided tape (No.2, Nichiban, Japan) on a home-made aluminum holder
(Appendix D.5, Meviy, Misumi, Japan) in a microscope on-stage 5% CO2 incubator
(WKSM, Tokai-Hit, Japan). A feedback thin-film K-type thermocouple was attached
to glass bottom of the microfluidic chip (60 µm-thick, Anbesmt, Japan) and regulated
the cell culture temperature at 37 ◦C. The reservoir on the on-stage CO2 incubator
was filled with sterilized pure water to minimize evaporation of the water in culture
media which would significantly affect the cell viability (Section 2.1.5).
4.2.4 Electrotaxis of glioma cells on different ECM coatings
To investigate the extracellular matrices preferred by glioma cells, various ECM coat-
ings in thermoplastic and PMMA/PDMSmicrofluidic chips were tested, such as poly(D-
lysine) (PDL), poly(L-ornithine) (PLO), PLO combined with laminin, collagen, fi-
bronectin, vitronectin and Geltrex®. PLO combined with laminin is a common ECM
coating to support cells originated in the CNS. Geltrex is a reconstituted basement
membrane purified from murine Engelbreth-Holm-Swarm (EHS) tumor containing laminin,
collagen IV, entactin, and heparin sulfate proteoglycan that has been used to support
human embryonic stem cells (ESCs) as well as induced pluripotent stem cells (iPSC).
The thermoplastic chip (Chapter 2.2) was prepared, vacuumed, and primed with
CO2 gas, water, and D-PBS sequentially to prevent bubbles202. The ECM coatings
were prepared at working concentrations accordingly (Table 4.1) and infused into
30×3×0.07mm (length×width×height) microchannels and incubated for 1 hour at
37 ◦C. The channels were washed once with 1X D-PBS and cell culture media before
seeding of cells. Glioblastoma cells were trypsinized and resuspended to 5× 106 cells mL−1
counted by a cell counter (Muse, Millipore, USA). The cells were seeded in the chan-
nels and allowed to adhere to the bottom for 3 to 5 hours at 37 ◦C. Afterward, primed
fluidic tubings and salt bridges were connected (Figure 2.10). A 300Vm−1 electric field
was applied through home-made 50×3 mm silver/silver chloride (Ag/AgCl) electrodes
that the fabrication process was described previously (Nilaco, Japan)196,202. A direct
electric current was sourced and measured by a source measure unit (2410, Keith-
ley, USA). The current required to establish the electric field can be calculated using
Equation 4.1:
I = EFS × σ × w × h, (4.1)
where EFS, σ, w, h are the electric field strength, conductivity, width, and height of
the microchannel, respectively.
The microscopic images of cells stimulated under 300Vm−1 and 0Vm−1 were taken
by an automated phase contrast microscopy over 6 hours (Ti-E, Nikon, Japan).
The PMMA/PDMS microfluidic chips were fabricated as previously described in
Section 2.3 and prepared according to the experimental workflow. Briefly, the mi-
crochannels were primed with 99.5% ethanol and washed with pure water before the
working solutions of ECM coatings were infused by gravity flow in micropipette tips.
The extracellular matrix coatings were incubated for 1 hour at 37 ◦C before washed
with 1X D-PBS. The top reservoir was filled with serum-containing culture media.
The glioblastoma cells were trypsinized, centrifuged by 300×g for 5 min, and resus-
pended in MEMα with 10% FBS to 1× 106 cells mL−1 counted by a cell counter (Muse,
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Table 4.1: Commonly used extracellular matrix coatings for cell migration.
ECM Stock conc. Working conc. Common use
poly(D-lysine) 500 µgmL−1 50 µgmL−1
Positively charged synthesized amino
acids for general cell adhesion.
Collagen I 3mgmL−1 50 µgmL−1
General coating for cell attachment,
migration and morphogenesis
Collagen IV 3mgmL−1 50 µgmL−1
General coating for cell attachment,
migration and morphogenesis
poly(L-ornithine)
0.01%
(0.1mgmL−1)
100 µgmL−1
Positively charged synthesized amino
acids for general cell adhesion.
poly(L-ornithine)
+Laminin
n/a
100 µgmL−1+ 50 µgmL−1
20 µgmL−1+ 10 µgmL−1
General coating for cells from
central or peripheral nervous system.
Laminin 100 µgmL−1
50 µgmL−1
10 µgmL−1
Maintenance of ESCs;
Epithelial differentiation; Neurite outgrowth
Vitronectin 0.5mgmL−1 5 µgmL−1
Feeder-free maintenance of stem cells
and primary neurons.
Fibronectin 1mgmL−1 10 µgmL−1
Fibrillar matrices for stem cells
and neural outgrowth.
iMatrix 511
(Laminin 511-E8)
0.5mgmL−1 50 µgmL−1
Truncated form of laminin for enhanced
iPSC feeder-free culture
Geltrex
0.12 – 0.18mgmL−1
(ready-to-use)
0.12 – 0.18mgmL−1
(ready-to-use)
Maintenance of ESCs;
Endothelial capillary formation
Millipore, USA). Appropriate amount was seeded in the channels using micropipettes
and cells were allowed to adhere to the bottom for 3 to 5 hours at 37 ◦C. After adhe-
sion, the top reservoir was easily removed from the PMMA/PDMS chip by shearing
and delaminating the de-ds tape. A 4mm-thick PDMS slab punched with two 21G
outlet holes (Accupunch, Syneo Corp, USA) was adhered on the component B of the
PMMA/PDMS chip, completing the chip for experiment.
To start electrotaxis experiment, fresh media were supplied in the reservoir on
component A of the PMMA/PDMS chip. Two sets of tubings (06419-01, Cole Parmer,
USA) with stainless tubes (23RW, New England Small Tubes, USA) on one end and
a double Luer gel dispensing needle on the other (23G, Musashi, Japan) were used.
The tubings were steam sterilized before primed with 1X D-PBS with 2.5mL syringes
(Terumo, Japan). The stainless tube ends were inserted into the 21G holes of the
PDMS slab on the PMMA/PDMS chip. The syringes were mounted on a syringe
pump (YSP-202, YMC, Japan) and set in withdrawal mode to perfuse the cells on
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PMMA/PDMS chips.
A 300Vm−1 direct current electric field strength (EFS) was established in section
I (Figure 4.3) through two home-made Ag/AgCl wire electrodes196,202 inserted in the
D-PBS reservoirs on component B by a source measure unit (2410, Keithley, USA).
Time lapse phase contrast images of each condition were taken on an automated phase
contrast microscope (Ti-E, Nikon, Japan).
4.2.5 Electrotaxis of T98G glioma cells under co-stimulation
of different chemical ligands
To test if chemical signalings from chemical ligands mediate the electrotaxis of T98G
cells, the thermoplastic chips were used. The thermoplastic chip was prepared, vacu-
umed, and primed with CO2 gas, water, and D-PBS sequentially to prevent bubbles.
The coverglass bottom of the chip was coated with Geltrex for 1 hour at 37 ◦C. The
microchannels were washed once with 1X D-PBS and cell culture medium before seed-
ing of cells. The cells were trypsinized and resuspended to 5× 106 cells mL−1 counted
by a cell counter (Muse, Millipore, USA). The cells were seeded in the channels and
allowed to adhere to the bottom for 3 to 5 hours at 37 ◦C. Afterward, primed fluidic
tubings and salt bridges were connected (Figure 2.10) and the culture media in the
microchannels were exchanged to serum-free media at flow rate of 20 µLmin−1. The
cells were starved for 8 hours before exchange to ligand-containing serum-free media.
The cells were stimulated with ligand-containing serum-free media for 1 hour before
starting time-lapse cell imaging and electrical stimulation. The microscopy images of
cells stimulated under 300Vm−1 and 0Vm−1 were taken over 6 hours.
4.2.6 Extracellular calcium dependency of glioma cell electro-
taxis
To test if the electrotaxes of T98G and U-251MG cells require extracellular Ca2+,
calcium-free Dulbecco’s minimum essential medium (Ca-free DMEM, 21068, Gibco,
USA) and cation chelators such as ethylenediaminetetraacetic acid (EDTA) (15575,
Thermo Fisher Scientific, USA) and ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-
tetraacetic acid (EGTA) (08907-84, Nacalai, Japan) were used. The PMMA/PDMS
microfluidic chips were fabricated as previously described in Section 2.3 and prepared
according to the experimental workflow. The microchannels were primed with 99.5%
ethanol and displaced with pure water before Geltrex solutions were infused by gravity
flow from micropipette tips. The Geltrex coatings were incubated for 1 hour at 37 ◦C
before being washed with 1X D-PBS. The top reservoir was filled with serum-containing
culture media afterward.
The glioblastoma cells were trypsinized, centrifuged by 300×g for 5 min, and re-
suspended in MEMα with 10% FBS to 1× 106 cells mL−1 counted by a cell counter
(Muse, Millipore, USA). Appropriate amount of cell suspension was seeded in the
channels using micropipettes and cell were allowed to adhere to the bottom for 3 to
5 hours at 37 ◦C. After adhesion, the top reservoir was easily removed from the PM-
MA/PDMS chip by shearing and delaminating the dual energy double-sided tape. A
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4mm-thick PDMS slab punched with two 21G outlet holes (Accupunch, Syneo Corp,
USA) was adhered on the component B of the PMMA/PDMS chip, completing the
chip for experiment.
Before the experiment, cells were incubated in Ca-free DMEM or MEMα with 10%
FBS mixed with calcium chelators at indicated molar concentrations for 2 hours at
20 µL h−1. Afterward a direct electric current was applied through Ag/AgCl wire elec-
trodes in D-PBS buffer on the component B by a source measure unit (2410, Keithley,
USA). Six-hour time lapse images were taken on an automated phase contrast micro-
scope (Ti-E, Nikon, Japan).
4.2.7 Pharmaceutical inhibition of voltage-gated ion channels
in electrotaxis of glioma cells
To test different inhibitors against various types of voltage-gated ion channels in high
throughput fashion (Table 4.2), PMMA/PDMS microfluidic chips were used.
The PMMA/PDMS microfluidic chips were fabricated as previously described in
Section 2.3 and prepared according to the experimental workflow. The microchannels
were primed with 99.5% ethanol and displaced with pure water before Geltrex solu-
tions were infused by gravity flow from micropipette tips. The Geltrex coatings were
incubated for 1 hour at 37 ◦C before washed with 1X D-PBS. The top reservoir was
filled with serum-containing culture media afterward.
The glioblastoma cells were trypsinized, centrifuged by 300×g for 5 min, and re-
suspended in MEMα with 10% FBS to 1× 106 cells mL−1 counted by a cell counter
(Muse, Millipore, USA). Appropriate amount of cell suspension was seeded in the
channels using micropipettes and cell were allowed to adhere to the bottom for 3 to
5 hours at 37 ◦C. After adhesion, the top reservoir was easily removed from the PM-
MA/PDMS chip by shearing and delaminating the dual energy double-sided tape. A
4mm-thick PDMS slab punched with two 21G outlet holes (Accupunch, Syneo Corp,
USA) was adhered on the component B of the PMMA/PDMS chip, completing the
chip for experiment.
For high throughput experiments, two PMMA/PDMS microfluidic chips could be
set up in a single experiment (Figure 4.4), enabling screening of electrotaxis response
of cells under four EFSs and four different conditions. A U-shaped PMMA salt bridge
filled with 1% molten agarose in PBS was used to connect the two chips electrically by
inserting into the PBS reservoirs on component B of the two PMMA/PDMS chips.
To start electrotaxis experiment with pharmaceutical inhibition, inhibitors were
added to fresh MEMα media supplemented with 10% FBS at appropriate working
concentrations (Table 4.2). The reagents were supplied in the reservoir on component
A of the PMMA/PDMS chip. The tubings were connected as same as previously
described in Section 4.2.4.
After cells were seeded and adhered well, the inhibitor-containing media were in-
fused into the channels at 20 µLmin−1 for 10 minutes before changing to 20 µL h−1
and incubated for 30 minutes. A direct electric current was applied through Ag/AgCl
wire electrodes in D-PBS buffer on the component B by a source measure unit (2410,
Keithley, USA). Six-hour time lapse images were taken on an automated phase contrast
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Table 4.2: Pharmacological inhibitors to study the voltage-gated calcium
channels in glioma electrotaxis.
Inhibitors Stock conc. Working conc. Actions
Cadmium chloride 1 M
50 µM
100 µM
HVA VGCC inhibitor
Gadolinium chloride 1 M 50 µM HVA L-type VGCC inhibitor
Nickel chloride 1 M
100 µM
500 µM
LVA T-type VGCC inhibitor
EDTA 0.5 M 2 mM Cation chelators (e.g., Ca2+)
EGTA 0.5 M 5 mM
Cation chelators
(more selective toward Ca2+)
Nicardipine 20 mM DMSO 10 µM L-type VGCC inhibitor
ω-Conotoxin GVIA 0.1 mM 3 µM N-type VGCC inhibitor
ω-Agatoxin IVA 0.1 mM 200 nM P/Q-type VGCC inhibitor
ω-Conotoxin MVIIC 0.2 mM 500 nM P/Q-type VGCC inhibitor
ω-Theraphotoxin-Hg1a (SNX482) 0.1 mM 500 nM
R-type VGCC inhibitor;
A-type K+ channel inhibitor
TTA-A2 0.1 M DMSO 100 µM T-type VGCC inhibitor
Amiloride hydrochloride 5 mM 100 µM
T-type VGCC inhibitor;
ENaC/ASIC/Degenerin inhibitor
Calmidazolium 10 mM DMSO 100 nM Calmodulin antagonist
AmmTx3 0.1 mM 5 µM A-Type K+ channel inhibitor
4-aminopyridine 50 mM
1 mM
4 mM
A-Type K+ channel inhibitor
Benzamil hydrochloride 10 mM DMSO 5 µM
Na+/Ca2+ exchanger inhibitor;
ASIC/ENaC inhibitor;
TRPP inhibitor; TRPA1 inhibitor
microscope (Ti-E, Nikon, Japan).
4.2.8 Single cell migration tracking and statistical inference
A Nikon Ti-E automated microscope with Perfect Focus System and motorized XYZ
stage was used to perform all microscopy experiments. A 10X phase contrast objective
and intermediate magnification of 1.5X were used for taking 10-minute interval phase
contrast images with a scientific CMOS (sCMOS) camera with 2×2 binning (Orca Flash
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Figure 4.4: The photoimage of setup for high throughput experiments with
PMMA/PDMS chips. The red dashed box indicates the magnified region with
PMMA/PDMS chips in an on-stage incubator. SMU: source measure unit
4.0, Hamamatsu, Japan) in NIS Element AR software (Nikon, Japan). The spatial
resolution at this setting was ≈ 0.87 µm pixel−1. All experiments were performed in
triplicate.
After each experiment, images were exported from NIS element software as tiff files
and automatically organized by XY positions into folders using an in-house developed
Python script. The cells in the raw images were segmented, tracked, and automati-
cally analyzed using the Usiigaci software (Chapter 3). Only cells tracked throughout
all the frames in one viewfield were analyzed. At least 100 cells in every conditions
were analyzed for cell-centric features such as the directedness, speed, and orientation
changes before and after electric field or chemical stimulation (Table 4.3).
Briefly, the definitions of key cell-centric features used to quantify cell electrotaxis
(Figure 4.5) were listed below:
• Directedness
The directedness of cell electrotaxis was defined as the average cosine of Euclidean
vector and EF vector,
N∑
i=1
cosΦi
N
, where Φi was the angle between the Euclidean
vector of each cell migration and the vector of applied EF (from anode to cath-
ode), and N was the total number of analyzed cells. A group of anodal moving
cells held a directedness of -1; and a group of cathodal moving cells held a di-
rectedness of +1. For a group of randomly migrating cells, the directedness was
zero.
4.2 Materials and methods 127
Figure 4.5: The single-cell migration parameters extracted from the elec-
trotaxis experiments.
Table 4.3: Step-centric and cell-centric variables for describing single-cell
migration.
Step-centric features
Instantaneous displacement di =
√
(xi − xi−1)2 + (yi − yi−1)2
Instantaneous speed si = d(pi−1, pi)/∆t
Turning angle αi = tan−1 (yi−yi−1)(xi−xi−1)
Directional autocorrelation dir − auti = cos (αi − αi−1)
Instantaneous directedness Indexdirectednessinstant =
N∑
i=1
cosΦinstanti
N
=
N∑
i=1
(xi−xi−1)
di×N =
1
N
N∑
i=1
(xi−xi−1)√
(xi−xi−1)2+(yi−yi−1)2
Cell-centric features
Cumulative distance dtotal =
N∑
i=1
d(pi−1, pi)
Net trigonometric distance
(Euclidean distance)
dnet = d(p0, pN) =
√
(xN − x0)2 + (yN − y0)2
Euclidean velocity v¯net = dnettelapsed
End-point directionality ratio ep_dr = dnet
dtot
Orientation Indexorientation =
N∑
i=1
cos 2θi
N
Directedness Indexdirectedness =
N∑
i=1
cosΦi
N
=
N∑
i=1
(xi−x0)
dnet×N =
1
N
N∑
i=1
(xi−x0)√
(xi−x0)2+(yi−y0)2
• Speed
The speed of cell electrotaxis was defined as the average of cell migration rate
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to travel the Euclidean distance,
N∑
i=1
(
dnet
telapsed
)i
N
, where the dnet was the Euclidean
distance traveled by each cell, and telapsed was the the time elapsed, and N was
the total number of analyzed cells.
• Orientation
The orientation was defined as the average cosine of two times angle between the
EF vector and the cell long axis,
N∑
i=1
cos 2θi
N
, where θi was the angle between the
applied EF vector and the long axis of a given cell; N is the total number of cells
analyzed. A group of cells aligned perpendicular to the EF held an orientation of
-1; and a group of cells aligned in parallel to the applied EF held an orientation
of +1. For a group of randomly shaped cells, the average orientation was zero.
The cell-centric features were computed automatically and saved as Excel spread-
sheets (Office365, Microsoft, USA) as part of the Usiigaci software analysis pipeline.
The data was further statistically inferenced by inputting the data in a statistical soft-
ware (Prism 7, GraphPad LLC, USA). All data were presented as the mean ± 95% con-
fidence interval, which is 1.96 of standard error of mean, from triplicate experiments.
One-way analyses of variance (ANOVA) with Tukey’s multiple-comparison post-hoc
tests were performed. The confidence level to reject a null hypothesis between two
datasets was set at 95%. A p-value (P, the probability for a true null hypothesis) less
than 0.05 represented a statistical significance at 95% confidence.
4.3 Results and discussion
4.3.1 Uniformly sparse cell seeding on chip by submerged op-
eration
To analyze single cell migration in microchannels, cells must be seeded sparsely and
allowed to adhere and culture reliably437,556. However, it is known that uneven dis-
tribution of cells due to fluid flow, convection in suspension and vessel movement af-
ter seeding can cause aggregation and differentiation of cells440. Different cell loading
methods affecting cell distribution in single cell migration experiments are investigated,
such as tip loading method, tip injection method, and a pressure-balanced submerged
cell seeding, as shown in Figure 4.6.
In tip loading method (Figure 4.6A), the cells flocculate in the small diameter of
pipet tip and cannot uniformly distribute in the microchannel (Figure 4.6D, G, J). In
tip injection method (Figure 4.6B), the cells are originally injected in the channels with
uniform cell distribution. However, without balancing the microchannel inlet/outlet
pressure, the minute hydrostatic pressure difference between inlets and outlets generate
small pressure-driven flow that displaces cells and cause formation of cell aggregates
(Figure 4.6E, H, K).
In tip injection method, due to the small dimension of the punched holes at in-
let/outlet interfaces, bubbles are easily trapped and may be introduced into microchan-
nels, disrupting fluid advection and chemical transport.
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Figure 4.6: The results of U-251MG cell seeding inside microchannels by
various methods. (A, D, G, J) In tip loading method, cells are introduced by using
gravitational flow with micropipette tips. The cells can flocculate inside the tips and in
microchannels as illustrated in (D). The microscopy image of seeded cells is shown in
(G) and magnified in (J); (B, E, H, K) In tip injection method, cells are injected into
the channels and tips are removed. The small hydrostatic pressure differences between
the inlet/outlet (shown as ∆h) will contribute to hydrodynamic flow and disturb the
cell distribution, causing non-uniform cell distribution and aggregates as shown in (E).
The microscopy image of seeded cells is shown in (H) and magnified in (K); (C, F, I,
L) In our pressure-balanced submerged cell seeding method, the hydrostatic pressure
difference is eliminated. The injected cells remain uniform throughout the channel as
shown in (F). The microscopy image of seeded cells is shown in (I) and magnified in (L).
The uniform and sparse cell seeding method is suitable for many different applications
from single cell tracking, ensemble cell studies to cell assembly. The scale bars in (G,
H, I) represent 500 µm. The scale bars in (J, K, L) represent 200 µm.
By submerging inlets and outlets underwater using a reversibly bonded top reservoir
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and balancing the pressure between inlets and outlets (Figure 4.6C), air bubbles can be
avoided and pressure-driven flow will be prevented to affect cell distribution. Moreover,
using this cell seeding method, only minute amount of cells is needed (the volume of the
microchannel). Uniformly distributed single cell seeding across the entire microchannel
is obtained for single cell migration experiments (Figure 4.6F, I, L). The top reservoir
in our submerged cell seeding method can be removed after cells are seeded and can
be adapted to a wide range of microfluidic chips.
Figure 4.7: Electrotaxis responses of T98G and U-251MG cells in various
ECMs in PMMA chips. (A) Directedness of T98G cells in PMMA chips; (B) Direct-
edness of U-251MG cells in PMMA chips. High poly(L-ornithine) (PLO): 100 µgmL−1;
low PLO: 20 µgmL−1; High laminin: 100 µgmL−1; Mid laminin: 50 µgmL−1; Low
laminin: 10 µgmL−1; ****:P<.0001; n.s.: not significant; SF: serum free; PDL: poly(D-
lysine).
4.3.2 Identification of appropriate ECM coatings for glioblas-
toma electrotaxis
An effective ECM coating on the substrate is essential for cell adhesion and formation
of focal adhesions for cell migration547,557. Glioblastoma can be molecularly classified
according to The Cancer Genome Atlas (TCGA) into proneural, neural, classical, and
mesenchymal types558. I investigated how different ECM coatings affected the adhesion
and electrotaxis of T98G and U-251MG glioblastoma cell lines in air-impermeable ther-
moplastic microfluidic chip and in air-permeable hybrid PMMA/PDMS chips. Both
cells lines are of caucasian male origin and classified as mesenchymal type with p53
mutant genotype559,560.
Using thermoplastic chips, the electrotaxes of T98G and U-251MG glioblastoma
cells in air-impermeable conditions on poly(D-lysine) (PDL), collagen I, Geltrex, and
various combinations of poly(L-ornithine)(PLO) and laminin are investigated (Fig-
ure 4.7). While standard PDL and PLO/laminin coatings have been used for glioblas-
toma electrotaxis, the directional and speed results are not always consistent and stably
reproduced (Figure 4.7 & Figure 4.8)292,294. The cell morphologies of T98G cells on
PDL, Geltrex, and PLO/laminin are shown in Figure 4.9. Spiky cell morphology can
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be seen in T98G cells on PDL surfaces, suggesting that the cells are not well adhered
on it. On Geltrex surfaces, T98G cells adhere well and demonstrate lamellipodia which
is less commonly seen in T98G cells on surfaces coated with PLO/laminin.
Figure 4.8: Electrotaxis responses of T98G and U-251MG cells in various
ECMs in PMMA chips. (A) Speed of T98G cells in PMMA chips; (B) Speed
of U-251MG cells in PMMA chips. High poly(L-ornithine) (PLO): 100 µgmL−1; low
PLO: 20 µgmL−1; High laminin: 100 µgmL−1; Mid laminin: 50 µgmL−1; Low laminin:
10 µgmL−1; ****:P<.0001; n.s.: not significant; SF: serum free; PDL: poly(D-lysine).
Figure 4.9: Phase contrast images of T98G on PDL, Geltrex, and
PLO/laminin (100/50 µg mL−1) in PMMA chips.
On Geltrex-coated substrate, both of the studied cells can adhere well on the sub-
strate and demonstrate reproducible electrotaxis results (Table 4.4). While PLO/laminin
is commonly used for cells of central nervous system (CNS) lineages, Geltrex coating
is simple to apply in one shot and does not require combinatorial optimization as in
cases of PLO/laminin.
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Figure 4.10: Phase contrast images of T98G & U-251MG cells on various ECMs. Scale bar: 100 µm.
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Figure 4.11: The electrotaxis of T98G & U-251MG glioblastoma cells on various ECMs after 6 hours under
300 V m−1 EF stimulation. (A) The electrotaxis directedness; (B) The electrotaxis speed; † indicate the electrotaxis groups
tested against those without EF stimulation; All other groups are statistically compared to their respective controls on GeltrexTM
ECM; n.s. indicates not significant; * indicates P<.05; ** indicate P<.01; *** indicate P<.001; **** indicate P<.0001; The
numbers in parentheses indicate actual P-values.
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The preference to Geltrex coating is also confirmed in air-permeable PMMA/PDMS
chips. The morphologies of T98G and U-251MG cells on Geltrex, PDL, PLO (100 µg mL−1),
PLO/laminin (100/50 µg mL−1), laminin (50 µg mL−1), collagen I, collagen IV, vit-
ronectin, iMatrix-511, and fibronectin in PMMA/PDMS chips are shown in Figure 4.10.
The adhesion and electrotaxis of T98G and U-251MG cells are investigated on various
ECMs in PMMA/PDMS chips (Figure 4.11).
While standard poly(D-lysine) (PDL) and various combinations of poly(L-ornithine)
(PLO) and laminin have been used for glioblastoma electrotaxis294,316, the directed-
ness and speed results are not always consistent and stably reproduced. T98G and
U-251MG electrotactic responses are also not stably reproduced on collagen I, colla-
gen IV, vitronectin, and fibronectin coatings. Both T98G and U-251MG cells adhere
well on substrates containing laminins which cells interact through various integrins
including α1β1, α2β1, α3β1, α6β1, α7β1561,562. The integrins are believed to par-
ticipate in the initiation of electrotaxis through mechanosensitive pathways224,230,231.
The cell morphologies of the two cell lines on various ECMs are shown in Supple-
mentary FIG. S.2. T98G cells do not adhere well on PDL surfaces or vitronectin as
indicated by the spiky or rounded cell morphology. On laminin containing surfaces
such as GeltrexTM or pure laminin coating, cells are well adhered and demonstrate
lamellipodia structures. Particularly, U-251MG cells demonstrate large lamellipodia
associated with high migratory speed (15.45 µm hr−1 under 300 V m−1, P<.0001)
on iMatrix-511-coated substrates but with diminished directedness (0.01, P< .0001).
Note that iMatrix-511 is a recombinant truncated laminin with α5β1γ1 subunits and
interacts with cells through the α6β1 integrin563,564. This suggests that the specific
molecular configuration of laminins in ECM may be vital for electrotaxis.
Particularly, T98G and U-251MG cells demonstrate high migratory speed on 50 µg mL−1
laminin and Geltrex surfaces. GeltrexTM is a growth factor-reduced complex basement
membrane extract purified from murine Engelbreth-Holm-Swarm tumors containing
laminin, collagen IV, entactin, and heparin sulfate proteoglycan565. The electrotactic
directionality and speed of both T98G and U-251MG are more prominent and repro-
ducible on Geltrex coatings, hence all the studies in the following sections are studied
with Geltrex coatings. The detailed results of T98G and U-251MG electrotaxis is
shown in Table 4.5.
While it is understood that ECMs in tumor microenvironment is important566,
glioblastoma cells demonstrate preference for adherence and electrotaxis on laminin-
coated surfaces. Within the brain microenvironment, laminin expressions are restricted
to the basement membrane of neural vasculature567 and perivascular tumor microenvi-
ronment is especially vital for glioblastoma metastasis537,568. Therefore, the correlation
among laminin, glioblastoma electrotaxis, and the perivascular invasion process may
be important in glioblastoma cancer biology that requires further elucidation.
4.3.3 Electrotactic heterogeneity in glioblastoma cell lines
To further analyze how T98G and U-251MG cells migrate under stimulation of direct
current electric fields, the electrotaxes of the two glioblastoma cells in serum-containing
and serum-free media were examined.
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T98G and U-251MG cells migrate toward opposite directions under elec-
trical stimulation Figure 4.12 shows the directedness and speed of T98G and U-
251MG electrotaxis. Upon 300Vm−1 dcEF stimulation, T98G cell migrate toward
anode (positive electrode) while the U-251MG migrate toward cathode (negative elec-
trode). Furthermore, the directedness in the electrotaxis of T98G cells does not depend
on the presence of fetal bovine serum (FBS) (P=.45) but the speed is significantly de-
creased (P<.0001). The directedness of U-251MG cell electrotaxis however is highly
dependent on the presence of FBS (P<.0001) and lack of FBS also decreases the speed
of U-251MG electrotaxis (P<.0001) (Figure 4.12A). The serum is rich in growth fac-
tors, proteins, and ions, which can enhance the chemical signaling in electrotaxis (Fig-
ure 4.1).
Glioblastoma can be molecularly classified according to The Cancer Genome At-
las (TCGA) into proneural, neural, classical, and mesenchymal types558. Both T98G
cells and U-251MG cells are categorized as mesenchymal type glioblastoma cells559,560,
however, their electrotactic responses are completely different. Similar results are re-
ported in the electrotaxis of glioblastoma spheroids295 and lung adenocarcinoma202
that although molecular and surface marker makeups are similar, the electrotaxis re-
sponses can be completely different. The opposite electrotaxis results may reflect the
fundamental heterogeneity among the glioblastoma cells which has been suspected to
contribute to the recurrence and therapeutic resistance after anti-tumor therapy569–573.
Further elucidation of the correlation among electrotactic responses, metastatic prop-
erties of glioblastoma, and in situ electric field around the lesion may be beneficial to
evaluate electrotaxis response as a predictive tool for glioma metastasis.
Figure 4.12: The electrotactic responses of T98G and U-251MG are com-
pletely different and dependent on serum supplementation. (A) The electro-
tactic directedness after 300Vm−1 stimulation for 6 hours; (B) The electrotactic speed
after 300Vm−1 stimulation for 6 hours. ****: P<.0001.
Figure 4.13 shows the time course change of directedness in T98G and U-251MG
glioblastoma cells electrotaxis. Immediately after the electrical stimulation, cells start
to respond to the electric field and show directional migration. The directedness become
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apparent and statistically significant (P<.05). This is similar to the observation found
in fibroblasts, keratinocytes, and lung adenocarcinoma cells202,234,574,575
Figure 4.13: Time series plot of directedness in electrically stimulated
glioblastoma cells. T98G cell results are indicated in closed symbols. U-251MG
cell results are indicated in open symbol. Under the electrical stimulation, cells imme-
diately start to respond to it. Note the directedness become apparent within the first
hour of stimulation.
Only T98G cells demonstrate prominent electro-alignment behavior under
electrical stimulation Aside from directional migration in the direct current elec-
tric fields, cells may also demonstrate long axial alignment in perpendicular to the
electric field vector. While this phenomenon is commonly observed among many cell
types109,202,576–578, the mechanism and role of it are not clear. Electro-alignment may
participate in the cytoskeletal restructuring in tissue morphogenesis579,580, but biophys-
ical studies show that in vitro microtubules align in parallel to electric field vectors
rather than perpendicular581,582.
Figure 4.14 shows the time course change of orientation in electrically stimulated
T98G and U-251MG cells over 6 hours. The orientation index is defined as average
cosine of two times the angle between the long axis of a cell and the electric field
vector. For a group of perpendicularly oriented cells, the average orientation index is
-1 and a group of parallely orientated cells, the average orientation index is 1. For
a group of randomly arranged cells, the average orientation index should be 0. For
a group of perpendicularly oriented cells, the average orientation is -1 and a group
of parallel orientated cells, the average orientation is 1. For a group of randomly
arranged cells, the average orientation should be 0. Only T98G cells show prominent
perpendicular alignment after electrical stimulation (Indexorientation at 0 hr v.s. 6 hr
is -0.11 v.s. 0.83, P<.0001, Figure 4.15). Serum deprivation slightly decreases the
alignment tendency and delays the onset but does not abolish it (Indexorientation of serum
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free v.s. 10% FBS at 6 hr is -0.48 v.s. -0.83, P<.0001). However, U-251MG does not
show any perpendicular alignment. These results further illustrate the heterogeneity
of glioblastoma cells.
Figure 4.14: Time series plot of orientation in electrically stimulated
glioblastoma cells. T98G cell results are indicated in closed symbols. U-251MG
cell results are indicated in open symbol. Only T98G cells demonstrate prominent per-
pendicular alignment after electrical stimulation. The dashed lines indicate the 95%
confidence interval for respective groups.
4.3.4 Glioma electrotaxis does not intersect with ligand-mediated
chemical signaling
Several ligand-mediated chemical signaling is reported to participate in cell electrotaxis,
including enzyme-linked receptors, G-protein coupled receptor, and cytokine receptors
(Figure 4.1). However, currently, no consensual signaling mechanism for electrotaxis
has been identified. Depending on the expression profiles of receptors, one signaling
pathway participating in the electrotaxis in cell type A does not necessarily take part
in cell type B as in cases of EGFR in lung cancer electrotaxis196. Furthermore, un-
der electric field stimulation, the polarized receptors by in situ electrophoresis can be
activated in lipid microdomains without the presence of ligands227.
I investigate if the electrotaxis of T98G cells is mediated when there is also presence
of ligand-mediated signaling (Figure 4.16 & Figure 4.17). If electrotaxis of T98G cells
is affected by the presence of chemical ligands, it implies a particular ligand-mediated
receptor signaling. However, the electrotaxis of T98G is completely unchanged even if
there is presence of ligand-mediated signaling, while only the TNFα-stimulated cells
have increased migration speed. The results suggest that the signaling of T98G cells
140 Electrotaxis of glioma cells using hybrid PMMA/PDMS microfluidics
Figure 4.15: Phase contrast images of T98G and U-251MG before and after
6 hours 300Vm−1 stimulation. The electric field vector is from left to right. Only
T98G cells demonstrate prominent perpendicular alignment after electrical stimulation.
electrotaxis does not intersect with that of ligand-mediated cellular signaling. The
result is consistent with a previous report that several receptor tyrosine kinases did
not involve in brain tumor initiating cells’ electrotaxis such as EGFR, FGFR, PDGFR,
and VEGFR2293.
4.3.5 Glioma electrotaxis is dependent on extracellular cal-
cium cations
Calcium ion flux is known to involve in the electrotaxis signaling of multiple cell types
including mouse fibroblasts, human prostate cancer cell, and neural crest cells214,583–586.
Deregulation of calcium influx in the cells reduces actin polymerization and affects the
cell motility speed but its effect on electrotactic directedness varied depending on cell
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Figure 4.16: The electrotactic directedness of T98G glioblastoma cells cos-
timulated with ligands for chemical signaling.
Figure 4.17: The electrotactic speed of T98G glioblastoma cells costimu-
lated with ligands for chemical signaling.
types214,586.
I further investigate if the extracellular calcium cation is important for glioblas-
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toma electrotaxis (Figure 4.18). In serum-free DMEM, both T98G and U-251MG
cell electrotaxes are significantly repressed in directedness (P<.001). Also, T98G cells
lose cell viability completely in Ca-free serum-free DMEM when subjected to electri-
cal stimulation (N=0). However, this loss of viability is rescued by the addition of
10% FBS which contains calcium and growth factors. The electrotaxis of U-251MG in
calcium-free, serum-free media is not affected compared to those in serum-free media
(P>.99). Interestingly, the electrotactic speed of U-251MG in calcium-free serum-free
media further increases (P<.0001).
To identify if calcium cations are important, cation chelators EDTA and EGTA were
used to chelate the free calcium in the MEMα with 10% FBS. Treatment of 2 mM EDTA
significantly represses the directedness of only U-251MG cells (P<.0001,Figure 4.18A).
To further confirm the electrotaxis inhibition is due to extracellular calcium cations,
EGTA, a divalent cation chelator with increased affinity towards Ca2+, is used. At
1 mM EGTA, the electrotactic directednesses of both cell lines are not affected but the
electrotactic speeds of them become more dispersed (P<.0001). Under 2 mM EGTA
treatments, the electrotactic directedness of U-251MG cells are reduced (P<.0001).
When 5 mM EGTA is used, the electrotaxis of both cell lines are further repressed in
both directedness and speed and the cells detach from the substrate. These results sug-
gest that glioblastoma electrotaxis requires extracellular calcium cations and calcium
influx may be important for electrotaxis, particularly that of U-251MG cells.
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Figure 4.18: The effects of extracellular Ca2+ on glioma electrotaxis after 6 hours. (A) The directedness of glioma
electrotaxis; (B) The speed of glioma electrotaxis; † indicate the electrotaxis groups tested against those without EF stimulation;
‡ indicate the electrotaxis group tested against those in serum-free media; All other groups are statistically compared to their
respective controls in cell culture media with 10% FBS; n.s. indicates not significant; * indicates P<.05; ** indicate P<.01; ***
indicate P<.001; **** indicate P<.0001; The numbers in parentheses indicate actual P-values.
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Figure 4.19: The electrotaxis of T98G & U-251MG glioblastoma cells under 300Vm−1 dcEF after 6 hours with
pharmacological inhibition on various ion channels. (A) The directedness of glioblastoma electrotaxis; (B) The speed of
glioblastoma electrotaxis. † indicates the electrotaxis tested against those without EF stimulation; ‡ indicate the electrotaxis group
tested against those with cytochrome C which prevents adsorption of short peptides to experimental apparatus; All other groups
are statistically compared to their respective controls in cell culture media with 10% FBS; n.s. indicates not significant; * indicates
P<.05; ** indicate P<.01; *** indicate P<.001; **** indicate P<.0001; The numbers in parentheses indicate actual P-values.
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4.3.6 Glioma electrotaxis is dependent on different types of
voltage-gated ion channels
Ions channels expressed on glioblastoma cells including various potassium, calcium,
sodium, and chloride ion channels are believed to facilitate pathogenesis of glioblas-
toma546,587–589. Although the expression of numerous ion channels varies among clinical
glioma samples544, ion channel expression profiles have been suggested to predict sur-
vival in glioma patients590,591. Glioblastoma cells are immersed in the local field poten-
tials within the brain, and extracellular calcium is required for glioblastoma electrotaxis
which can influx into the cells through voltage-gated calcium channels (VGCCs), so if
and how VGCCs participate in the electrotaxis of glioblastoma may shed new insights
for inhibiting glioblastoma infiltration.
VGCCs are known to play important roles in glioma biology such as cell prolifera-
tion, apoptosis, and sensitization to ionizing radiation546,552,553. VGCCs can be cate-
gorized as high voltage activated (HVA) or low voltage activated (LVA) types172,554,555.
Among the HVA VGCCs, four subtypes can be categorized by electrophysiological
property and genetic phylogeny, including L-type (long-lasting, Cav1.1–1.4), P/Q-type
(purkinje/unknown, Cav2.1), N-type (neural, Cav2.2), and R-type (residual, Cav2.3)
VGCCs. The LVA VGCCs are composed of T-type channels (transient, Cav3.1–3.3).
Although the involvement of VGCCs in the electrotaxis of glioblastoma is not yet elu-
cidated but VGCCs’ role in electrotaxis of other cell types is suggested. Trollinger
et al., find that a stretch-sensitive VGCC mediates the electrotaxis of human ker-
atinocytes213. Aonuma et al., report that T-type VGCC mediates the electrotaxis of
green paramecia592. L-type VGCCs also regulate the chondrogenesis during early limb
development which is known to be a bioelectricity process593.
Another class of membrane proteins that are bioelectrically activated are voltage-
gated potassium channels (VGKCs), which are represented by 12 families (Kv1–Kv12).
VGKCs are involved in diverse physiological and pathological processess regulating the
repolarization of neuromuscular action potential, calcium homeostasis, cellular prolif-
eration, migration, and cancer proliferation594–600. Voltage-gated potassium channel
Kv1.2601 and non voltage-gated inwardly-rectifying potassium channel Kir4.2602 have
been shown to be involved in the sensing of electric field and signaling of cell electro-
taxis. The potassium ion transporters confer biophysical signals that are key for regu-
lating stem cells and tumor cells behavior in microenvironment603. In prostate cancer
cells, VGKC expressions are linked to the increased metastatic potential604. Further-
more, inhibition of Kv1.3 VGKC has been shown to induce apoptosis of glioblastoma
cells in vitro605.
I further investigate if HVA and LVA VGCCs play a role in the electrotaxis of T98G
and U-251MG cells by using various inhibitors against L-type, P/Q type, R-type, and
T-type VGCCs (Table 4.2). Many of these inhibitors are short peptides purified or
recombinant engineered from venoms of poisonous species. When testing inhibition,
cytochrome C was added to prevent non-specific adsorption of peptide inhibitors to
microfluidic chips606. The detailed results of pharmacological VGCC inhibition on the
electrotaxis of T98G and U-251MG cells are shown in Table 4.6.
In both glioblastoma cell lines, inhibition of L-type HVA VGCC with gadolinium607
or nicardipine608 exhibit no effect on electrotactic directedness (P>.99, Figure 4.19A)
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as well as speed (P>.15, Figure 4.19B). Inhibition of N-type HVA VGCCs with ω-
Conotoxin GVIA609,610 also has no effect on the electrotaxis of either cell type (P>.92).
T98G electrotaxis may depend on R-type HVA VGCC and A-type voltage-
gated potassium channel The electrotaxis of T98G is repressed when treated with
cadmium which is a broad spectrum HVA VGCCs inhibitor at both 50 µM and 100 µM
(P<.0001)611,612. Upon further identification, the directedness in T98G electrotaxis is
repressed by use of SNX-482, a R-type VGCC inhibitor613,614 (P=.0497, Figure 4.19).
Calmodulin, a calcium binding protein, mediates many of the Ca2+ dependent-
signaling by interacting with VGCCs and maintaining intracellular calcium homeosta-
sis615,616. However, the electrotaxis of T98G is not dependent on calmodulin by inhibi-
tion with calmidazolium (P>0.99) and Ni2+ treatment has no inhibition on T98G cells
(P>0.99) which has partial inhibition on R-type VGCC614,617. These results imply an
alternative mechanism might be at play.
Cadmium and SNX-482 have been reported to also block a rapid inactivating (A-
type) transient outward VGKC (Kv4.3) and experimental results using SNX-482 should
be interpreted carefully618–620. Using 5 µM AmmTx3, a member of the α-KTX15 fam-
ily of scorpion toxins, to block A-type VGKCs (Kv4.2 & Kv4.3)621–623, T98G electro-
taxis directedness (FBS v.s. AmmTx3 = -0.69 v.s. -0.39, P=.0025) and speed (FBS
v.s. AmmTx3 = 9.99 v.s. 4.42, P<.0001) are repressed but not completely abolished.
Furthermore the inhibition on T98G directeness caused by SNX-482 is stronger than
AmmTx3 (SNX-482 v.s. AmmTx3 = -0.27 v.s. -0.39, P=.039, two-tailed t test). An-
other broad spectrum transient VGKC inhibitor, 4-aminopyridine (4-AP), was used to
confirm the results624–626. Under 1 mM 4-AP, the directedness and speed in T98G elec-
trotaxis were both repressed (P<.0001). Increasing of 4-AP to 4 mM, though results
suggest that electrotactic directedness has not changed (P>.99) compared to control,
but the migration speed is decreased(P<.0001). This is likely an artifact from part
of T98G cells starting to detach from the surface rather than actual electrotaxis (Fig-
ure 4.20). These results suggest that T98G electrotaxis may be mediated by A-type
VGKCs (Kv4.3), but the involvement of R-type VGCCs cannot be completely ruled
out. Further molecular studies into the roles of VGCCs and VGKCs in glioblastoma
electrotaxis are required.
4.3
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Figure 4.20: Phase contrast images of T98G & U-251MG cells under EF stimulations in different microenviron-
ments after 6 hours.. The scale bars represent 100 µm. 4-AP: 4-aminopyridine. T98G cells demonstrate perpendicular alignment
after electric field stimulation in cell culture media with or without FBS. However, without calcium and FBS in the cell culture
medium, T98G cells’ viability decreases. Furthermore, in cell culture medium supplemented with 4 mM 4-AP, T98G also lose
viability and start to detach from the substrate. These trends were not observed in the U-251MG cells, suggesting heterogeneity
between cell lines.
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Figure 4.21: The signaling pathways of glioblastoma electrotaxis identi-
fied in this study. Laminin-based ECMs is necessary for glioblastoma electrotaxis
suggesting that integrins may play a role. The voltage-gated ion channels and ion
transporters also mediate glioblastoma electrotaxis that requires extracellular calcium.
U-251MG electrotaxis may depend on P/Q-type HVA VGCCs with involve-
ment of sodium channels U-251MG electrotaxis is also dependent on high voltage
activated VGCCs. Decreased directedness and speed are seen in U-251MG cells treated
with 100 µM cadmium (P=.0372, Figure 4.19). Upon further identification, U-251MG
electrotaxis is repressed when treated with P/Q-type HVA VGCC inhibitor using aga-
toxin IVA and conotoxin MVIIC (P<.0001). However, the electrotactic speed is not
affected by agatoxin IVA (P>0.99) but decreased by conotoxin MVIIC (P<.0001). The
electrotactic directedness of U-251MG is dependent on calmodulin (P<.0001).
Furthermore, the electrotactic directedness of U-251MG cells is repressed with
nickel (P<.0001) and amiloride (P<.01) as well as the electrotactic speed (P<.0001).
The results suggest a possible involvement of T-type VGCC627 in U-251MG elec-
trotaxis. However, U-251MG electrotaxis is not affected when tested using another
potent T-type VGCC inhibitor, TTA-A2628,629. Nickel at high concentrations may
also inhibit acid-sensing ion channel (ASIC) and epithelial sodium channel (ENaC),
which are members of a superfamily of voltage-insensitive mechanosensitive sodium
channels630,631. Amiloride is also reported to inhibit ASIC/ENaC sodium channels,
transient receptor potential polycystic 3 (TRPP3) channels, and sodium proton ex-
changer 1 (NHE1)632–634. Furthermore ASIC sodium channels are specifically ex-
pressed in the high-grade glioma cells but not in normal brain tissue or low grade
glial cells635,636. Nickel at high concentrations may also inhibit acid-sensing ion chan-
nel (ASIC) and epithelial sodium channel (ENaC), which are members of superfamily
of voltage-insensitive mechanosensitive sodium channels630,631. Amiloride is also re-
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ported to inhibit ASIC/ENaC sodium channels, transient receptor potential polycystic
3 (TRPP3) channels, and sodium proton exchanger 1 (NHE1)632–634.
To confirm the involvement of ASIC/ENaC in U-251MG electrotaxis, U-251MG
cells are treated with 5 µM benzamil hydrochloride (Alomone labs, USA)634,637,638. The
directedness of U-251MG electrotaxis is significantly repressed by benzamil treatment
(FBS v.s. benzamil = 0.58 v.s. 0.29, P<.0001) but not the speed (P=.42). The ENaC
sodium channel has been shown to mediate the electrotaxis of human keratinocytes575.
Sodium ion flux may also be important in mediating electrotaxis. Voltage-gated sodium
channels (VGSCs) have been suggested to direct the electrotaxis and potentially also
direct the metastasis of prostate cancer cells164,639,640.
Furthermore, when inhibition of A-type VGKCs are tested on U-251MG electro-
taxis using AmmTx3 and 4-AP, the electrotaxis directedness is inhibited by both com-
pounds (P<.0001) and the speed is repressed in only 4-AP (P<.0001) but not AmmTx3
(P=.09). These results suggest that multiple voltage-gated ion channels as well as ASIC
sodium channels mediate the electrotaxis of U-251MG cells.
Various ion channels participated in the electrotaxis of glioblastoma cells of
different origins The pharmacological studies on the ion channels in T98G and U-
251MG electrotaxes suggest that multiple ion channels, which may be voltage-sensitive
or not, can mediate the sensing of electric field and initiate the migratory response.
A-type VGKC, R-type VGCC, and ASIC sodium channels mediate the electrotaxis
of T98G cells while P/Q-type VGCCs, A-type VGKC, and ASIC sodium channels
mediate the electrotaxis of U-251MG cells. The mechanisms investigated in this work
is shown in Figure 4.21.
Although the expression of numerous ion channels varies among clinical glioma
samples544, ion channel expression profiles have been suggested to predict survival in
glioma patients590,591. Correlating ion channel expressions and electrotactic phenotypes
of cancer cells may be beneficial to provide new insights of novel metastasis-aimed ther-
apeutics641,642. The downstream molecular signaling of VGCCs, VGKCs, and ASIC
sodium channels in glioblastoma electrotaxis is an interesting future direction to in-
vestigate. Moreover, systematic screening of other potassium channels and sodium
channels’ ability to mediate glioblastoma electrotaxis is necessary to identify signaling
pathways that may contribute to glioblastoma metastasis. The high-throughput hy-
brid microdevices developed here can be very useful for systematic phenotype profiling
and identification of molecular mechanisms in cell electrotaxis.
4.4 Summary and prospects
The hybrid PMMA/PDMS microfluidic chip is a robust platform for high throughput
electrotaxis studies. Cell migration in multiple electric fields under multiple condi-
tions can be studied in one experiment in combination with automated microscopy.
The submerged operation balances the inlet/outlet pressure guarantees a stable mi-
croenvironment that avoids microbubbles, ensures uniform cell seeding, and minimizes
required number of cells. Uniformly distributed single cells can be reliably seeded in
microfluidic chip that further increases the robustness for high throughput experiments.
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Table 4.6: The detailed results of glioblastoma electrotaxis in the presence
of antagonists against ion channels or calcium signaling after 6 hours. CytoC:
Cytochrome C; sem: standard error of mean.
Condition CytoC
(1 mg mL−1)
EF
(V m−1)
T98G U-251MG
N Directedness sem Speed
(µm hr−1)
sem N Directedness sem Speed
(µm hr−1)
sem
FBS no 300 128 -0.69 0.04 9.99 0.57 288 0.58 0.03 7.33 0.39
0 264 -0.18 0.04 4.85 0.21 330 0.08 0.04 4.98 0.25
Serum free no 300 212 -0.46 0.04 5.50 0.35 250 0.16 0.05 3.27 0.23
0 338 -0.11 0.04 5.16 0.35 186 0.26 0.05 3.67 0.25
CaFree DMEM
(10% FBS)
no 300 116 -0.80 0.03 9.95 0.70 104 0.44 0.06 8.15 1.14
0 117 -0.22 0.06 8.07 0.58 108 -0.22 0.07 7.19 0.61
CaFree DMEM
(Serum free)
no 300 0 n/a n/a n/a n/a 119 0.21 0.07 9.02 1.09
0 106 0.24 0.07 6.56 0.73 123 -0.03 0.07 9.24 0.79
Cytochrome C
(1 mg ml−1)
yes 300 476 -0.51 0.03 9.34 0.37 302 0.58 0.03 4.73 0.28
0 334 -0.21 0.04 5.61 0.27 368 0.18 0.04 4.22 0.21
Cd
(50 µM)
no 300 119 -0.21 0.07 6.71 0.62 314 0.48 0.03 4.92 0.20
0 196 -0.14 0.05 4.11 0.37 276 0.02 0.03 5.12 0.21
Cd
(100 µM)
no 300 339 -0.25 0.04 4.64 0.22 232 0.34 0.04 3.37 0.18
0 294 -0.12 0.04 2.88 0.17 348 -0.21 0.04 2.21 0.11
Gd
(50 µM)
no 300 118 -0.67 -0.27 10.82 0.65 188 0.59 0.04 5.56 0.37
0 209 0.05 0.04 7.21 0.59 340 -0.11 0.05 5.47 0.23
Ni
(100 µM)
no 300 359 -0.81 0.02 13.97 0.46 485 0.21 0.03 2.94 0.17
0 400 -0.13 0.04 5.33 0.22 423 -0.09 0.03 5.50 0.29
Ni
(500 µM)
no 300 226 -0.55 0.04 10.64 0.55 350 0.25 0.04 4.48 0.25
0 264 -0.35 0.04 6.15 0.37 380 0.23 0.04 3.33 0.19
EDTA
(2 mM)
no 300 461 -0.54 0.03 8.62 0.31 359 0.19 0.04 7.25 0.35
0 473 -0.16 0.03 7.13 0.25 524 0.06 0.03 5.85 0.25
EGTA
(1 mM)
no 300 141 -0.57 0.07 7.22 1.71 107 0.48 0.06 7.74 2.09
0 153 -0.07 0.07 7.15 1.61 109 0.01 0.08 2.49 1.95
EGTA
(2 mM)
no 300 1028 -0.68 0.02 6.97 0.18 587 0.14 0.03 4.38 0.23
0 1367 -0.20 0.02 2.93 0.08 365 0.04 0.04 4.49 0.24
EGTA
(5 mM)
no 300 160 -0.36 0.05 2.21 0.11 472 -0.14 0.03 2.42 0.09
0 139 0.18 0.07 1.77 0.15 376 -0.04 0.03 2.42 0.11
Nicardipine
(10 µM)
no 300 218 -0.65 0.04 8.19 0.43 315 0.64 0.03 6.94 0.35
0 128 0.04 0.06 6.92 0.50 297 -0.03 0.04 5.43 0.31
ω-Conotoxin GVIA
(3 µM)
yes 300 211 -0.67 0.03 12.43 0.63 320 0.44 0.03 6.01 0.33
0 108 0.14 0.07 4.98 0.44 194 0.01 0.05 3.94 0.29
ω-Agatoxin IVA
(200 nM)
yes 300 145 -0.53 0.05 9.64 0.61 177 0.13 0.05 7.13 0.47
0 105 -0.08 0.07 4.77 0.47 235 -0.14 0.05 6.79 0.38
ω-Conotoxin MVIIC
(500 nM)
yes 300 309 -0.75 0.02 12.59 0.51 477 -0.09 0.03 4.61 0.22
0 362 -0.30 0.03 6.55 0.25 375 -0.24 0.03 2.77 0.15
ω-Theraphotoxin-Hg1a
(500 nM)
yes 300 153 -0.27 0.06 7.56 0.48 341 0.41 0.03 6.31 0.34
0 127 0.01 0.08 5.24 0.54 369 -0.12 0.04 4.99 0.26
TTA-A2
(200 µM)
no 300 677 -0.69 0.02 6.65 0.17 625 0.47 0.03 6.00 0.27
0 501 -0.20 0.03 7.73 0.23 556 0.11 0.03 4.53 0.20
Continued on next page
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Condition CytoC
(1 mg mL−1)
EF
(V m−1)
T98G U-251MG
N Directedness sem Speed
(µm hr−1)
sem N Directedness sem Speed
(µm hr−1)
sem
Amiloride hydrochloride
(100 µM)
no 300 352 -0.77 0.02 12.96 0.42 332 0.32 0.04 4.87 0.30
0 524 0.06 0.03 6.02 0.23 413 -0.19 0.04 3.57 0.20
Calmidazolium
(100 nM)
no 300 229 -0.80 0.02 12.26 0.45 346 0.22 0.04 6.42 0.32
0 437 -0.18 0.03 5.75 0.24 449 -0.01 0.03 4.25 0.22
AmmTx3
(5 µM)
yes 300 549 -0.39 0.03 4.42 0.17 816 0.13 0.02 6.06 0.15
0 337 -0.10 0.04 3.63 0.20 555 -0.15 0.03 4.27 0.16
4-aminopyridine
(1 mM)
no 300 1335 0.11 0.02 4.95 0.11 1033 0.07 0.02 3.37 0.10
0 1220 0.56 0.02 4.76 0.10 570 0.08 0.03 3.66 0.16
4-aminopyridine
(4 mM)
no 300 963 -0.79 0.01 4.89 0.09 749 0.11 0.03 2.83 0.11
0 678 0.85 0.01 3.69 0.06 654 0.06 0.03 2.48 0.10
Benzamil hydrochloride
(5 µM)
no 300 856 -0.42 0.02 5.48 0.14 428 0.29 0.03 6.05 0.26
0 1108 -0.08 0.02 4.43 0.11 455 0.14 0.03 6.81 0.27
Use of Usiigaci software automates the single cell migration data analysis workflow for
reliable quantitative data which in the past has hindered high-throughput experiments.
Geltrex coating has been identified to support reproducible electrotaxis model of
T98G and U-251MG glioblastoma cells. Although no ligand-mediated chemical signal-
ing intersects with the electrotaxis signaling in T98G cells, the importance of calcium
signaling in T98G and U-251MG electrotaxis is identified. By further identification, the
electrotaxis of T98G cells may depend on R-type HVA VGCCs and that of U-251MG
may depend onf P/Q-type HVA VGCCs. Furthermore, the electrotaxis of both cells
are mediated also by A-type VGKCs and ASIC/ENaC sodium channels. Multiple ion
channels, which may be voltage-sensitive or not, can mediate the sensing of electric
field and initiate the electrotaxis in glioblastoma. The roles of ion channels on glioma
metastasis and survival with regard to physiological electric field require further studies
and in vivo validation.
As proof of principle, the hybrid PMMA/PDMS microfluidic design demonstrates
robustness and versatility for high throughput experiments. The microfluidic chip
design can be tailor-made for specific biological study. By using a robust, flexible, and
high-throughput microfluidic platform together with machine learning software, the
bottleneck of data analysis in high throughput experiments can be resolved, opening
new opportunities for quantitatively studying cell responses in microenvironments.

Chapter 5
Study of glioma-vasculature
adhesion using a quick-fit
PMMA/PDMS microfluidic chip
Abstract
In this work, I introduce a reversibly sealed quick-fit hybrid biomedical microdevice that
is operator-friendly and bubble-free, requires low reagent and cell consumption, enables ro-
bust and high throughput performance for biomedical experiments. Specifically, a quick-fit
poly(methyl methacrylate) and poly(dimethyl siloxane) (PMMA/PDMS) prototype to il-
lustrate its utilities by probing the adhesion of glioblastoma cells (T98G and U251MG) to
primary endothelial cells. In static condition, I confirm that angiopoietin-Tie2 signaling in-
creases the adhesion of glioblastoma cells to endothelial cells. Next, to mimic the physiologi-
cal hemodynamic flow and investigate the effect of physiological electric field, the endothelial
cells are pre-conditioned with concurrent shear flow (with fixed 1Pa shear stress) and direct
current electric field (dcEF) in the quick-fit PMMA/PDMS chip, namely shear flow and elec-
tric field co-stimulation microfluidic chip (SFEFC). With shear flow alone, endothelial cells
exhibit classical parallel alignment; while under a concurrent dcEF, the cells align perpendic-
ularly to the electric current when the dcEF is greater than 154Vm−1. Moreover, with fixed
shear stress of 1Pa, T98G glioblastoma cells demonstrate increased adhesion to endothelial
cells conditioned in dcEF of 154Vm−1, while U251MG glioblastoma cells exhibit no differ-
ence. The quick-fit hybrid BMMD provides a simple and flexible platform to create multiplex
systems, making it possible to investigate complicated biological conditions for translational
research398.
5.1 Introduction
Glioblastoma, the most common primary high-grade brain tumor type in adults, can
diffuse and metastasize intracranially through white matter tracts or defined perivas-
cular structures, such as blood vessels and the subarachnoid space643,644. Although
intravasation and extracranial metastasis in glioblastoma seldom occur34,645, endothe-
lial cells and the associated blood-brain barrier contribute greatly to establishing and
maintaining the tumor microenvironment of glioblastoma646,647. An in vitro cell-cell
interaction model of glioblastoma and endothelial cells could further our understanding
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of the perivascular tumor microenvironment of glioblastoma50. In the hemodynamic
system, endothelial cells serve as inner linings of the blood vessel and regulate vasodi-
lation and vasoconstriction to supply nutrient and gas vital to cell survival. In blood
vessels, endothelial cells subject to conditioning from hemodynamic flow and the shear
stress is vital to maintaining the quiescent, non-inflammatory phenotype of endothelial
cells under normal physiological conditions648. Endothelial cells cultured in vitro can
be conditioned chemically or physically through mechanical or electrical stimulation,
and the cell adhesion molecules or cell morphology more mimicking to those in phys-
iological conditions can be induced243,244,649–653. To study endothelial physiology, an
robust in vitro platform that can mimic the in vivo conditioning of endothelial cells is
a prerequisite.
In this work398, I introduce a hybrid quick-fit PMMA/PDMS BMMD, combining
the advantages and mitigating the disadvantages of PMMA and PDMS to create an
air-tight but reversibly sealed cell culture platform with low reagent dead volumes.
Reversibly sealed BMMDs are empowered by mechanical or vacuum sealing of an elas-
tomeric PDMS slab to a rigid substrate, thus allowing the BMMD to be sealed and
dismantled quickly before and after each experiment385,389,654–656. This hybrid device
enables further cellular treatment (i.e., fixation and immuno-staining) in the BMMD.
To validate this setup, the cell-cell interaction model between glioblastoma and en-
dothelial cells is studied by applying by applying concurrent electrical and mechanical
conditioning on the endothelial cells and further investigate the adherence of glioblas-
toma cells on the conditioned endothelium.
The design and fabrication of a shear flow and electric field co-stimulation mi-
crofluidic chip (SFEFC) with the quick-fit hybrid BMMD principle was described in
Section 2.4. The adhesion of glioblastoma to endothelial cells in a static condition
and in a coexisting shear flow and electric field microenvironment are discussed in this
chapter with summary being provided in details in Section 5.4.
5.2 Materials and methods
5.2.1 Shear flow and electric field co-stimulation chip (SFEFC)
using hybrid PMMA/PDMSmicrofluidic design and fab-
rication
The design and fabrication of the SFEFC was discussed in detail in Section 2.4.
Briefly, the SFEFC was designed to quick-fit a top PMMA interface chip with a
bottom PMMA/PDMS microchannel device where cells were cultured (see schematic
in Figure 5.1). The SFEFC was constructed to create multiple electric fields in an R-2R
resistor ladder configuration202,455. Two 2mm-wide main microchannels with intercon-
nected 100 µm by 1.5mm (length×width) channels at a spatial interval of 7.5mm in
SFEFC created 10 channel segments with various electric field strengths (EFSs) (Fig-
ure 5.1). The segments on the top side of SFEFC had electric current vector flowing
against the shear flow direction, while the segments on the bottom side of SFEFC
had electric current vector flowing along the shear flow direction. This multiplex con-
figuration provided a platform for high-throughput screening of cellular responses to
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coexisting shear flow and electric field. Cells were observed only in the 4.5mm-long
observation area, in the middle of each segment, 1.5mm from the interconnection chan-
nels (where the electric fields were stable).
Figure 5.1: Experimental setup of concurrent shear flow and electric field
conditioning of endothelial cells in a shear flow and electric field co-
stimulation microfluidic chip (SFEFC). Endothelial cells are cultured in the bot-
tom PMMA/PDMS microchannel device in a user-friendly manner. To pre-condition
the cells, the PMMA/PDMS chip is reversibly sealed with the top PMMA interface
chip before applying the shear flow and electric field. After conditioning, the chip can
be easily recovered. SMU: source measure unit; SB: salt bridge. Detailed configuration
of PMMA top interface chip and PMMA/PDMS microchannel chip can be found in
Figure 5.2.
5.2.2 Cell culture and maintenance
Primary human umbilical vein endothelial cells (HUVECs) were cultured in the en-
dothelial cell growth medium (C12203, PromoCell GmbH, Germany). T98G (CRL-
1690, ATCC, USA) and U251MG (IFO50288, JCRB, Japan) glioblastoma cells were
cultured in minimum essential medium α (MEMα, 12000022, Gibco, USA) supple-
mented with 2.2 g L−1 NaHCO3 and 10% fetal bovine serum (FBS, Invitrogen, USA).
All cells were cultured in a humidified 5% CO2 atmosphere (Forma Steri-cycle i160,
Thermofisher, USA) and passaged whenever confluency reached 80%. Cells from pas-
sages 2 to 8 were used in the adhesion study.
Red fluorescent protein-expressing clones of T98G (T98G-dsRed) and U251MG
(U251MG-dsRed) cells were established by transfecting a plasmid which carries open
reading frame (ORF) for translation elongation factor-1 alpha conjugated with a red
fluorescent protein into the two cell lines (EF1alpha-DsRed-Express2, 631979, Takara
Bio, Japan) with lipofectamine (Lipofectamine 3000, Thermo Fisher Scientific, USA).
Stable fluorescent clones were selected by subculture in media containing 500 µgmL−1
G418 and aseptically sorted by flow cytometry (Aria II, BD, USA) using PE-Texas
Red filter set with CST and AccuDrop calibration.
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5.2.3 General experimental workflow
The usage of quick-fit hybrid devices consisted of two steps: user-friendly on-chip cell
culture and quick-fit assembly. The step for on-chip cell culture included priming, ECM
surface coating, cell seeding.
Briefly, in the first step, the cells were prepared and cultured in the microchannels
on the PMMA/PDMS microchannel chip (Figure 5.2A).
Figure 5.2: Liquid manipulation on the SFEFC. (A) Operator-friendly under-
water fluid manipulation at early stage of chip preparation using the PMMA/PDMS
microchannel chip. Cells are cultured in the microchannels in the PMMA/PDMS
chip; (B) The complete chip can be assembled just prior to on-chip experiments. The
PMMA top interface chip is shown in red dashed box. PDMS slabs on the PMMA top
interface chip compress and seal the interface to the PMMA/PDMS microchannel chip
(inside the black dashed box). After each experiment, the cells in the PMMA/PDMS
microchannel chip can be easily recovered after disassembly.
To prepare for confluent HUVEC culture, the PMMA/PDMS chip was filled with
99.5% ethanol (Wako, Japan) to remove bubble439. The solution in the microchannels
was then replaced by deionized water and D-PBS. The buffer held in fluid reservoirs
on the PMMA part of the PMMA/PDMS chip (Figure 5.2A) ensured that no bubbles
were trapped at the interface of the inlets and outlets and prevented accidental bubble
injection into the microchannels that would cause disruption of microfluidic flow and
cell death.
At an early stage of preparing cells, no complex tubing connections were required.
Manipulation of the PMMA/PDMS chip was user-friendly because micropipet tips
could be used to deliver fluids and cells by either active pressure delivery or by gravity
driven flow. Furthermore, the fluid volume needed to fill the microchannels was very
low (on the order of microliters), so the amount of extracellular matrix protein and the
number of cells required were limited.
To start endothelium culture in the PMMA/PDMS chip, the glass bottom was
coated with 10 µgmL−1 of human plasma fibronectin for 2 hours. HUVEC cells at
concentration of 1× 107 cells mL−1 were injected into the microchannels and allowed
to adhere for 3 hours at 37 ◦C.
To assemble the complete quick-fit microfluidic chip, the fluidic tubing and salt
bridges (1.5% agarose in D-PBS) were first connected to the PMMA interface chip
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and primed with cell culture media. The PMMA interface chip was then brought
into contact with PMMA/PDMS microchannel chip and sealed tight with four M4
stainless hex screws and nuts. The four screw clamp slots were located on both the
PMMA interface chip and PMMA/PDMS microchannel chip so that an even pressure
can be applied to the PDMS slabs on the PMMA interface chip. The SFEFC was
assembled after a tight seal was achieved by applying 15 cNm of torque on the four hex
screws with a torque driver (RTD60CN, Tonichi, Japan) (Figure 5.2B). The pressure
applied on the PDMS slabs deforms the slabs and seals the interface between the top
interface chip and the microchannel chip. Moreover the reagents were primed in the
channels of the PMMA interface chip, thus, after quick-fit assembly, the dead volume
was reduced and the reagents could be delivered to cells with reduced delivery time.
After each experiment, the cells in the PMMA/PDMS chip could be quickly recovered
by removing the hex screws. In addition, the PMMA interface chip could be reused to
assemble with another PMMA/PDMS chip to increase experimental throughput with
low liquid dead volume.
5.2.4 Endothelium conditioning by external fields in SFEFC
Endothelium conditioned by shear flow The assembled SFEFC with a conflu-
ent HUVEC cell layer in the microchannel was set up in the incubator as shown in
Figure 5.1 and Figure 5.3. I conditioned the endothelium by shear flow mimicking the
physiological conditions in hemodynamic flows657. The shear stress imposed on the
endothelial cells in a rectangular channel can be calculated according to the modified
Hagen-Poiseuille equation in Equation 5.1448:
(τ ∗s )max = 2.95×
6µQ
w × h2 , (5.1)
where µ, Q, w, and h are the dynamic shear viscosity, volumetric flow rate, width, and
height of the rectangular microchannel, respectively.
Primary endothelial cells like HUVECs are reported to respond to shear flow and
align in parallel to the flow direction when shear stress exceeds 10 dyn cm2 (equivalent
to 1Pa)446,447. Based on Equation 5.1, to impose 1Pa shear stress on the endothelial
cells in a 2mm-wide and 100 µm-high microchannel filled with a cell culture medium
with dynamic viscosity of 0.756mPa s, the flow rate should be 1.49 µL s−1 (equivalent
to 5.4mLh−1).
Specifically, the flow was delivered by pulling ECGM supplemented with antibiotics
cocktail (1X PSN, Invitrogen, USA) from a 250mL serum bottle by two 50mL syringes
(Terumo, Japan) using a dual channel syringe pump (YSP-202, YMC, Japan). The
syringe pump was controlled remotely with the control software (Syringepump Pro,
USA). The flow rate was set starting at 0.1mLh−1 and doubled every 3 hours until
the flow rate reached 5.4mLh−1.
For conditioning in shear flow, the confluent endothelial cells were conditioned in
the 5.4mLh−1 flow rate for 24 hours.
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Figure 5.3: A snapshot of the experimental setup of concurrent shear flow
and electric field conditioning of endothelial cells in a “shear flow and elec-
tric field co-stimulation microfluidic chip (SFEFC)”. Both the media bottle
and the SFEFC chip are placed in a humidity-controlled incubator for cell culture.
The shear flow is imposed by withdrawing the media using a syringe pump with pro-
grammable control software. The electric field is applied by a source measure unit
(SMU). The top right image in the yellow dash-box is the zoomed-in picture of the
assembled quick-fit SFEFC.
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Endothelium conditioned by both shear flow and electric field For endothe-
lium conditioned by coexisting shear flow and electric field, once the flow rate reached
5.4mLh−1 (corresponding to the shear stress of 1 Pa), a direct current electric field
(dcEF) was applied to HUVECs in sections I to V and VI to X at 300:153.6:75.5:30.9:0
V m−1 respectively based on the simulation results (described in Section 2.4). Specifi-
cally, the dcEF was applied by a source measure unit (2410, Keithley, USA) through
two silver/silver chloride electrodes in D-PBS where the salt bridges were immersed
(Figure 5.1). The simultaneous conditioning of the HUVECs with shear flow and elec-
tric field were carried out for 24 hours prior to glioblastoma cell adhesion experiments.
Upon filling of the syringes, the content was discarded prior to restarting the syringe
pump.
5.2.5 Glioblastoma cell adhesion on statically cultured endothe-
lium
In a static adhesion experiment, glass bottoms of 8-well chambered slides (Lab-tek
II, Nunc, USA) were coated with 10 µgmL−1 of human plasma fibronectin (Invitrogen,
USA). 1× 105 HUVEC cells were seeded in each well and allowed to adhere for 24 hours.
Angiopoietin 1 (Ang1), an endothelial cell-specific tyrosine kinase receptor ligand that
upregulates adhesion molecules on glioblastoma cells was purchased from Peprotech
USA. Both glioblastoma cells were incubated with 100 ngmL−1 of Ang1 for 24 hours
prior to adhesion experiments. Activated endothelial cells were prepared by incubating
HUVECs with 10 ngmL−1 tumor necrosis factor α (TNFα) for 24 hours (Invitrogen,
USA). Prior to adhesion experiments, confluent HUVECs were labeled by incubation
with 1 µM CellTracker Green CMFDA dye (C2925, Invitrogen, USA) for 15 minutes
and washed twice with Dulbecco’s phosphate buffered saline (D-PBS).
To commence static adhesion experiments, T98G-dsRed and U251MG-dsRed cells
were trypsinized and resuspended in ECGM. The two glioblastoma cell lines were
seeded at glioblastoma (2) : HUVEC (1) ratio. Glioblastoma cells were allowed to
adhere to endothelial cells for 1 hour at 37 ◦C. Unadhered cells were washed away
by gentle pipetting with D-PBS. Cells were fixed with 4% paraformaldehyde in D-
PBS immediately and imaged using an epifluorescence microscope with filter sets for
FITC and TRITC channels. Densities of adhered glioblastoma cells were counted
and averaged over four 1mm2 fields in the middle of each well (16 fields total). All
experiments were performed in triplicates and the data were represented as the mean ±
95% confidence interval, which is 1.96 standard errors of the mean. One-way analysis of
variance with Tukey’s post-hoc multiple-comparison tests were performed on collected
data using Prism 7 (Graphpad, USA). The confidence level to reject a null hypothesis
between two data sets was set at 95%. A p-value (P), the probability for a true null
hypothesis less than 0.05 represents a statistical significance at 95% confidence.
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5.2.6 Glioblastoma cell adhesion on shear/EF conditioned en-
dothelium on SFEFC
After shear flow and dcEF conditioning, the PMMA interface chip was immediately
removed by unscrewing M4 Hex screws. The confluent HUVECs were labeled by
incubation with 1 µM CellTracker Green for 15 minutes and washed twice with 1X
D-PBS before the glioblastoma cell adhesion experiment. T98G-dsRed and U251MG-
dsRed cells were trypsinized and suspended in ECGM. The two types of glioblastoma
cells were seeded at 2×106 cells mL−1 in 200 µL by gravity-driven flow. Glioblastoma
cells were allowed to adhere for 1 hour at 37 ◦C. Unadhered cells were washed away
with 200 µL of D-PBS by gravity flow. Cells were fixed with 4% paraformaldehyde in
D-PBS and imaged with an epifluorescence microscope. Cell counting and statistical
inferences in these adhesion experiments followed the same statistical measurements as
those on statically cultured endothelium (Section 5.2.5).
5.2.7 Immunofluorescence staining, microscopic imaging and
statistical inference
The presence of glial fibrillary acidic protein (GFAP) and Tie2 receptor in T98G-dsRed
and U251MG-dsRed cells were examined by immunofluorescence staining. Both cells
were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 in D-
PBS. Fluorophore-conjugated species-specific secondary antibodies against the primary
antibodies were used to detect the two proteins.
The expression of CD31 membrane adhesion molecule (PECAM-1) and cytoskeleton
F-actin of conditioned endothelial cells was also characterized by immunofluorescence
staining on chip following the same fixation and permeabilization protocol described
above. The detection of CD31 and F-actin was conducted with an anti-CD31 primary
antibody and a fluorophore-conjugated secondary antibody (NBP1-71663SS, Novus
Biological, USA & A21467, Invitrogen, USA) as well as the fluorophore-conjugated
phalloidin (A12380, Invitrogen, USA). The stained cells were scanned under a confocal
laser scanning microscope with a 10X objective (A1R+, Nikon, Japan).
5.3 Results and discussion
5.3.1 Reversibly sealed quick-fit microfluidic chip tolerates high
flow rate
Although the sealing of SFEFC is reversible, it can withstand high flow rates necessary
in microfluidic channels to create shear stress conditions similar to that in physio-
logical hemodynamics (0.1–0.6 Pa in normal vein and 1.0–7.0 Pa in normal artery as
reported657). HUVECs cultured in SFEFC under simultaneous shear flow and electric
field conditions demonstrated characteristic morphological changes (Figure 5.4).
The shear flow imposes a shear stress on adhered endothelial cells and induces
an aligned morphology and a quiescent anti-inflammatory and anti-thrombotic phe-
notype651. Electric field stimulation on endothelial cells instead induces a perpen-
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dicular alignment with upregulation of a pro-angiogenic response and the release of
VEGF243,244.
Figure 5.4: Microscopy images of endothelial cells cultured in sections I,
II, III, and V in SFEFC. (A) Endothelial cells conditioned with shear flow (1 Pa)
and 300 V m−1; (B) Endothelial cells conditioned with shear flow (1 Pa) and 153.6
V m−1 showing perpendicular alignment as a result of electrical stimulation; (C) En-
dothelial cells conditioned with shear flow (1 Pa) and 75.5 V m−1; (D) Endothelial cells
conditioned with shear flow (1 Pa) demonstrated more parallel alignment phenotypes.
5.3.2 Mediation of endothelial cells alignment by shear flow
and electric field
Under concurrent 5.4 mL hr−1 shear flow with 1 Pa shear stress and 300 V m−1 dcEF
stimulation, endothelial cells aligned perpendicular to the electrical current vector and
the dcEF caused some cell death that rendered the endothelial cell layer patchy as
shown in Figure 5.4A. Strong perpendicular cell alignment was also evident in cells stim-
ulated with concurrent 5.4 mL hr−1 shear flow and 153.6 V m−1 dcEF (Figure 5.4B).
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Figure 5.5: Immunofluorescence staining of HUVECs conditioned with
shear flow (shear stress fixed at 1 Pa) and electric fields at various strengths.
F-actin cytoskeleton staining by phalloidin shows stress fiber alignment under increas-
ing electric field. CD31 is the platelet endothelial adhesion molecule expressed on
endothelial cells. Evident perpendicular alignment of cells and the intracellular stress
fibers are observed in cells stimulated with 154Vm−1 and 300Vm−1 electric field. The
shear flow alone induces parallel alignment of cells and the stress fiber.
Under the fixed shear flow rate (1 Pa), perpendicular cell alignment by electrical field
stimulation was not observed in cells conditioned with 75.5 V m−1 electric field (Fig-
ure 5.4C), suggesting that a minimum electric field stimulation on cells is required
to induce the perpendicular cell alignment. Under the 5.4 mL hr−1 shear flow stim-
ulation alone, the 1 Pa shear stress induced classical parallel alignment of HUVECs
(Figure 5.4D), consistent with prior observations446,447. Without any shear flow, the
HUVECs exhibited no alignment preference (Figure 5.6A). These results imply that
the SFEFC in our experimental setup can support long-term shear flow and electrical
stimulation conditioning of endothelial cells on chip (Figure 5.4).
The alignment of HUVECs in SFEFC under simultaneous shear flow and electric
field was further characterized by immunofluorescence staining against F-actin and
CD31 (Figure 5.5). CD31 was expressed on conditioned endothelial cells. Under shear
flow conditioning, endothelial cells displayed parallel alignment that was also demon-
strated by the parallel orientation of actin stress fibers. When a co-existing electric
field increased in strength, electrical stimulation induced cells to undertake a more
perpendicular phenotype as the stress fibers became more perpendicularly oriented.
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5.3.3 Adherence of glioblastoma cells to endothelial cells in
static condition with stimulation of angiotensin signaling
Phenotyping endothelial cells and glioblastoma cells cultured in static condi-
tion: Prior to adhesion experiment, the phenotypes of endothelial cells and glioblas-
toma cells in static condition were verified. Endothelial cells cultured in static con-
dition expressed random orientation (Figure 5.6A). The immunofluorescence staining
confirmed that both T98G and U251MG glioblastoma cells exhibited both GFAP and
Tie2 expressions, indicating a glial phenotype with potential angiopoietin/Tie2 signal-
ing (Figure 5.6B & Figure 5.6C).
Figure 5.6: Microimages of endothelial cells and glioblastoma cells. (A)
Endothelial cells cultured in static condition show random orientation; Both (B) T98G
and (C) U251MG glioblastoma cells exhibit both GFAP and Tie2 expressions.
Glioblastoma cell adhesion to endothelial cells in static condition: U87MG
and U251MG cells are reported to adhere to endothelial cells through Ang1/Tie2 sig-
naling285. I first tested the adhesion of T98G and U251MG glioblastoma cells under
similar conditions.
The adhesion of T98G-dsRed and U251MG-dsRed glioblastoma cells to confluent
endothelial cells was examined (Figure 5.7). After 1 hour of adhesion, glioblastoma
cells adhered to the endothelial and displaced them. The adhesion of glioblastoma
cells with and without Ang1 to confluent HUVECs with and without activation with
TNFα were quantified and statistically examined in Figure 5.8 (microscopy images are
shown in Figure 5.9 & 5.10).
Without Ang1 treatment, adhesion of U251MG-dsRed to endothelium was greater
than that of T98G-dsRed (P<.0001). Ang1 treatment increased the adhesion of both
T98G-dsRed and U251MG-dsRed to endothelium (P<.001). This is consistent with
existing reports that glioblastoma cells demonstrate enhanced interaction with endothe-
lial cells via Ang1/Tie2 signaling285. TNFα is a cytokine known to upregulate adhesion
molecules on endothelial cells652,658. However, only T98G cells activated with Ang1
showed increased adhesion to TNFα-activated HUVECs but not U251MG cells. This
result suggests that the Ang1/Tie2 signaling of glioblastoma may not directly cross-
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Figure 5.7: The adhesion of (A) T98G-dsRed, and (B) U251MG-dsRed,
to static confluent endothelium (fluorescently labeled green). The cells with
yellow color (next to the white arrows) indicate the colocalization of CellTracker Green
dye in endothelial cells and dsRed fluorescent protein in glioblastoma cells. The colo-
calization implies cell fusion or intercellular exchange events that may be important in
the perivascular microenvironment of glioblastoma.
talk with TNFα signaling-related adhesion molecules expressed on HUVECs. Further
identification of the adhesion molecules is needed.
In addition to glioblastoma adhesion, colocalization events were observed between
the dsRed fluorescence of glioblastoma and CellTracker Green fluorescence of endothe-
lial cells in vitro (Figure 5.7). Colocalization events were quantified and calibrated
by adhesion events as shown in Figure 5.11. The colocalization events did not in-
crease or decrease (P>.05) due to Ang1 stimulation or TNFα activation, although
Ang1-stimulation increased the adhesion in both glioblastoma cell lines. Interestingly,
more colocalization events were detected in Ang1-stimulated T98G-dsRed but not in
U251MG-dsRed (Figure 5.11A, P<.0001).
Colocalization events suggest that glioblastoma cells and endothelial cells under-
went a fusion event or an intercellular transport event659,660. Cell fusion may con-
tribute to the origin of cancer stem cells and acquisition of drug resistance. Specifically,
glioblastoma-endothelial cell hybrids have been proposed to play a pivotal role in the
perivascular microenvironment of glioblastoma and the maintenance of glioblastoma
cancer stem cells661. Further identification of the molecular signaling underlying the
intercellular transport and elucidation of glioblastoma-endothelial hybrid function in
glioblastoma progression can further our understanding of the angiogenesis of glioblas-
toma. However, it has been reported that brain microvascular endothelial cells show a
distinct phenotype compared to endothelial cells isolated from umbilical cord, suggest-
ing that closer physiological models may require the use of tissue-specific endothelial
cells662,663.
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Figure 5.8: The adhesion of T98G-dsRed and U251MG-dsRed to endothe-
lium under the stimulation with Ang1 and TNFα in static condition. ***
denotes P<.001; **** denotes P<.0001; n.s. denotes no significance.
5.3.4 Adherence of glioblastoma cells to shear flow and electric
field conditioned endothelial cells
I next examined how simultaneous shear flow and electric field stimulation affected
the adhesion of the two glioblastoma cell lines on the endothelial cells (Figure 5.12).
Only T98G-dsRed cells (not U251MG-dsRed cells, P>.05) showed increased adhesion
to the endothelial cells preconditioned under 153.6 V m−1 dcEF and 1 Pa shear stress
when compared to two pre-conditioned control studies: shear-flow conditioned control
(P<.01, section V of Figure 5.12) and the static control (P<.01). The endothelial cells
preconditioned under 300 V m−1 dcEF and shear flow with 1 Pa shear stress were patchy
due to some cell death at this electric field strength (Figure 5.4A), which may contribute
to the lower adhesion of glioblastoma cells (P>.05). Even though the endothelial
cells conditioned in shear flow of 1 Pa and electric fields of 75.5 V m−1 and 30.9
V m−1 were confluent, the adhesion of both glioblastoma cell lines on pre-conditioned
endothelial cells were similar when compared to the control groups. This suggests a dose
dependent response of electric field conditioning which was observed in the adhesion
of osteosarcoma to polyethylene substrate664 and migration of fibroblasts274. Future
identification of the molecular targets that contribute to the difference of adhesion
could facilitate molecular typing of glioblastoma cells and further our understanding
on the cell-cell interaction between glioblastoma and the endothelial cells that may
contribute to the metastasis665,666.
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Figure 5.9: The adherence of T98G-dsRed cells (red fluorescence) to en-
dothelial cells (green fluorescence). Yellow fluorescence represents the inter-
cellular transport between the two cells. (A) T98G-dsRed adherence to HUVECs;
(B) Increased adherence of Ang1-stimulated T98G-dsRed cells to HUVEC as evident by
increased number of red fluorescent cells; (C) T98G-dsred adherence to TNFα-activated
HUVECs; (D) Ang1-stimulated T98G-dsRed cells adherence to TNFα-activated HU-
VECs. Increased adherence is detected when the number of glioblastoma cells increases.
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Figure 5.10: The adherence of U251MG-dsRed cells (red fluorescence) to
endothelial cells (green fluorescence). Yellow fluorescence represents the
intercellular transport between the two cells. (A) U251MG-dsRed adherence to
HUVECs; (B) Increased adherence of Ang1-stimulated U251MG-dsRed cells to HU-
VEC, as evident by increased number of red fluorescent cells; (C) U251MG-dsred
adherence to TNFα-activated HUVECs; (D) Ang1-stimulated U251MG-dsRed cells
adherence to TNFα-activated HUVECs. Increased adherence is detected when the
number of glioblastoma cells increases.
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Figure 5.11: The intercellular transport events between glioblastoma and
endothelial cells in static condition. (A) the intracellular transport events per
unit area observed in static condition; (B) The calibrated intercellular transport event
ratio (CITER) observed in static condition calibrated by adhesion count in Figure 5.8.
**** denotes P<.0001; n.s. denotes no significance. Signs of + and - denote whether
the glioblastoma cells are stimulated with angiopoietin. Circle symbol denotes if the
glioblastoma adhere to HUVECs or TNFα-stimulated HUVECs. The intercellular
transport events in T98G cells increase when T98G are stimulated with Ang1 but no
increase is observed in U251MG cells. TNFα stimulation has no statistically significant
effect on intercellular transport events.
In addition, under the static condition, the adhesion of U251MG-dsRed was higher
than that of the adhesion of T98G-dsRed cells (Figure 5.8), but such difference was
not observed in the on-chip static control (Figure 5.12). The shear force from the
gravity flow in on-chip glioblastoma adhesion experiments could contribute to this
discrepancy. It is known that hydrodynamic flow could alter the adhesion dynamics
and cell-cell contact. Quantitative study of glioblastoma-endothelial adhesion dynamics
under a hydrodynamic flow can elucidate the underlying biophysical mechanism in
future studies667.
5.4 Summary and prospects
I demonstrated a quick-fit hybrid BMMDmade of PMMA and PDMS that provided ad-
vantages over single-material counterparts, such as bubble prevention, user-friendliness,
low dead volume, and air-tight sealing. The quick-fit design allows high experimental-
throughput setup so that by reusing the top interface chip, multiple experiments can
be performed sequentially by assembling and disassembling the quick-fit chip. The
reagent waste was significantly reduced.
I verified the operation of quick-fit SFEFC by conditioning endothelial cells on-chip
to concurrent shear flow and electric field. No leakage or bubbles at high volumet-
ric flow rate was observed. The applied electrical current induced perpendicular cell
alignment and shear flow instigated a parallel alignment on endothelial cells, thus cells
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Figure 5.12: Adherence of glioblastoma cells to endothelium conditioned
under shear flow and electric field or endothelium cultured in static flow on
the SFEFC. ** denotes P<.01; *** denotes P<.001; **** denotes P<.0001.
were subjected to competing physical cues. In the future, a microfluidic design with
orthogonal electric field and shear flow configuration can be useful for investigating the
synergistic cell alignment effect in a complex microenvironment.
The SFEFC was validated by studying adhesion of glioblastoma cells to shear
flow and electric field-conditioned endothelial cells. T98G-dsRed and U251MG-dsRed
glioblastoma cell adhesion under static culture and shear flow with electric field-conditioned
endothelium was examined. Angiopoietin 1 activation increased the adhesion of both
glioblastoma cell lines on a statically cultured endothelial cell layer. T98G-dsRed
glioblastoma cells also showed increased adhesion to an endothelial cell layer condi-
tioned with intermediate electric field and shear flow. On the other hand, U251MG-
dsRed showed no adhesion difference. Further identification and typing of adhesion
molecules is expected to further our understanding of how glioblastoma interacts with
endothelial cells. I envision that the quick-fit hybrid microdevice can be applied to
study other cell-tissue interactions in controlled shear flow and electric field condi-
tions. The quick-fit hybrid device can also aid in drug screening on cells conditioned
under biomimetic conditions.

Conclusion
Glioblastoma, a high grade form of glioma, contributes to high mortality and high
recurrence of brain cancer. To study how the physical and chemical factors in the
cancer microenvironment participate in the glioma biology, a robust in vitro platform
that can mimic the microenvironment is required. Furthermore, how to accurately and
quantitatively analyze the cell behaviors on the platform in an automated fashion is
essential for accelerating systematic studies.
In this thesis, I have created a new hybrid microfluidic design to create robust and
flexible microfluidic platforms by combining PMMA and PDMS based substrates. The
advantages of the two materials can be combined and the disadvantages can be mit-
igated. Using PMMA fabrication, complex microfluidic layout can be easily designed
and fabricated while high spatial accuracy microchannels can be created in PDMS
soft lithography fabrication. By using a dual-energy double sided tape, facile het-
erogenous bonding between PMMA and PDMS further improves the design flexibility
and fabrication speed. A novel submerged cell seeding operation further guarantees
uniformly distributed single cells being seeded in the microchannels with advantages
such as bubble-free and low cell number requirement. The hybrid microfluidic design
can be tailor made to answer specific biological questions. In particular, the PMMA
components in hybrid microfluidics can be quickly designed to accommodate special
world-to-chip interface requirements in biomedical applications. Therefore, the po-
tential of using hybrid microfluidics in combination of hydrogels to mimic complex
microenvironments for 3D tissue engineering and stem cell biology is an appealing
future direction.
Analyzing single cell migration and morphological changes have been the hallmark
of single cell microscopy. However, label-free optical contrast techniques such as phase
contrast microscopy or differential interference contrast microscopy, increase the con-
trast for transparent cells non-uniformly. As a result, the images are not easily seg-
mented by computer vision due to image intensity gradients. Therefore, the data
analysis has been a bottleneck in high-content analysis of cell migration. To that end,
I have developed a machine learning software, Usiigaci, to segment, track, and analyze
single cell migration in label-free phase contrast microcopy images. Using Usiigaci, the
cell movement and morphological changes can be reliably analyzed in an automated
fashion. The trainable nature of convolutional neural networks further suggests that
small differences in cell appearance under different conditions and health states could
be recognized in the future. Thus, many possibilities exist for using neural networks
in image cytometry without specific labeling of cells. A machine learning-augmented
microscopes in future can provide real-time prediction and quantitative measurements
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to researchers and clinicians, which can vastly decrease turn around time of data in-
terpretation.
A hybrid PMMA/PDMS microdevice and the Usiigaci software are used as an inte-
grated platform to study the electrotaxis of glioblastoma cells. I find that the electro-
taxis of glioblastoma cells require optimal ECM coatings, such as Geltrex. The T98G
and U251MG glioblastoma cell electrotaxis are dependent on extracellular calcium and
different voltage-gated ions channels are involved. For voltage-gated calcium channels,
U251MG electrotaxis is dependent on the P/Q-type VGCC and T98G electrotaxis is
dependent on the R-type VGCC. The electrotaxis of both cells are also mediated by
A-type voltage-gated potassium channels and acid-sensing sodium channels. These
results show that the electrotaxis of different glioblastoma cell lines can be mediated
by different signalings, which means that if ion channels are pharmaceutical targets
to inhibit the infiltration of patient’s glioblastoma, a patient-specific ion channel ex-
pression profiling will be required to identify the appropriate targets and to formulate
cocktails inhibiting them. Further clarification of the role of VGCCs, VGKCs, and
sodium channels in glioblastoma metastasis may help to shed insight to this new ther-
apeutic strategy. The physiological electric field is a common but often overlooked
physical factor existing in the body throughout the life cycle of organisms. By further
understanding of how electric fields mediate cell behavior and cellular signaling, we
can explore how to use it to our advantage in tissue engineering and suppress it in
pathophysiological processes.
Another hybrid PMMA/PDMS chip that can be reversibly sealed is established
to condition endothelial cells with both shear flow and electric field. The adhesion
of glioblastoma to conditioned and unconditioned endothelial cells were studied. An-
giopoietin/Tie2 signaling increases the adhesion of glioblastoma to endothelial cells.
Furthermore, the T98G glioblastoma adhesion to endothelial cells conditioned with
shear flow and moderate electric field also increased. The flexibility of hybrid mi-
crofluidic platform further demonstrates its versatility to answer a broad spectrum of
biological questions. Furture incoporation of 3D hydrogels and more cell types to bet-
ter mimic the peri-vascular glioblastoma environment and study the whole process of
glioblastoma transvasational process will be interesting to characterize the fundamen-
tal mechanisms underlying the intracranial dissemination of glioblastoma through the
brain vasculature.
In conclusion, the hybrid microfluidic approach provides design flexibility, cell cul-
ture robustness, and fabrication capacity to establish reliable in vitro microenviron-
ments for a variety of biological studies. Furthermore, by adapting instance-aware ma-
chine learning technologies for cell classification and segmentation, single cell studies
in an automated fashion can be achieved, and take us one step closer toward high-
throughput quantitative understanding of biological phenomena.
Appendix
During my time at OIST, several studies were completed during the rotation or as
part of experiments that do not fall within the scope of the thesis. These results are
summarized and discussed in the appendix. The open-source models and software arise
from the thesis are listed for interested readers to reuse them for research purposes.
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Appendix A
Physical properties of the in vitro
microenvironment
Abstract
Understanding the physical properties of the liquids in the microfluidic microenvironment
is necessary for setting correct experimental conditions. Here, I characterize the densities,
electrical conductivities, refractive indexes, and dynamic shear viscosities of various buffers
and cell culture media at biologically relevant temperature. Although the densities, refractive
index, and dynamic viscosities of the water-based buffers and cell culture media are generally
similar to those of pure water, slight differences exist. Densities and refractive indexes slightly
increase as the solute composition becomes more complex as in cell culture media supple-
mented with sera. Dynamic shear viscosities are temperature-dependent and correlate with
the complexity of the solute slightly. The electrical conductivity of the solutions correlate
with the ionic strengths of the solutions. The measurement results can be used as simulation
parameters and for setting experimental boundary conditions in the following sections.
A.1 Introduction
The physical properties of fluids such as density, viscosity, and surface tension are
important for designing and controlling the engineering process668. The physical prop-
erties have to be kept in mind when designing experiments, performing simulation, and
interpreting the results. However, the biological fluids from organisms or its artificial
reconstitutes are complex. In cases of cell culture media, they are composed of carbo-
hydrates, salts, amino acids, and sometimes further supplemented with blood-derived
serum. Although no large molecular weight macromolecule is added in cell culture
media, in other words, they are similar to water, the dynamic viscosity measurements
of these solutions may still be challenging.
Modern viscometers or shear rheometers incorporate stress-controlled transducers
to precisely read the stress from the sample upon an applied shear. However, the
reliable torque sensitivities, sample surface tension, secondary flow, and inertial in-
stabilities in the measurement geometry can limit the measurement accuracy of low
viscosity solutions669. On the other hand, while microfluidic-based viscometers are in-
vented to provide viscosity measurements at very high shear rates with minute amount
of sample670, the accuracies at low shear rate are still limited by detection sensitivities.
175
176 Physical properties of the in vitro microenvironment
The viscosities and densities of the cell culture media are important as they are
inherent properties of the fluids necessary for simulation as well as calculation for ex-
perimental conditions such as shear stress. However, the viscosities and densities of
commercially available buffered solutions and cell culture media are not commonly
provided by the manufacturer and not reported in detail in the literature. It is re-
ported that Dulbecco’s minimum essential medium (DMEM) has a dynamic viscosity
of 0.78mPa s at 37 ◦C671,672 and its variant supplemented with 10% fetal bovine serum
(FBS) is 0.94mPa s673.
The conductivities of the cell culture media are also important in cell-dcEF inter-
action studies202 as well as in electroporation studies674. To control the electric field
strength in the experimental system, the electrical conductivity of the fluids must be
known. For example, it is reported that the minimum essential medium (MEM) has
an electrical conductivity of 1.82 Sm−1 at 37 ◦C675.
In the following sections, I introduce the experimental approaches for collecting
physical properties of relevant buffer solutions and cell culture media used in this
thesis.
A.2 Materials and methods
A.2.1 Preparation of cell culture media
The ultrapure water, buffer solutions, and cell culture media were prepared in-house
from commercial sources in powder or solution form. The 18.2MΩ water was prepared
from Milli-Q® Integral Water Purification System (Merck KGaA, Germany) and au-
toclaved (SX500, TOMY, Japan).
Two commonly used isotonic buffer solutions namely Dulbecco’s phosphate buffered
solution (D-PBS) and Hank’s balanced salt solution (HBSS) were purchased from com-
mercial sources (Nacalai Inc, Japan & Thermo Fisher Scientific, USA). The 1X working
solutions were used directly or after dilution from 10X stock solution and autoclaved.
Several cell culture media recipes used in this work, such as Minimum essential
medium α (MEMα), Dulbecco’s minimum essential medium (DMEM) and Roswell
Park Memorial Institute 1640 (RPMI1640), were purchased directly from the man-
ufacturer either in powder or liquid form. The liquid form was used directly. For
preparation from powder form, the displacement of the serum was considered. The
powder was dissolved in appropriate amount of reagent grade water, e.g., 950mL for
serum free media or 850mL for 10% serum containing media. 50mL of reagent grade
water was used to dissolve an appropriate amount of sodium carbonate, e.g., 2.2 g L−1
for 1 L of DMEM and MEM in 5% CO2 incubator. The NaHCO3 solution was saturated
with 99.9% CO2 gas for 2 minutes before being combined with the media solution. No
additional pH adjustment was done. The solutions were filtered through a filter cup
(Stericup, Merck KGaA, Germany) into sterile serum bottles. Appropriate amount of
sera, such as fetal bovine serum (FBS) or calf serum (CS), were added afterward. The
media were stored under 4 ◦C and used within two weeks of preparation.
Several media varied in recipe composition were characterized, including low glucose
DMEM (08456-36, Nacalai, Japan), fluorobrite DMEM (A18967-01, Thermo Fisher
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Scientific, USA), high glucose with pyruvate DMEM (11995-065, Thermo Fisher Scien-
tific, USA), neural basal medium (21103-049, Thermo Fisher Scientific, USA), calcium
free DMEM (21068-028, Thermo Fisher Scientific, USA), and endothelial cell growth
medium (C22210, Promocell, USA).
A.2.2 Density measurement using densimeter
The densities of the solutions at 25 ◦C and 37 ◦C were characterized using oscillating
U-tube method on a handheld densimeter (DMA 35 basic, Anton Paar GmbH, Aus-
tria)676,677.
In the oscillating U-tube method, the sample liquids were filled into a U-shaped
glass tube and subjected to an oscillation by a piezo actuator. The internal volume
was known and the eigenfrequency of the oscillation was influenced by the sample’s
mass. Based on the relationship between the mass and the volume, the density of the
sample liquid was derived.
A.2.3 Viscosity measurement using rotational rheometry and
capillary rheometry
Rotational rheometry measurement The viscosities of buffers and cell culture
media were measured first on a rotational rheometer (ARES-G2, TA Instruments, USA)
using either a 1° cone and flat plate geometry (402763.903 & 402619.901, Figure A.1A)
or a concentric cylinder geometry (402620.901 & 402621.901, Figure A.1B).
Figure A.1: Geometry used in rotational rheometry using ARES-G2 (TA
Instruments). (A) A flat plate (Left) and 1° cone (Right) geometry (B) A cup (Left)
and bob (Right) geometry.
Due to the low viscosities of the liquids, there was risk of sample spilling at high
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shear rates, which may damage the motor and temperature controller electronics when
using cone and plate geometry. In addition, the surface tension of sample liquid and
drying artifacts may affect the reading in the cone plate geometry. Only water and
MEMα samples were tested with the cone plate geometry for results comparison be-
tween different geometries. All other results were measured using concentric cylinders
on ARES-G2. Sample fluids of 110% of the minimum required volume were loaded into
the geometry and standard gap was used. Triplicate flow sweep measurements were
carried out with logarithmic sweep of shear rates between 0.01 to 1000 s−1 at 25 ◦C
and 37 ◦C using a peltier system (Advanced Peltier System, TA Instruments, USA).
The torque measurable by the instrument is limited and thus limits the measur-
able shear stress. To avoid bad data, the condition for acceptable data is set so that
measured torque is above some minimum limit T > Tmin 669, so the viscosity satisfies:
η >
FτTmin
γ˙
, (A.1)
where η is the minimum shear viscosity, Fτ iss the geometry factor, Tmin is the minimum
measurable torque, γ˙ iss the apparent shear rate.
The geometry factors for the cone-plate geometry and the concentric cylinder are
given as:
Fτ =
3
2piR3
, (cone-plate)
Fτ =
1
2piR2b ×Hb
, (concentric cylinder)
where, R is the radius of the cone, Rb is the radius of the bob, and Hb is the height of
the bob.
In the concentric cylinder geometry, when the inner cylinder is rotating at suffi-
ciently large velocity, secondary flow instability can generate axisymmetric vortices,
also known as the Taylor-Couette flow. Since the low viscosity fluids are more prone
to secondary flow, the viscosity of the testing should satisfy the following:
η >
(Ro −Ri) 52
1700R
1
2
i
ργ˙, (A.2)
whereRo is the outer diameter of the geometry, Ri is the inner diameter of the geometry,
ρ is the density, γ˙ is the shear rate.
On ARES-G2, the minimum measurable torque specified by the manufacturer was
0.1 µNm. The cup I used had an inner diameter of 29.989mm and the bob had a
diameter of 27.681mm and a length of 41.620mm. The compliance of upper geometry
was 0.648mradN−1m and no value was reported for the lower geometry. The inertia
for the geometry was 62.1 µNm s2. The measured viscosities (Pa s) at different shear
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rates using a concentric cylinder geometry should satisfy the following:
η >
1.996× 10−3
γ˙
, (minimum detectable viscosity)
η > 2.262× 10−7γ˙. (secondary flow limit)
The triplicate data were averaged, and standard deviations were calculated in Ex-
cel (Microsoft, USA). Considering the sensitivity limit and the secondary flow limit,
the viscosity values from rotational rheometry were reported by taking average values
between shear rate of 10 to 100 s−1 or fitted as Newtonian fluids in TRIOS software
(TA Instruments, USA).
Capillary rheometry measurement In capillary rheometry (m-VROC, Rheosense,
USA), a microfluidic channel of rectangular cross-sectional profile laden with pressure
sensors along the channel is fabricated by MEMS technologies. The pressures of the
Hagen-Poiseuille flow at segments along the channel are measured and pressure drops
are fitted to find the apparent viscosity of the liquid678:
γ˙app =
6Q
wh2
, (A.3)
τ = −slope∆p wh
2w + 2h
, (A.4)
ηnewtonian =
τ
γ˙app
, (A.5)
where, Q is the flow rate, w is the channel width, h is the channel depth, τ is the
wall shear stress calculated from slope of pressure drop (∆p) from m-VROC sensor
by unit surface area, and γ˙app is the apparent shear rate. In cases of non-Newtonian
fluids, the true shear rate is calculated by Weissenberg-Rabinowitsch correction from
the apparent viscosity:
γ˙ =
γ˙app
3
(2 +
d ln γ˙app
d ln τ ). (A.6)
Using the capillary rheometry, liquid viscosities at very high shear rates can be
measured with very small sample volume without artifacts from flow instabilities or
interfacial effects. The dynamic viscosities of the sample liquids were measured using a
capillary rheometry (m-VROC, Rheosense, USA) using a A05 sensor (Table A.1) with
a 1mL gas-tight loading syringe (VWR, USA). Triplicate measurements of viscosities
with R2 value above 0.98 were taken and averaged.
Table A.1: Specification of the A05 m-VROC sensor for low viscosity fluids.
A05 sensor, 50 µm depth Shear rate range (s
−1)
Low shear
0.1 - 500
Medium shear
500 - 6000
High shear
6000+
Viscosity range (mPa s) 5 - 500 0.5 - 50 0.2 - 4
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A.2.4 pH and electrical conductivity measurement
The electrical conductivities of the media were vital to calculate the amount of electrical
current needed to establish appropriate electric field strength in the microchannels.
Samples of buffered solutions and media were first equilibrated in the 37 ◦C, 5% CO2
incubator, then before experiment incubated in a 40 ◦C water bath for 10 minutes.
Afterward they were aliquoted to a 100mL beaker under room temperature. The tips
of a calibrated pH probe (9618S, Horiba, Japan) and a conductivity probe (3552-10D,
Horiba, Japan) were submersed in the sample fluids and allow to reach to 37 ◦C before
triplicate readings were taken (F74, Horiba, Japan). Both the conductivity probe and
the pH probe were calibrated with reference solutions prior to the measurement. The
setup is shown in Figure A.2.
Figure A.2: Measurement setup for pH and electrical conductivity. (A) An
electrical conductivity probe; (B) An internal temperature compensated pH probe.
A.2.5 Refractive index measurement using refractometry
The refractive indexes of the sample fluids were measured using a modern automatic
Abbe’s refractometer (Abbemat MW, Anton Paar GmbH, Austria). The automatic
refractometer was based on the original Ernst Abbe’s design679,680. In Abbemat MW,
a monochromatic light, usually the Na-D line at 589.3 nm, is generated by a white light
emitting diode (LED) light source and a interferometric grating. The incident light
beam passed through an Yttrium-Aluminum-Garnet (YAG) prism to the samples on
the opposite side and the reflected lights at various angles were detected by a charge
coupled device (CCD). The refractive index of the sample was inferred with minimum
interference from color and transparency of the sample. All the measurements were
done in triplicate at 37 ◦C maintained by the integrated temperature controller on
Abbemat MW.
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A.3 Results and discussion
A.3.1 Density, electrical conductivity, and refractive index of
different media
The measured results of density at 25 ◦C and 37 ◦C, electrical conductivity at 37 ◦C,
and refractive index at 589.3 nm, 37 ◦C are shown in Table A.2.
The densities of all solutions resemble that of water but increased slightly due to
solutes and inversely correlate with the temperature.
The electrical conductivities of all the solutions are also measured at 37 ◦C. The
electrical conductivities of cell culture media based on Eagle’s or Dulbecco’s original
recipe yield similar electrical conductivities. Although the conductivity of MEMα is
slightly smaller than reported (1.62 versus 1.82 Sm−1)675, it could result from the dif-
ference of the sodium bicarbonate amount. In early cell culture systems, 10% CO2
was used instead of 5% in contemporary cell culture incubator. The amount of sup-
plemented sodium bicarbonate is different for buffering at physiological pH, which can
contribute to electrical conductivity.
Many reports have attempted to create an algebratic expression of electrical con-
ductivity by the ionic strength of the solution, which is contributed by the dissolution
and ionization of the ionic solute681. The ionic strengths of the solutions are calculated
based on the recipe provided by the manufacturer. From the measured data, the best
curve fit shows the linear relationship between the ionic strength and the electrical
conductivity (Figure A.3).
Figure A.3: Correlation between the ionic strength and the conductivity of
cell culture media.
The refractive indexes of all the test solutions are very close to that of water (nD ≈
1.33) (Table A.2). The effect from the solute may be only minute except in experiments
demanding high optical sensitivity. However, the refractive index information maybe
helpful if precise index matching is needed in high resolution microscopy.
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A.3.2 The geometry effect on the rotational rheometry results
The geometry in rotational rheometry has critical effects on measurements670,682. In
conventional parallel-plate geometry, the results are limited by the torque sensitivity
of the transducer, the surface tension of the sample, and the radial shear gradient in
the parallel-plate geometry. The radial shear gradient is mitigated in the cone-plate
geometry. However, the surface tension from the air/liquid interface can still create
artifacts in measurement. On the other hand, in the concentric cylinder geometry,
geometry is submerged in the sample fluids and the effect from the surface tension can
be reduced but the inertia of the bigger geometry may introduce additional artifacts669.
Figure A.4: The geometries effect to water viscosity measurement in rota-
tional rheometry. The viscosity data are shown in filled symbols and shear stress
data are in open symbols. The dashed lines indicate the lower torque sensitivity limit
and the upper secondary flow limit. For visualization purposes, the data points were
displayed but excluded during analysis as they were considered as bad data.
The flow sweep measurements of water and MEMα medium are performed at 25 ◦C
in both cone-plate and concentric cylinder geometries. In pure water, some artifacts
were detected above the torque resolution limit with the cone-plate geometry showing
a false low viscosity at low shear rate, which can originate from the interfacial effect
of water (Figure A.4), while the concentric cylinder (cup and bob) geometry yields
better resolution at low shear rates. However, at high shear rates, although below
the theoretical secondary flow limit, the viscosities measured by concentric cylinder
geometry increase (but not in cone-plate geometry), which suggest potential inertial
artifacts from the cup and bob geometry.
The similar results are observed in the MEMα medium. With the added complex
solute in the cell culture medium, interfacial phenomena may further influence the mea-
surement and demonstrate increased shear stress at low shear rates (Figure A.5). This
suggests that different geometries subject to different disadvantages and the dynamic
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viscosity measurement of low viscous fluids needs to be treated carefully.
Figure A.5: The geometries effect to MEMα viscosity measurement in ro-
tational rheometry. The viscosity data are shown in filled symbols and shear stress
data are in open symbols. The dashed lines indicate the lower torque sensitivity limit
and the upper secondary flow limit. For visualization purposes, the data points were
displayed but excluded during analysis as they were considered as bad data.
A.3.3 Dynamic shear viscosities of selected buffer solutions
and cell culture media
The dynamic viscosities of numerous buffer solutions and cell culture media are listed in
Table A.3. Specifically, the dynamic viscosities of water and DMEM supplemented with
or without calf serum or fetal bovine serum are measured with rotational rheometry
and capillary rheometry (Figure A.6).
While qualitatively, we can see that the more complex the cell culture media is,
the higher viscosity is observed. However, the data from rotational rheometry contain
measurement artifacts stemming from sample surface tension, secondary flow, and
instrumental inertia. The lower limit for good data point selection will need to be
set considering the effect of torque sensitivity, sample surface tension, and geometrical
inertia.
The viscosity measured with capillary rheometry shows that the cell culture media
are Newtonian in high shear rates, but there are systematic errors between the mea-
surement results of ARES-G2 and m-VROC, suggesting that a reference-calibration is
needed if no additional interfacial effect is at play.
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Figure A.6: The measured viscosities at different shear rates for water and
DMEMmedia supplemented with different sera in rotational rheometry and
capillary rheometry. The dashed line A shows the lower torque sensitivity limit and
B shows the secondary flow limit for ARES-G2. Good data for analysis is arbitrarily
taken between shear rate 10 to 100 s−1.
A.4 Summary and prospects
I carried out the measurement of physical properties of several buffer solutions and
cell culture media used in this thesis work using available instruments. The physical
properties are used for numerical simulation and setting experimental conditions in
this thesis.
It is generally accepted that cell culture media can be considered as Newtonian fluids
because no long macromolecules are present. However, if macromolecules are added
as part of proprietary recipe or in the supplemented sera, or if cells actively produce
extracellular matrix macromolecules, the fluid might become non-Newtonian683–685.
Accurate measurement of physical and biochemical parameters of the microenvi-
ronments will be important for designing successful microsystems to quantitatively
manipulate them.
Appendix B
Uniform electrical cell stimulation
in circular cultureware by 3D
microfluidics
Abstract
Applying uniform electric field (EF) in vitro in the physiological range conventionally has been
achieved in rectangular-shaped microchannels where the cross-sectional area is a constant.
In contrast, in circular-shaped devices, it is difficult to create uniform EF from two electric
potentials due to dissimilar electrical resistances originated from the length difference between
the diameter and the length of any parallel chord across the bottom circular chamber in
which the cells are cultured. To address this challenge, I developed a three-dimensional (3D)
computer-aided designed (CAD) polymeric insert to create uniform EF in circular-shaped
multi-well culture plates. A uniform EF with a coefficient of variation (CV) of 1.2% in the
6-well microplate can be generated with an effective stimulation area percentage of 70.2%.
In particular, NIH/3T3 mouse embryonic fibroblasts were used to validate the performance
of the 3D designed Poly(methyl methacrylate) (PMMA) insert in a circular-shaped 6-well
microplate. The CAD based inserts can be easily scaled up and down (e.g. from 18 mm in 24-
well microplate to 100 mm dishes) to further increase effective stimulation area percentages,
and be implemented in commercially available cultureware for a wide variety of EF-related
research such as EF-cell interaction and tissue regeneration studies.
B.1 Introduction
A weak direct-current electric field (dcEF) exists at the tissue level due to the transep-
ithelial potential difference established by the tissue polarity110. Cells demonstrate di-
rectional migration (electrotaxis) or orientation-change (electro-alignment) in response
to a physiological dcEF in both in vitro and in vivo settings. The electrotaxis and dcEF
stimulation have played pivotal roles in physiological processes such as embryonic de-
velopment, neurogenesis, morphogenesis, and wound healing107,110,161,162,686. Numerous
cellular signaling pathways are mediated by electric field (EF) stimulation. Various
membrane receptors233,243,247,251,687 or ion channels164,212,215,688,689 have been suggested
to act as EF sensors and initiate many intracellular signaling cascades in different cell
types212,213,247,256,260,264,690,691. Further investigations are required to clarify the func-
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tional roles of EF sensory proteins and signaling networks in regulating the electrotaxis
phenomena.
However, to gain a better understanding of signaling pathways demands a reliable
and convenient electrical stimulation platform for microscopy imaging and cell prod-
uct recovery with subsequent biochemical and molecular analysis. Even though an
electrical cue can direct cell migration comparable to that of a chemical cue275 and
synergistically promote directional migration with other physical factors such as shear
stresses274, electrotaxis is less well studied than chemotaxis, possibly due to the lack
of experimental tools for convenient EF stimulation comparable to a boyden chamber
(transwell chamber) that is routinely used for chemotaxis692. Furthermore, there is a
lack of standardize electrical stimulation apparatus for cell studies.
Conventional in vitro electrical stimulations are performed either by direct stimu-
lation using electrodes, or stimulation in a microfluidic chamber with salt bridges. The
dcEF created through direct electrode stimulation is not uniform and cells are often
exposed to toxic electrolysis products. Thus, many conventional electrotaxis studies
employ a confined microfluidic chip in which cells are cultured in the bottom of the
culture chamber196,198,258,266,574,693. The small cross-section of the chamber limits the
required voltage for the applicable electrical current and reduces the Joule heating
that could be harmful to the cells. Despite the success of using microfluidic chips for
electrical stimulation in recent studies, these microfluidic chips often require special
fabrication procedures on cell culture dishes days prior to the actual experiment, lim-
iting the adaptivity under common laboratory settings. Further, a simple rectangular-
shaped cell culture microchamber is usually placed on a circular shaped tissue-culture
polystyrene (TCPS) petri dish to generate the uniform EF. As a result, a large portion
of the cell culture area on the dish is unused, leading to low cell yield and poor cell
product recovery. Even though larger cell yields have been recently achieved by scaling
up the rectangular shaped microchamber with increased cell culture area196,258, a large
fraction of the circular shaped TCPS dish is not utilized.
In a circular-shaped area in a petri dish that exists in every biomedical labora-
tory, a uniform EF cannot be intuitively created by two electric potentials due to
dissimilar electrical resistances originated from the length difference between the di-
ameter of the circle and the length of any parallel chord of the bottom circular chamber
where cells are cultured. However, even without the uniformity, the approach is still
adapted in academic and commercial settings such as those by Marotta et al.694 and
by IonOptix695–698. There are also other approaches using transwell like configuration
of micropatterned electrodes. Lin et al. used a modified transwell assay to study cell
electrotaxis by applying EF through the transwell insert coupled with platinum elec-
trodes699. Alternatively, Garciá-Sánchez et al. used patterned electrodes to stimulate
cells in multi-well plates700. Their systems not only require sophisticated microfab-
rication procedures but small EF-null gaps between electrodes also decrease the EF
homogeneity. Recently, Ahirwar et al. used electromagnetic induction method with a
boyden chamber to demonstrate non-contact induction of electrotaxis, but non-uniform
EF persisted701.
Computer aided design and computer aided manufacturing (CAD/CAM) use com-
puter software to precisely design models and program manufacturing processes. Math-
ematically depicted 3D structures for workpieces can be easily created in CAD/CAM
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software and conveniently adopted for numerical simulations. Thus time, material, and
manpower are greatly reduced for prototyping effort. In recent years, additive man-
ufacturing (3D printing)702 takes the advantage of CAD/CAM to rapidly prototype
workpieces through layer-by-layer stacking of raw materials and this technology has
been used to fabricate microfluidic chips318,359,703,704. In this study, I solve the non-
uniform EF challenge by applying the CAD principle to modulate the electrical resis-
tance in a polymeric insert, which is then fabricated by CAM methods and retrofitted
to a common multi-well plate. Using Ohm’s law, an optimized CAD structure is cre-
ated to equalize the electrical resistance in the circular shaped bottom chamber to
generate a uniform EF. As a result, a large area of contemporary cell culture dish can
be stimulated with the uniform EF and higher cell yield is obtained.
I describe the design principle and numerical simulation of 3D CAD polymeric
insert in section B.2. The microfabrication and experimental setup is described in
section B.3. The validation of the polymeric insert and the discussion is followed in
section B.4.
B.2 Theoretical design and numerical simulation
B.2.1 Design principle of a 3D CAD insert to create a uniform
EF in different sizes of circular cultureware
In contrast to conventional in vitro EF stimulation systems using a rectangular cham-
ber, to apply a uniform EF in a circular shaped chamber (e.g. tissue culture polystyrene
petri dish, multi-well plate) is extremely difficult. The reason is due to the electrical
resistance across the entire area between two opposite electrical potential sources are
different. To illustrate, the electrical resistance ratio between two electric potential
sources A and B through the diameter and through the circumference is 2 : pi (R1 : R2,
Figure B.1).
Figure B.1: Schematic representation of electric resistance difference in a
circular cultureware. The electrical resistances between potential source A and B
through the diameter (R1) and through the circumferences (R2) are different, thus the
electric field is not uniform in the cultureware.
First, to apply electric field to cells, a person will intuitively insert two electrical
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potentials694. If two electric potentials are applied on top of this liquid cylinder, the
EF will not be uniform due to differences of electrical resistance for all current paths
between both potentials through the bottom chamber (Figure B.2).
Figure B.2: Numerical simulation of an EF stimulation device designed by
Marotta et al.694. (A) The 3D model consists of a 2 mm-deep bottom chamber in
a 6-well plate and two thin platinum electrodes inserted on the opposite sides of the
chamber; (B) The electric potential distribution of the EF. The non-uniform decrease
of the electric potential between the electrodes creates a non-uniform EF; (C) With an
electrical current with density of 500Am−2 introduced from one electrode and flows to
the other at ground potential, a wide distribution of the electric field strength (EFS)
in the bottom chamber renders a non-uniform EF in the bottom chamber.
A similar approach but with bigger electrodes is taken in a commercial electrical
stimulation system for cardiomyocyte pacing (C-Pace, Ionoptix Corp, USA). In C-Pace
system, carbon plate electrodes are inserted into multi-well plates and the established
EF is also not uniform (Figure B.3).
Figure B.3: Numerical simulation of a commercial C-dish EF stimulation
device from Ionoptix Corp. (A) The 3D model consists of a 2 mm height bottom
chamber in a 6-well plate and two carbon plate electrodes inserted on the opposite sides
of the chamber; (B) The electric potential distribution of the EF. The non-uniform
decrease of the electric potential between the electrodes creates a non-uniform EF; (C)
The EF distribution at the bottom of the chamber is generated by an electrical current
with density of 500Am−2 flowing from one electrode to the other at ground potential.
The non-uniformity of the EF is evident by the rough surface of the EFS distribution
in the bottom chamber.
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Therefore, conventional approaches to create uniform electric field often choose to
sacrifice the surface area of the cultureware to ensure the electric field is uniform, i.e.,
configure the chamber in rectangular-shaped constant cross-section area.
In this work, I created a microfluidic device to possess circular-shaped area in which
a uniform EF can be generated. The cells were stimulated in a circular microfluidic
chamber with a given height (red, Figure B.4). The electric field were applied through
a thin layer of fluid volume surrounding the perimeter of the bottom chamber through
an insert, and the fluid volume could be treated as a thin liquid column (LC, purple
block in Figure B.4).
Figure B.4: 3D schematic of the design principle. Two identical axial symmetric
paraboloids (P1&P2) along BC are used to equalize the electrical resistance in the
bottom chamber (red region) by trimming the liquid column LC (purple region) to
form our designed structure (green region).
To create a uniform EF, the electrical resistance from one electrode to the other
through any cross-section in the system must be the same. To satisfy the requirement,
I designed a 3D structure to equalize the electrical resistances through any arbitrary
current line that passes through the bottom circular chamber. Such structure can be
approximated as the liquid column (LC) intersected by two identical paraboloids whose
apexes are at the midpoint of the circumference of the bottom circular chamber (grey,
Figure B.4) The designed 3D CAD structure (green block, Figure B.4) to equalize the
electrical resistance can be created by trimming the liquid column by the two circular
paraboloids using the Boolean difference tool in the non-uniform rational basis spline
(NURBS)-based CAD software (Rhinoceros 5, Robert McNeel & Associates, USA).
The 3D CAD model can then be used for simulation in COMSOL or to make the
microfluidic chip for creating a uniform EF.
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According to Ohm’s law, electrical resistance R can be described as follows705:
R = ρ
l
Across−section
=
ρl
wh
, (B.1)
where ρ is the electrical resistivity, l is the length, Across−section is the cross-sectional
area, w is the width, and h is the height of the conductor (microchannel).
I need to identify the arc length of the curves in our system to calculate the elec-
trical resistance. Using a polar coordinate system, the bottom chamber (red circle,
Figure B.4) resides on the xy plane and the liquid column on top possesses a diameter
of BC. For paraboloid P1, its apex resides with the origin O in the liquid column and
the yz plane. the paraboloids intersects with the liquid column at the curveM ′ =
⌢
AOD
(white dashed line, Figure B.4). the projections of points A and D on xy plane are
B and C. Consider an electrical current flowing from point A to point D. By Ohm’s
law, in order to have a uniform EF in the chamber bottom, the resistance of
⌢
AOD
(white dashed path, Figure B.4) must be equal to that of AB + BC + CD (yellow
path, Figure B.4), equivalently, RM ′ = RAB + RBC + RCD. If I assume the resistivity
is the same across the model,
⌢
AOD
AM ′
=
M
′
AM ′
=
AB
AAB
+
BC
ABC
+
CD
ACD
. (B.2)
Equation B.2 shows that a uniform EF distribution is true when the ratio of the
rectification of the curve M ′ over the cross-sectional area of the liquid column equals
to the ratio of AB+CD over the cross-sectional area of the liquid column, in addition
to BC over the cross-sectional area of the bottom chamber. Assuming all electrical
currents pass through sufficiently thin paths.
M
′
column thickness
=
2× AB
column thickness
+
BC
chamber depth
. (B.3)
Since AB and BC can be easily measured, the value of M ′ can be subsequently
extracted by using Equation B.3. With the information of M ′ , I can determine the
shape of the circular paraboloid P1 and P2 as follows.
x2 + y2
a2
=
z
b
, (B.4)
where a2/b is the constant describing the level of curvature in xz and yz planes of the
paraboloid, which defines the shape of the paraboloid.
The equation for the liquid column can be considered as
x2 + (y − r)2 = r2, (B.5)
where r is the radius of the column (also the radius of the circular bottom chamber,
i.e., the culture area in the cultureware)
The coordinates of points O, A, and D can be presented in parametric form
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(
r cos θ, r(1− sin θ), 2br2
a2
(1− sin θ)), with
O :
(
r cos pi
2
, r(1− sin pi
2
),
2br2
a2
(
1− sin pi
2
))
= (0, 0, 0) , (B.6a)
A :
(
r cos 0, r(1− sin 0), 2br
2
a2
(1− sin 0)
)
=
(
r, r,
2br2
a2
)
, (B.6b)
D :
(
r cos pi, r(1− sin pi), 2br
2
a2
(1− sin pi)
)
=
(
−r, r, 2br
2
a2
)
. (B.6c)
The rectification of curve M ′ along the paraboloid P1 can be calculated by inte-
grating parametric equations706,
M ′ =
pi∫
0
√(
dx
dθ
)2
+
(
dy
dθ
)2
+
(
dz
dθ
)2
dθ (B.7a)
=
pi∫
0
√
(−r sin θ)2 + (−r cos θ)2 +
(
−2br
2
a2
× cos θ
)2
dθ (B.7b)
=
pi∫
0
√
r2 +
(
2br2
a2
)2
−
(
2br2
a2
)2
sin2 θdθ. (B.7c)
The constant of the paraboloid a2
b
can be solved by solving Equation B.3. Equa-
tion B.3 is difficult to solve explicitly due to the elliptic integral of the second kind
related to M ′ along the paraboloid P1 (Equation B.7). But Equation B.3 can be eval-
uated using Mathematica with the following code (Listing B.1) by denoting a constant
c = 2br
2
a2
(r is the radius of the circular bottom chamber) to simplify the calculation.
Listing B.1: Example code to find the descriptor for the paraboloid P1
Plot [Evaluate [ Integrate [ Sqrt [225+ c^2−c^2*Sin [ x ]^2 ,{ x , 0 ,Pi } ]
/0.5−2* c /0 .5 −30/0 .26 ] , { c ,−4.715 ,−4.71}]
To design an insert for 6-well plates, denote the thickness of the liquid column to
be 0.5mm, the diameter of the bottom chamber to be 30mm, and the thickness of the
bottom chamber to be 0.26mm, the parameter c = 2br2
a2
(containing the constant for the
paraboloid P1) can be evaluated and used to create the 3D model (described below) in
a commercial CAD software for further numerical simulation and device fabrications.
b
a2
= −0.01047. (B.8)
P1 : x
2 + y2 = − z
0.01047
. (B.9)
With this design principle, two extreme cases can be considered: electrical current
passing through the shortest chord (i.e., diameter) and the longest chord (i.e., circum-
ference), which will yield the constant of the paraboloid and the height of the liquid
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column required to achieve uniform EF.
The electrical resistance for all arbitrary current lines passing through each dif-
ferent path without the structure (only the liquid column), the following equation in
Listing B.2 can be used.
Listing B.2: examples code for all M paths without structure
Table [Evaluate [ 2 * Sqrt [ ( 1 5 * (Pi/2−y ))^2+( −4 .713)^2 ]/0 .5
+2*15*Sin [ y ] / 0 . 2 6 ] , {y , 0 , Pi /2 , Pi /180} ]
To find the electrical resistance for all arbitrary current lines passing through each
different paths (for example, pathline curves M ′′ , M∗∗, M∗, and M ′ , see Figure B.4)
between the shortest chord (θ = 90◦) and the diameter (θ = 0◦), where θ is the polar
coordinate azimuth, the following equation in Listing B.3 can be used.
Listing B.3: examples code for all M paths with CAD structure
Table [Evaluate [ 2 * Integrate [ Sqrt [225+4.713^2−4.713^2*Sin [ x ] ^ 2 ] ,
{x , 0 , y }]/0.5+2*(−4.713)*(1−Sin [ y ] )/0 .5+2*15*Sin [Pi/2−y ] / 0 . 2 6 ] ,
{y , 0 ,Pi /2 , Pi /180} ]
The calculated resistance range with θ ∈ (0◦, 90◦) is plotted in Figure B.5. The
relative resistance of AB + BC + CD corresponds to θ = 0◦ and that of
⌢
AOD cor-
responding to θ = 90◦. The results show that resistances of all path lines converge
toward both extreme cases and our current model provides a good approximation to
achieve uniform EF in a circular chamber. For future work, I plan to use quadratic
surface integral to further improve our design.
B.2.2 Numerical simulation
Configuration
The CAD models were either created directly in COMSOL Multiphysics software or in
Rhinoceros CAD software and imported into COMSOL for simulation. The material
of all models was set as water using the measured properties of culture medium in Ap-
pendix 2. Briefly, DMEM was set as the ionic fluid and the electric potential between
the salt bridges was numerically simulated by solving steady-state Maxwell’s equations
using the alternating current/direct current (AC/DC) module in COMSOL. The con-
ductivity of DMEM was set as 1.515 Sm−1 with relative permittivity set arbitrarily as
80 like water.
In experiments, an electrical current input interface was needed. Two 2 mm in
diameter circular holes were designed on top of the device to connect to two electric
potentials. Two shell-shaped structures then interconnected the holes to the liquid shell
in the microdevice. A current density of 376.1Am−2, aiming to create a 100Vm−1 EF
in the 30 mm in diameter and 0.26 mm-thick bottom chamber was calculated using
the equation B.10.
I = EFS × σ × w × h. (B.10)
where I, EFS, σ, w, and h are the required electrical current in µA, electric field
strength (EFS) in Vm−1, electrical conductivity in Sm−1, width in mm, and height in
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Figure B.5: The change of relative resistance between each arbitrary current
line in the insert. The change of relative resistance between each arbitrary current
line passing through each chord in the bottom chamber from the shortest chord to the
diameter, by varying θ from 0◦ to 90◦ with or without the designed CAD structure.
The CAD structure modulates the electrical resistances, so the EF becomes uniform.
mm, respectively.
The current density was set as the boundary condition at one circular hole (salt
bridge connection), and a ground potential was set at the other circular hole until
otherwise noted (Figure B.6). The electric field is numerically simulated for the plain
polymeric insert (Figure B.6A), the smooth polymeric insert with the designed 3D
structure (Figure B.6B), and the layered approximation ((Figure B.6C). The electric
field strengths (EFSs) at the bottom of the cell culture chamber were analyzed to assess
the EF uniformity at a height of 10 µm. The EFS data points at positions where the
liquid column resides were excluded. The numerical simulation results were exported
and analyzed in Prism 7 software (Graphpad, USA).
Numerical investigation of CAD structure’s effect on electrical resistance
modulation
I show side-by-side comparisons of simulated EF results for plain polymeric inserts,
smooth 3D CAD inserts, and layered 3D CAD inserts (Figure B.7). In plain insert
without the 3D designed structure, a large portion of the electrical current (red ar-
rows) passes through the liquid column instead of through the bottom chamber where
the cells are located (Figure B.7A). As a result, the EF stimulated on cells are lower
(75.03Vm−1 and non-uniform (7.91% CV) (Figure B.7B). With the 3D designed struc-
ture, the current lines (in red arrows) are uniformly distributed in the bottom chamber
(Figure B.7B), indicating that a uniform and directional EF is created (95.1Vm−1
with 1.22% CV) (Figure B.7E). The technical requirement to fabricate the paraboloid
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Figure B.6: CAD models of liquid in 3D inserts for numerical simulation.
(A) A 3D model without any designed structure; (B) 3D models of liquid within an
insert with designed CAD structure (left) and corresponding layered approximation
(right). The liquid volume modified by CAD design is shown in blue. The current
density was set as the boundary condition at one circular hole (salt bridge connection)
and a ground potential was set at the other circular hole.
surfaces are high, however, a simple layered approximation method can be adopted to
approximate the structure. By layered approximation, the established EF are slightly
weaker than those created by a smooth 3D CAD insert but are reasonably uniform
(89.06Vm−1 with 1.30% CV) (Figure B.7F). The simulated results of 3D CAD in-
serts designed for 0.26 mm-thick and 0.13 mm-thick bottom chambers are shown in
Table B.1.
Table B.1: Numerical simulation of EF in a plain insert, smooth 3D CAD
insert, and layered 3D CAD insert.
6-well 0.26 mm thick 0.13 mm thick
EFS
(V m−1)
CV (%) EFS
(V m−1)
CV (%)
Plain 75.03±5.94 7.91 74.0±10.06 6.80
Smooth 3D CAD 95.10±1.18 1.22 96.47±1.38 1.43
Layered 89.06±1.63 1.30 88.92±1.69 1.90
Figure B.8 shows the uniform decrease in electric potential in the bottom chamber,
suggesting a highly directional EF created by using the smooth 3D CAD insert as well
as the layered 3D CAD insert. This indicates that inserts are suitable not only for
cell stimulation but also for electrotaxis study where a uniform and directional electric
field is required.
Numerical simulation results of devices for different sizes of cultureware
By adaption of the design principle described in section B.2, 3D CAD inserts for
different sizes of cultureware can be designed. The numerical simulation results of
3D CAD devices for different sizes of cultureware are summarized in Table B.2. The
coefficient of variation of the EFs in 3D CAD inserts of different sizes range from 1.22%
to 1.75% demonstrates the broad applicability of this approach.
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Figure B.7: Numerical simulation of EF in various designs (A) The current
vector map in an insert without designed structure. A large portion of electrical cur-
rent flows bypass the cells in the bottom chamber through the liquid column. The
corresponding EF as shown in (D) is thus lower and non-uniform; (B) The current vec-
tor map in an insert with the designed CAD structure. The electrical resistances are
modulated and passes through the cells in the bottom chamber. Thus a uniform EF
is obtained as shown in (E); (C) The current vector map in the layered approximation
of the designed CAD structure also shows electrical current can be delivered into the
bottom chamber. The corresponding electric field is also uniform as shown in (F).
Figure B.9 shows the numerical simulation of uniform EF created in 3D CAD inserts
made for 100 mm TCPS petri dish. In the smooth 3D CAD model, the mean EFS and
the CV of the EFS are 97.44± 1.47Vm−1 and 1.51% in (B). The mean EFS and the
CV of the EFS in the layered 3D CAD insert (D) are 94.73± 1.59Vm−1 and 1.67%.
The layered insert is less ideal than the 3D CAD model due to its rough surfaces but
it does not affect the uniformity of the created EF.
Effect of variation in bottom chamber thickness to EF uniformity
The double-sided tape used in this study is a pressure sensitive adhesive prone to
deformation under pressure or stretching. Effect of slight deformation in the chamber
thickness to the EF uniformity was examined by numerical simulations (Figure B.10).
The CAD design was intended for a 0.26 mm thick chamber (the exact thickness of
double-sided tape I used for fabrication). By varying the thickness of the bottom
chamber thickness between 0.2 mm to 0.3 mm, the mean electric field strength (EFS)
generated in the bottom chamber slightly changes, however, the EFS is still very close
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Figure B.8: The electric potential distribution in 3D CAD inserts. Electric
potential distribution shown as (A) surface plot and (B) contour plot at the bottom
of the insert with smooth 3D CAD structures. Electric potential distribution shown
as (C) surface plot and (D) contour plot at the bottom of a 6-layered PMMA insert.
Both inserts with smooth 3D CAD structures and the layered PMMA insert can create
a uniform and directional EF. The directionality of the EF can be reversed by placing
the high voltage to the opposite salt bridge as shown in (A) and (C). The uniform
distribution of electric potential yields the uniform EF in the bottom chamber.
to the intended value of 100Vm−1. The coefficient of variation of the EFS is the lowest
in the intended 0.26 mm-thick chamber, but in all thicknesses examined, the CVs are
below 3%. This demonstrated the robustness of the CAD design for creating a uniform
EF.
B.3 Materials and methods
B.3.1 Device fabrication
Whole device fabrication by 3D printing
The designed structure contains two paraboloid surfaces so the fabrication is not easy.
The first method I tried was by using fused deposition modeling (FDM) with Acry-
lonitrile butadiene styrene (ABS) (Dimension BST/SST 1200es, Stratasys, USA) and
powder based fusion method (Zprinter 450, Z Corp, USA) (Figure B.11). However,
neither method could generate a water proof device for testing and for cell culture
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Table B.2: Specification and numerical simulation results of 3D CAD de-
vices for different sizes of cultureware
Cultureware size 100 mm 6-well (35 mm) 12 well 24 well
Well diameter
86 (Corning®)
93.8(Eppendorf®)
34.6 (Eppendorf®)
21.1 (Volamo®)
22.4 (Eppendorf®)
15.6 (Nunc®)
16.2 (Eppendorf®)
Insert diameter 85 34 34 20 14
Culture area
diameter (mm)
80 30 30 16 10
Culture area
thickness (mm)
0.26 0.26 0.13 0.1 0.1
Height (mm) 8 3.9 4.5 3 2
2br2
a2
12.5675 4.713 4.713 3 1.875
Paraboloid X & Y 165 48 49 67.5 33
Paraboloid Z 50 13 13 50 20
Shell thickness (mm) 0.5 0.5 0.25 0.2 0.2
EF stimulation
area (mm2)
4901.7 660.5 683.5 191.1 72.4
Whole culture
area (mm2)
5674.5 940.2 940.3 391.1 208.9
EFS area
percentage (%)
86.4 70.2 72.7 48.9 34.6
Mean EFS
(Vm−1)
97.44 96.1 96.5 95.73 94.8
Standard deviation 1.47 1.18 1.38 1.34 1.66
EFS CV (%) 1.51 1.22 1.48 1.40 1.75
Current (µA)
for 100Vm−1
3151.2 1181.7 590.85 242.4 151.5
experiments. The ABS device fabricated by FDM method appeared to be fused and
water-tight, however, at high pumping pressure, solution would leak in between the
fused layers. The powder-based fusion method used an adhesive to join powder layers
patterned by the 3D printer. The joining of powder by the adhesive was also not strong
enough to create a water-tight microdevice even after postprocessing.
PMMA 3D CAD insert fabrication and simple channel PMMA device fab-
rication
Due to the difficulties to fabricate the smooth 3D CAD insert (Figure B.7B) reliably, I
fabricated functional prototypes using the 6-layer approximation model (Figure B.7C).
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Figure B.9: Numerical simulations of a scaled-up 3D CAD insert for a
100 mm TCPS petri dish. (A) Smooth CAD model for the insert with paraboloid
surfaces; (B) The uniform EF created in (A); (C) The 6-layered approximated 3D CAD
insert; (D) The uniform EF created in (C).
The composition of the 3D CAD insert is shown in Figure B.12. The detailed fabrica-
tion procedure was previously reported334,454.
Briefly, patterns for each layer were designed in AutoCAD software (Autodesk,
USA). A 1 mm thick PMMA substrate (Comoglas, Kuraray, Japan) was cut based on
the patterns by using a CO2 laser cutter (VLS2.30, Universal Laser Systems, USA). The
layers were aligned and joined by thermal bonding (Figure B.13A). Adapters for fitting
connection were super-glued onto the inserts (406 Prism Instant Adhesive, Loctite,
USA). The double-sided tape for the insert was then affixed to the insert bottom
(0.26 mm-thick, F9473PC, 3M, USA). The assembled device is shown in Figure B.13B.
The fabrication process of the simple rectangular channel chip followed the same
procedure as those for the circular insert (Figure B.14).
PDMS device by molding
With the assistance from OIST machine shop, a stainless steel mold set was fabricated
using computer numerical control (CNC) milling (Figure B.15A & B). I casted and
cured PDMS (10:1 ratio, Sylgard 184, Dow Corning, USA) inside the mold. Because
the mold was not fine-polished, the surface roughness caused the final device being
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Tolerance of thickness to EF
uniformity in 3D insert from simulation
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Figure B.10: Effect of chamber thickness on EF uniformity by numeri-
cal simulation. By varying the thickness of the bottom chamber thickness between
0.2 mm to 0.3 mm, the resistance decreases and the mean EFS slightly increases (dark
circles). But the simulated mean EFSs in the chamber with this thickness range are
very close to the intended value of 100Vm−1. The coefficient of variation (CV) de-
scribing the non-uniformity in the EFS is the lowest in the intended 0.26 mm-thick
chamber. Nevertheless the CVs in all thicknesses examined are below 3%, verifying
the robustness of the CAD design for creating a uniform EF.
Figure B.11: Prototyping inserts by 3D printing. (Left) The ABS prototype
made by FDM method; (Right) A prototype made by powder fusion method.
hazy (Figure B.15C). However, the 3D CAD structure was correctly molded in the
final device visualized by food dye in water. There is a possibility that deformation
of PDMS could disrupt the fluidics in the fabricated device. Based on these results,
fabrication using PDMS is proven viable but a more rigid solution may still be preferred
to ensure that the 3D CAD structure does not deform.
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Figure B.12: Schematics of the layered insert. PMMA top assembly containing
current rectifying chambers (CRC) and 3D CAD structures are affixed to the cell
culture dish through a piece of double-sided tape (ds tape) to form the assembled
microfluidic chip. Salt bridge is abbreviated as SB.
Figure B.13: Photoimages of fabricated layered PMMA 3D CAD insert.
(A) A layered PMMA insert thermally bonded. Yellow arrow indicates the layered 3D
structures embedded in the insert; (B) A layered PMMA insert affixed to a 35 mm
dish.
Metal-PMMA composite 3D CAD insert
Besides the difficulty to fabricate the paraboloid surfaces, the structures are also small
(0.5 mm or 0.25 mm-wide), thus fabrication requires extreme precision. One approach
to ensure an economical manufacturing of such structure is to split the 3D CAD insert
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Figure B.14: Schematics of a PMMA microfluidic chip containing two sim-
ple rectangular channels. (A) Three-layer patterned PMMA pieces are thermally
bonded. The PMMA piece affixes to the dish by a double-sided tape. Adapters for
inlets, outlets, and salt bridges (SB) are glued on; (B) A photoimage of the final as-
sembled device.
Figure B.15: Fabrication of 3D insert by casting PDMS on a CNC machined
mold. (A) The CNC milled stainless steel mold on the left with spacing ring in the
middle and top lid on the right with current rectifying chambers; (B) The assembled
and silanized mold before casting the PDMS and closing the top lid; (C) The casted
PDMS device filled with water with blue dye to visualize the CAD structure in the
insert.
204
Uniform electrical cell stimulation in circular cultureware by 3D
microfluidics
in two pieces with one of which containing the paraboloid structures (Figure B.16).
The two structures could be manufactured with high precision using microinjection
molding and joined afterwards to form a solid assembly.
Figure B.16: Two-piece assembly approach. An outer ring with paraboloid
structures and an inner cylinder that can be precisely mate with the outer ring.
I used a selective laser sintering (SLS) 3D printer to fabricate a titanium-based outer
ring (EOSINT M280, EOS GmbH, Germany) outsourced to DMM.Make (Japan). The
technique uses ultrafast fiber laser to sinter patterns on a metal powder bed and the
final workpiece is generated from sintering layers of patterns. A plain ring (left) or
an outer ring with 0.5 mm-wide paraboloid structures (right) can be fabricated (Fig-
ure B.17A). A PMMA inner cylinder with paraboloid structures or a PMMA inner
cylinders were fabricated by CNC micromilling from 10 mm-thick PMMA blocks (Mis-
umi, Japan) using 1.5 mm-diameter flat endmill (RSE-230, NS Tools, Japan) on a CNC
micromill (SLS Micro Mill/GX, Minitech, USA). The CAM tool path was generated
in Fusion 360 software (Autodesk, USA). The metal ring and the inner PMMA piece
were assembled afterwards (Figure B.17B).
By this approach, I confirmed that the two-piece assembly is feasible for economical
fabrication of fine structures in 3D CAD inserts. The SLS fabricated titanium parts
although were reasonable priced, they may not be practical for commercial deployment.
Reversible o-ring sealing 3D CAD insert fabricated in PMMA
An improved device was further developed using PMMA. A PMMA cylinder with
paraboloid structures, outer ring with a O-ring sealing slot, and a top current rectifying
chamber piece with O-ring sealing slots were fabricated on a CNC micromill (SLS
Micro Mill/GX, Minitech, USA) (Figure B.18A). The CAM toolpaths were generated
in Fusion 360 software (Autodesk, USA). I fabricated the inner cylinder to be slightly
bigger than the outer ring by 100 µm. The device could be assembled by briefly placing
the outer ring in a 60 ◦C oven to expand and quickly assemble with the inner piece
before cooling down. The assembled device was tight and difficult to disassemble.
Thereafter, the assembled device was reversibly sealed to a 10 cm-diameter glass wafer
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Figure B.17: Two-piece assembly of metal-PMMA 3D CAD insert (A) A plain
titanium ring and its corresponding PMMA workpiece with paraboloid structure on
the left; A titanium ring with paraboloid structures fabricated directly from selective
laser sintering of titanium powder and a lathe-fabricated PMMA cylinder; (B) The
tight assembly of the metal-PMMA 3D CAD inserts from A.
by mechanical sealing when compressive force was applied on O-rings (Figure B.18B).
The approach was more operator-friendly for biologists.
Summary: microdevices for cultureware across broad range of sizes
In summary, I developed several approaches to fabricate the 3D CAD inserts with
small paraboloid structures. These approaches aimed at economical fabrication of
devices with the potential to transfer to the industry at high manufacturing volume
instead of restricted to laboratory settings.
The design principle described in section B.2 can be used to fabricate small (16 mm-
diameter) to large (100 mm-diameter) devices to accommodate a broad range of cell
cultureware.
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Figure B.18: Reversible sealing 3D CAD PMMA insert. (A) A PMMA cylin-
der with paraboloid structures (left) joins the outer ring with a o-ring slot (right); (B)
The assembled device showing the 100 mm 3D CAD insert assembled to a 100 mm
glass.
B.3.2 Cell culture and maintenance
A Swiss murine embryonic fibroblast cell line with 3-day transfer protocol, NIH/3T3
(American Type Culture Collection, ATCC, USA), was used in this study to demon-
strate the electrical stimulation functionality with the polymeric circular insert and
the rectangular microchannel. The cells were cultured on TCPS dishes in Dulbecco’s
minimum essential medium (DMEM, 12800017, Gibco, USA) supplemented with 10%
fetal bovine serum (FBS, Sigma-Aldrich, USA) at 37 ◦C in a 95% relative humidity
atmosphere supplemented with 5% CO2. The cells were sub-cultured twice a week by
the recommended split ratio with trypsin-EDTA (Life Technologies, USA). For long
term storage, the cells supplemented with 10% dimethylsulfoxide (DMSO) were cryop-
reserved in liquid nitrogen.
B.3.3 EF measurement setup
To measure the EF in the bottom chamber in the insert, an array of holes in 0.3 mm
diameter was drilled on a 1 mm-thick PMMA substrate198,574. The spacing between
each hole was 3 mm. The holes were temporarily sealed with a Kapton tape. The
insert was filled with DMEM. A 46 V electric potential was applied through Ag/AgCl
electrodes (25 mm × 100 mm) by a DC power supply (E3641A, Keysight technologies,
USA). Preparation of Ag/AgCl electrodes was described elsewhere196. To measure the
voltage differences, two Ag/AgCl based electrodes (0.3 mm in diameter) were inserted
into two adjacent holes after piercing the tape cover (Figure B.19)196,202. The voltage
differences between any two electrodes in the chamber were measured by a digital
multimeter (2100, Keithley Instruments, USA) for 20 samples at every position by
using the Excel add-in function provided by the manufacturer (KI-LINK, Keithley
Instruments, USA). The EFSs can then be calculated by dividing the voltage differences
by the distance between respective electrodes. The results of mean EFSs and standard
deviations are calculated and exported using a custom MATLAB script (Mathworks,
USA).
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Figure B.19: A photo snapshot of the EF measurement setup. The inset
shows a magnified image of a PMMA layered 3D CAD insert on a custom 3D printed
holder for EF measurement.
B.3.4 Microfluidic chip assembly, EF stimulation and microscopy
analysis
Each six-layered PMMA insert was disinfected and then affixed to individual wells in
a 6-well TCPS plate or to a 35 mm TCPS dish (Figure B.12). Similar procedure was
applied to the simple rectangular channel chip. To avoid entrapment of bubbles, which
could disrupt EF uniformity and cause cell death, assembled microfluidic chips were
primed by CO2 gas, and filled with phosphate buffered saline (PBS, Life Technologies,
USA) as shown in Figure B.20A. Alternatively, the inserts can be affixed to the well
bottom with the presence of PBS as shown in Figure B.20B to further reduce bubble
entrapment because the double-sided tape has a limited adhesiveness in protein-free
buffer solution.
To start the cell experiment, PBS pre-filled chamber was first replaced by serum-
containing cell culture medium, and a suspension of 5× 105 cells was subsequently
loaded into the chamber through the salt bridge ports by gravity feeding. After
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overnight culture for cell adhesion and growth, fittings to supply culture medium and
for salt bridges (containing 1.2% agarose (LE agarose, Lonza, USA) in PBS) were con-
nected to the top of the inserts. A syringe pump (YSP-202, YMC, Japan) was used
to exchange cell culture medium during the time lapse experiment at a flow rate of
100 µL h−1 for the circular insert and 20 µL h−1 for the rectangular channels to obtain
similar shear stress acting on the cells. A DC voltage and the current was applied
and measured by a high voltage source meter unit (2410, Keithley Instruments, USA)
through Ag/AgCl electrodes in PBS. The required current for a 300Vm−1 EF in a
chamber of 30 mm in diameter and 0.26 mm in thickness was 3.545mA. The EF stim-
ulation setup diagram and a snapshot of the 6-well plate is shown in Figure B.21 and
Figure B.22.
Figure B.20: The workflow of the cell experiment by using the polymeric
insert. (A) The insert is affixed to the dish first, PBS, cell culture medium, and cell
suspension are infused into the microfluidic chip sequentially; (B) To further avoid
bubble entrapment, the insert can be affixed to the dish in PBS. Thereafter the buffer
is replaced by cell culture medium and cell suspension is then seeded.
The time lapse electrotaxis experiments on simple channel chips were carried out on
an automated microscope (Ti-E, Nikon, Japan) (Figure B.23). The phase contrast cell
images were taken at different positions across the devices at an interval of 5 minutes.
The morphology and centroid of cells were tracked manually for the duration of 5 hour
time lapse using ImageJ analysis software package.
To quantify the cell migration and alignment, two parameters (directedness and
orientation) are used with the following definition (Figure B.24).
• The directedness of cell electrotaxis is defined as the average of cosΦ =
N∑
i=1
cosΦi
N
,
where Φi is the angle between the Euclidean vector of each cell migration and
the vector of applied EF (from anode to cathode), and N is the total number of
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Figure B.21: The schematic diagram of electrical stimulation setup.
Figure B.22: A photo snapshot showing the setup of EF stimulation of cells
on a 6-well microplate in a temperature-controlled water bath. Fresh cell
culture medium was infused by a syringe pump. The DC electric potential bias to
create an EF was applied by a BioRad DC power supply.
analyzed cells (Figure B.24). A group of anodal moving cells holds a directedness
of -1; and a group of cathodal moving cells holds a directedness of +1. For a
group of randomly migrating cells, the directedness is zero.
• The orientation is defined as the average of cos 2θ =
N∑
i=1
cos 2θi
N
, where θi is the
angle between the vector of applied EF and the long axis of a given cell; N is the
total number of cells analyzed. A group of cells aligned perpendicular to the EF
holds an orientation of -1; and a group of cells aligned in parallel to the applied
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Figure B.23: A photo snapshot showing the microscopy setup for the time
lapse cell electrotaxis experiment. The device was placed on top of a transparent
heater on the microscope stage to provide temperature control for cell survival. Con-
tinuous culture medium was pumped through a syringe pump. The direct current for
electrical stimulation was applied and monitored through a source meter. The inset
shows how the devices were fixed on the microscope stage.
EF holds an orientation of +1. For a group of randomly shaped cells, the average
orientation is zero.
All data are represented as the mean ± 95% confidence interval, which is 1.96 of
standard error of mean, from triplicate experiments. Kruskal-Wallis one-way analysis of
variance on ranks tests with Dunn’s multiple comparison post-hoc tests were performed
when non-Gaussian distribution of sample data was indicated from Bartlett’s test. The
confidence level to reject a null hypothesis between two data sets was set at 95%. A
p-value (the probability for a true null hypothesis) less than 0.05 represents a statistical
significance at 95% confidence.
B.4 Results and discussion
B.4.1 Validation of EF uniformity in the chamber
Figure B.25 shows the experimentally measured EFS in the bottom chamber by the
Ag/AgCl wire electrodes. The EFSs were measured between adjacent holes parallel
to the electric current vector. The mean EFS of all measurement is 141.4± 1.3Vm−1
with a CV of 0.92%, suggesting that a highly uniform EF is created in the bottom
chamber. The 46V electric potential created an expected 150Vm−1 EFS in the bot-
tom chamber. The measured mean EFS is about 94.3% of the expected value, which
coincides with the measurement errors reported in previous studies196,258. The CV of
B.4 Results and discussion 211
Figure B.24: Schematic representation of the angle to calculate cell migra-
tion directedness and orientation.
the measured EFSs is comparable to the 1.30% value expected from numerical sim-
ulation (see Table B.1). This value is also comparable to the 2.3% CV of measured
EFS from the largest rectangular electrical stimulation device reported previously196.
Finally, the EFSs along the perpendicular direction to the electric current vector is
measured to be 4.68± 1.90Vm−1, only 3% of that in the parallel direction, confirming
that the EF is highly directional.
Figure B.25: The measured EFS in a layered 3D CAD insert is shown as
the mesh plot and the standard deviations are shown in black error bars.
B.4.2 High performance and high stimulation area percentage
cell EF stimulation
While conventional in vitro electrical stimulation devices either sacrifice the culture
area to stimulate cells uniformly, or stimulate large areas of cells with non-uniform EF,
the polymeric circular insert utilized in this study can provide uniform EF stimulation
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to large area percentage of cells.
The effective stimulation area is defined as the area of the bottom chamber sub-
tracting the area of where the liquid column resides. The effective stimulation area
percentage is the ratio of the effective stimulation area over the total surface area of
the TCPS dish. The effective stimulation area percentages using the polymeric insert
are listed in comparison to those reported in existing literature, see Table B.3. Most
existing devices cannot achieve uniform EF stimulation in more than 50% of the total
cell culture area. Our polymeric inserts can provide uniform EF stimulation in more
than 69% of the total area in a 6-well plate (or a 35 mm dish), and up to 87.5% in a
100 mm petri dish. Thus the cell yields are higher by using polymeric inserts for elec-
trical stimulation. The higher cell yields will greatly benefit subsequent biochemical
and molecular biology analysis.
Table B.3: Stimulation area and effective stimulation area percentage of in
vitro EF stimulation device
Report Substrate
Thickness
(mm)
Stimulation
area (cm2)
Total area
(cm2)
Effective stimulation
area percentage (%)
Song et al.266 100 mm TCPS 0.13-0.16 2.2 55 4.0
Song et al.266 100 mm TCPS 0.13-0.16 22 55 36.0
Tandon et al.707 60 mm Glass 0.25 6.5 21 30.9
Babona-Pilipos et al.297 60 mm TCPS 0.17 2.2 21 10.5
Huang et al.258 150 mm TCPS 0.07 19.2 152 12.6
Tsai et al.196 150 mm TCPS 0.6 69 152 45.4
This work
6-well TCPS;
35 mm TCPS
0.26 6.61 9.4 70.2
6-well TCPS;
35 mm TCPS
0.13 6.83 9.4 72.7
100 mm TCPS 0.26 49 56.7 86.4
100 mm TCPS 0.13 49.6 56.7 87.5
B.4.3 Cell migration and alignment under uniform EF stimu-
lation
NIH/3T3 fibroblast cells were used to verify the performance of the inserts because
they are known to align perpendicular to the EF vector after stimulation and they
have shown cathodal electrotaxis229,708,709. The phase contrast microscopy images of
the cells under 300Vm−1 EF stimulation over 5 hours were taken and analyzed in
Figure B.26.
The directedness and orientation of the cells with and without EF stimulation are
shown in Figure B.27. NIH/3T3 cells demonstrate strong cathodal electrotaxis under
300Vm−1 EF for 5 hours in both rectangular microfluidic chips and in circular inserts
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Figure B.26: The phase contrast microscopy of NIH/3T3 cells after 5 hours
of experiment with the circular 3D CAD insert. (A) NIH/3T3 cells without EF
stimulation; (B) NIH/3T3 cells with 300Vm−1 EF stimulation.
(P < 0.0001, in comparison to their respective controls without EF stimulation) (Fig-
ure B.27A). While the directedness of NIH/3T3 cells in the polymer insert is slightly
lower than that in the rectangular channels (0.78± 0.02 v.s. 0.87± 0.01), there was no
statistical significance between the two (P > 0.05). This deviation is possibly caused by
un-optimized cell culture medium flow rate. While the shear stress in the polymer in-
sert device and the rectangular channel is of the same order, the medium replenishment
takes longer for the circular insert due to its bigger cross-sectional area.
Before EF stimulation, cells in both rectangular channels and circular inserts demon-
strated random orientation (0.05 to 0.09). After 300Vm−1 EF stimulation, the orien-
tation of cells in rectangular channels and circular insert decreased to -0.60±0.05 and
-0.49±0.06, indicating perpendicular alignment (Figure B.27B). The difference of cell
alignment in rectangular channels and circular inserts are significant before and after
the stimulation (P < 0.0001). The control cells in both rectangular channels and the
circular inserts do not show any alignment. These results validated the performance
of the inserts for electrotaxis experiments comparable to the performance of a rect-
angular channel. However, the circular inserts have at least two-fold higher effective
stimulation percentage in comparison to that of rectangular channels, thus more cell
yield can be achieved by using circular 3D CAD inserts.
B.5 Summary and prospects
Establishment of a uniform EF in a circular-shaped microdevice is extremely difficult
so the majority of existing EF stimulation devices avoided this issue by using a simple
rectangular shaped chamber. The rectangular configuration requires modification to fit
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Figure B.27: Quantification of the cell electrotaxis and electro-alignment
measurements. (A) Directedness of cell migration in a rectangular channel and a
layered 3D CAD insert with and without EF stimulation; (B) Cell orientation in a
rectangular channel and a layered 3D CAD insert with and without EF stimulation.
Four asterisks indicate P<.0001 from Dunn’s post-hoc test.
with the commercial labware, and only a small portion of the cell culture dish is used
for cell culture, thus limiting the cell yield. By using a 3D CAD insert in a circular
shaped cell culture chamber, we have demonstrated that a uniform EF can be created
in a circular-shaped area by modulating the electrical resistance across the device. I
highlight the key contributions and outlooks below.
• The effective stimulation area percentage using the insert is at least 2 fold higher
than that of existing EF stimulation devices. The yield of cells and its products
can be increased for further molecular and biochemical analysis.
• The same CAD design principle can be easily scaled up or down to tailor design
inserts for different sized TCPS dishes. Mass production of the polymeric insert
can be achieved by CNC fabrication, injection molding, or other similar technol-
ogy. The polymeric insert is useful for adapting electrical stimulation studies in
a common laboratory due to the high effective stimulation area percentage and
the ease of use.
• The polymeric insert is applicable for various studies. For tissue engineering,
EF stimulation has been reported to induce synchronously contracting cardiac
tissue707,710–713. Osteoblastic differentiation from mesenchymal stem cells can be
promoted under EF stimulation714. Uniform EF stimulation to circular shaped
area could also be useful to stimulate an entire brain slice or tissue slice.
• For future improvement, the workflow can be simplified to bring convenience of
using the device to biologists.
Appendix C
Characterization of common
thermoplastics for microfluidics
C.1 Introduction
Sourcing and adaptation of stable materials for microfluidic prototyping are important
for quality assurance of microfluidic product both in the laboratory and in commercial
application. However, the exact materials adapted in commercial products are often
considered as commercial secrets and not revealed, restricting research and development
of new methods to extensive trial and error processes.
New cell culture substrates products such as µDish® (Ibidi GmbH, Germany) and
Lumox® (25 µm TPX film, Sarstedt GmbH, Germany), have low autofluorescence, and
high gas permeability that are appropriate for culturing sensitive cells such as neurons.
Adaptation of the same substrate in microfluidic chip is required to generate consensus
data compared to that collected on these commercial products.
Fourier-transform infrared (FTIR) spectrometry is an absorbance optical technique
that can be used to fingerprint the molecular bonding of the tested material715. The
C-H bond stretching and bending in an organic material generates large absorbance
in infrared spectra. The chemical bonds absorb infrared energy and vibrate. The ab-
sorbance spectra will also differ depending on other properties such as dipole moment,
making the FTIR spectra unique for different chemicals and mixtures.
C.2 Samples and measurement
A Bruker VERTEX 80v FTIR spectrometer was used to measure the IR spectrum of
several commercially available thermoplastic substrates in order to identify the high
gas permeable substrate used in similar commercial products.
The samples measured include, PDMS, 0.5 mm-thick PMMA (CM205x, Chi-Mei
Corp, Taiwan), µDish (µTreat, Ibidi GmbH, Germany), Lumox (Sarstedt GmbH, Ger-
many), cyclic olefin copolymers (COC) such as 5013C & 5014DP (Mitsui Chemicals
Co, Japan) and 8007s (TOPAS Advanced Polymers GmbH, Germany), cyclic olefin
polymers (COP) substrate (480R, ZEON, Japan), and COP films (100 µm, ZF14 &
ZF16, ZEONOR, ZEON, Japan).
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The samples were cut and fixed on a holder in the optical path and measured in
transmittance mode with reference of air. MIR source with KBr beam splitter and
RT-DlaTGS infrared detector were used. 16 scans at resolution of 4 cm−1 between
400–4000 cm−1 wave number were taken and averaged. The spectra were analyzed
with QPUS software (Bruker, USA).
C.3 Results
The measured FTIR spectra of each materials is shown in Figure C.1. The spectra sug-
gested that the gas permeable materials used in µDish is similar to the COP films from
Zeon. Use of COP film in microfluidic prototyping is suitable to build heterogenous
high-gas permeability microfluidic chips for sensitive cells.
C
.3
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Figure C.1: Fourier-transform infrared spectra of various materials.

Appendix D
List of open-source models for
laboratory applications
This chapter lists the 3D model designs that were used during the course of this thesis
for various research and developments. The design schematics and 3D printable models
can be find here released under
1. 3D printed Nikon Ti-E custom stage
The 3D printed custom stage can mount on a Nikon Ti-E microscope XY motor-
ized stage with a transparent heater. The model was printed using a Connex3
Objet 500 inkjet-based 3D printer (Stratasys, USA) with Veroblack resin. For
connection with ITO glass transparent heater, pogo pins were mounted on holes
tapped with M2.5 threads.
Figure D.1: The 3D printed Nikon Ti-E custom stage with transparent
heater.
2. PDMS casting station for 4” and 2” wafers
A PDMS casting station for making PDMS microfluidic chips with precise thick-
ness was milled by CNC micromill (SLS MicroMill/4, Minitech, USA) with a 6
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mm-diameter flat end mill (NS Tools, Japan) on a piece of poly(tetrafluoroethylene)
block.
Figure D.2: The CNC milled PTFE casting station for PDMS soft lithog-
raphy supporting 2-inch and 4-inch wafer.
3. Washing stand for 24×60 mm cover glasses.
The washing stand for washing thin cover glasses (24×60 mm, Marienfeld Supe-
rior, Germany) was printed by stereolithography in Grey Pro resin on Form2 3D
printer.
4. A PDMS lined copper holder for sturdy microscopy imaging of microfluidic chips
bonded to No. 1.5 coverglasses.
Due to the thinness of No. 1.5 coverglasses, the microfluidic chip can flex and
cause focus drift during high resolution microscopy imaging. A copper holder
was made from wire electrical discharge machining (wire-EDM). A 0.5mm-thick
PDMS sheet was lined on one side of the copper holder with dual energy double
sided tape (No.5302A, Nitto, Japan). The PDMS lining can help to fix the copper
with the cover glass with Van der Waals force to avoid flexure.
5. Custom holder for Tokai hit incubator
221
Figure D.3: The 3D printed washing stand for cover glasses.
Figure D.4: The PDMS lined copper holder. (A) The design layout; (B) The
fabricated copper holder.
The custom holder is made by CNC milling on A5052 aluminum alloy that can
interface with Tokai Hit WKSM CO2 incubator. Two hybrid PMMA/PDMS
chips (Chapter 2.3 & 4) can be assembled on the custom holder in one experiment.
The surface of the custom holder was lined with a Teflon tape (ASF-110, Chukoh,
Japan) to allow easy fixing and delaminating PMMA/PDMS chips with double
sided tape.
6. Resolution testing reticle design
The resolution testing reticle design is developed as a 5-inch chrome mask with
high resolution patterns to test the exposure limit and lithographical parame-
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Figure D.5: The CNCmilled custom holder for Tokai Hit WKSM incubator.
ters in 1:1 exposure system such as a Suss Microtech MA/BA6 mask aligner.
The resolution testing reticle is licensed under a Creative Commons Attribution-
ShareAlike 4.0 international license.
Figure D.6: A resolution testing reticle.
In each section, I laid out the same design containing the following patterns in
both positive and negative format:
(a) 5mm micrometer with 50 µm div (lineweight 5 µm and 10 µm).
(b) 1mm micrometer with 10 µm div (lineweight 3 µm).
(c) Siemens section star (72 sections, 5 degrees per section).
(d) Ronchi ruling of 10, 20, 50, 100, and 200 lp mm−1.
(e) Grid of 50, 100, 150, 200 lp mm−1.
(f) Pin hole resolution dots of diameter of 5, 7.5, 10, 12.5, 15, 20, 25, 50 µm
with spacing of 75, 50, 40, 30, 25, 20, 10, 7.5 µm.
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(g) A USAF 1951 target from group 1 to group 8.
(h) A group of different line weight, 1, 2,3, 5, 7.5, 10, 15, 20, 25, 37.5, 50, 75,
100, 125, 150, 175, 200.
(i) 50 µm line weight with different spacing from 1, 3, 5, 7.5, 10, 12.5, 25, 37.5,
50, 75, 100, 150, 200, 250 µm.
7. A blocking shield for resolution testing with resolution testing reticle on MA/BA6
mask aligner
A blocking shield to use in combined with resolution testing reticle was 3D printed
with poly(lactic acid) resin with Ultimaker 3 (Ultimaker, USA). The blocking
shield is composed of a holder and a wheel. Each section can be exposed with
different parameters to rapidly optimize lithography parameters for microfabri-
cation.
Figure D.7: A blocking shield for resolution testing on MA/BA6 mask
aligner.
8. 10 cm glass wafer washing stand
The 10 cm glass wafer washing stand is 3D printed by fused deposition modeling
with autoclavable filament (Nylon680, Taulman 3D, USA).
9. A universal chip holder with transparent heater for confocal scanning
A universal chip holder that can hold a microfluidic chip in place for confocal
scanning is 3D printed with Connex3 Objet 500 (Stratasys, USA).
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Figure D.8: The 3D printed washing stand for 1 cm glass wafers.
Figure D.9: The 3D printed confocal holder for imaging with a transparent
heater.
Appendix E
List of source code of software
generated in this thesis
The source code of software used in part of this thesis is deposited on the open-source
repository on Github.
1. Usiigaci
2. Data preparation for OpenQCM
3. Cell segmentation by fully convolutional DenseNet
4. Phase contrast channel-only segmentation by Deepcell architecture
5. Automatic categorization script for images exported from NIS element
6. Python-Arduino temperature controller
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